
<html lang="en"     class="pb-page"  data-request-id="853bb438-0509-4a1f-8be4-95e80b555b6d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501833t;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2015.58.issue-6;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design" /></meta><meta name="dc.Creator" content="Christopher R.  Butler" /></meta><meta name="dc.Creator" content="Michael A.  Brodney" /></meta><meta name="dc.Creator" content="Elizabeth M.  Beck" /></meta><meta name="dc.Creator" content="Gabriela  Barreiro" /></meta><meta name="dc.Creator" content="Charles E.  Nolan" /></meta><meta name="dc.Creator" content="Feng  Pan" /></meta><meta name="dc.Creator" content="Felix  Vajdos" /></meta><meta name="dc.Creator" content="Kevin  Parris" /></meta><meta name="dc.Creator" content="Alison H.  Varghese" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Ricardo  Lira" /></meta><meta name="dc.Creator" content="Shawn D.  Doran" /></meta><meta name="dc.Creator" content="David R.  Riddell" /></meta><meta name="dc.Creator" content="Leanne M.  Buzon" /></meta><meta name="dc.Creator" content="Jason K.  Dutra" /></meta><meta name="dc.Creator" content="Luis A.  Martinez-Alsina" /></meta><meta name="dc.Creator" content="Kevin  Ogilvie" /></meta><meta name="dc.Creator" content="John C.  Murray" /></meta><meta name="dc.Creator" content="Joseph M.  Young" /></meta><meta name="dc.Creator" content="Kevin  Atchison" /></meta><meta name="dc.Creator" content="Ashley  Robshaw" /></meta><meta name="dc.Creator" content="Cathleen  Gonzales" /></meta><meta name="dc.Creator" content="Jinlong  Wang" /></meta><meta name="dc.Creator" content="Yong  Zhang" /></meta><meta name="dc.Creator" content="Brian T.  O’Neill" /></meta><meta name="dc.Description" content="The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) has historically been thwarted by an inability to maintain alignment of pote..." /></meta><meta name="Description" content="The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) has historically been thwarted by an inability to maintain alignment of pote..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 9, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501833t" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501833t" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501833t" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501833t" /></link>
        
    
    

<title>Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501833t" /></meta><meta property="og:title" content="Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0017.jpeg" /></meta><meta property="og:description" content="The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metabolism, and excretion (ADME) properties. In this paper, we describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or negatively impacting brain penetration and ADME alignment, as exemplified by 36. Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog. In addition, chronic treatment in aged PS1/APP mice effects a decrease in the number and size of Aβ-derived plaques. Most importantly, evaluation of 36 in a 2-week exploratory toxicology study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histology findings in the eye, issues observed with earlier BACE1 inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501833t"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501833t">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501833t&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501833t&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501833t&amp;href=/doi/10.1021/jm501833t" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2678-2702</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501601b" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501889t" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Butler">Christopher R. Butler</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Brodney">Michael A. Brodney</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+M.++Beck">Elizabeth M. Beck</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gabriela++Barreiro">Gabriela Barreiro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+E.++Nolan">Charles E. Nolan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Feng++Pan">Feng Pan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Felix++Vajdos">Felix Vajdos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Parris">Kevin Parris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alison+H.++Varghese">Alison H. Varghese</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ricardo++Lira">Ricardo Lira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn+D.++Doran">Shawn D. Doran</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Riddell">David R. Riddell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leanne+M.++Buzon">Leanne M. Buzon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason+K.++Dutra">Jason K. Dutra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Luis+A.++Martinez-Alsina">Luis A. Martinez-Alsina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Ogilvie">Kevin Ogilvie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Murray">John C. Murray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+M.++Young">Joseph M. Young</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin++Atchison">Kevin Atchison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ashley++Robshaw">Ashley Robshaw</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cathleen++Gonzales">Cathleen Gonzales</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinlong++Wang">Jinlong Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Zhang">Yong Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+T.++O%E2%80%99Neill">Brian T. O’Neill</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Neuroscience Worldwide Medicinal Chemistry and <sup>‡</sup>Neuroscience Research Unit, Pfizer Worldwide Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span></div><div class="aff-info" id="aff2"><span class="aff-text"><sup>§</sup>Neuroscience Worldwide Medicinal Chemistry, <sup>∥</sup>Center of Chemistry Innovation and Excellence, and <sup>⊥</sup>Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">#</span> <span class="aff-text">Departamento de Inovação, Eurofarma Laboratorios S.A., Avenida Vereador José Diniz, 3465, Campo Belo, São Paulo, Brasil</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∇</span> <span class="aff-text">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div><div class="corresp-info"><strong>*</strong>Phone: 617 395 0670. E-mail: <a href="/cdn-cgi/l/email-protection#3e5d564c574d4a514e565b4c104c105c4b4a525b4c7e4e5857445b4c105d5153"><span class="__cf_email__" data-cfemail="b6d5dec4dfc5c2d9c6ded3c498c498d4c3c2dad3c4f6c6d0dfccd3c498d5d9db">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501833t&amp;href=/doi/10.1021%2Fjm501833t" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2678–2702</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 19, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 November 2014</li><li><span class="item_label"><b>Published</b> online</span>9 March 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 March 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501833t" title="DOI URL">https://doi.org/10.1021/jm501833t</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2678%26pageCount%3D25%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BR.%2BButler%252C%2BMichael%2BA.%2BBrodney%252C%2BElizabeth%2BM.%2BBeck%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D6%26contentID%3Djm501833t%26title%3DDiscovery%2Bof%2Ba%2BSeries%2Bof%2BEfficient%252C%2BCentrally%2BEfficacious%2BBACE1%2BInhibitors%2Bthrough%2BStructure-Based%2BDrug%2BDesign%26numPages%3D25%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2702%26publicationDate%3DMarch%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501833t"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3653</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">36</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501833t" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Butler&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Brodney&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;M. Beck&quot;},{&quot;first_name&quot;:&quot;Gabriela&quot;,&quot;last_name&quot;:&quot;Barreiro&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;E. Nolan&quot;},{&quot;first_name&quot;:&quot;Feng&quot;,&quot;last_name&quot;:&quot;Pan&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Vajdos&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Parris&quot;},{&quot;first_name&quot;:&quot;Alison&quot;,&quot;last_name&quot;:&quot;H. Varghese&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Ricardo&quot;,&quot;last_name&quot;:&quot;Lira&quot;},{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;D. Doran&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Riddell&quot;},{&quot;first_name&quot;:&quot;Leanne&quot;,&quot;last_name&quot;:&quot;M. Buzon&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;K. Dutra&quot;},{&quot;first_name&quot;:&quot;Luis&quot;,&quot;last_name&quot;:&quot;A. Martinez-Alsina&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Ogilvie&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Murray&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;M. Young&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;Atchison&quot;},{&quot;first_name&quot;:&quot;Ashley&quot;,&quot;last_name&quot;:&quot;Robshaw&quot;},{&quot;first_name&quot;:&quot;Cathleen&quot;,&quot;last_name&quot;:&quot;Gonzales&quot;},{&quot;first_name&quot;:&quot;Jinlong&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;T. O’Neill&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;2678-2702&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501833t&quot;},&quot;abstract&quot;:&quot;The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metabolism, and excretion (ADME) properties. In this paper, we describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or negatively impacting brain penetration and ADME alignment, as exemplified by 36. Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog. In addition, chronic treatment in aged PS1/APP mice effects a decrease in the number and size of Aβ-derived plaques. Most importantly, evaluation of 36 in a 2-week exploratory toxicology study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histo&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501833t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501833t" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501833t&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501833t" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501833t&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501833t" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501833t&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501833t&amp;href=/doi/10.1021/jm501833t" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501833t" /></input><a href="/doi/pdf/10.1021/jm501833t" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26pmid%3D25695670%26genre%3Darticle%26aulast%3DButler%26date%3D2015%26atitle%3DDiscovery%2Bof%2Ba%2BSeries%2Bof%2BEfficient%252C%2BCentrally%2BEfficacious%2BBACE1%2BInhibitors%2Bthrough%2BStructure-Based%2BDrug%2BDesign%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D6%26spage%3D2678%26epage%3D2702%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jmcmar.2015.58.issue-6/20150326/jmcmar.2015.58.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer’s disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metabolism, and excretion (ADME) properties. In this paper, we describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or negatively impacting brain penetration and ADME alignment, as exemplified by <b>36</b>. Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog. In addition, chronic treatment in aged PS1/APP mice effects a decrease in the number and size of Aβ-derived plaques. Most importantly, evaluation of <b>36</b> in a 2-week exploratory toxicology study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histology findings in the eye, issues observed with earlier BACE1 inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a devastating neurological disorder that brings about a slow progression of cognitive decline, dementia, and ultimately death. Amyloid β (Aβ)-derived plaques in the hippocampal and cortical regions of the brain are hallmarks of this disease. The amyloid hypothesis suggests that an increase in Aβ, engendered either through its increased production or decreased clearance, initiates a molecular cascade that eventually leads to neurodegeneration and AD.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Aβ production occurs by the consecutive degradation of amyloid precursor protein (APP) by β- and γ-secretases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The initial proteolytic event occurs via β-site APP cleaving enzyme (BACE1) within the endosome, to afford a soluble N-terminal ectodomain of APP (sAPPβ) and the C-terminal fragment C99.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The membrane-bound C99 is subsequently cleaved by γ-secretase to release the Aβ isoforms, including Aβx-40 and Aβx-42.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Recently, an APP mutation has been reported that has been shown to have protective effects against AD; this mutant protein is cleaved more slowly by BACE1.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The ability to safely, but effectively, inhibit BACE1 (and thus modulate the Aβ cascade) has therefore been a target of great interest for a number of groups over the last 2 decades.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><div class="NLM_p">One of the consistent challenges in the effective inhibition of BACE1 in vivo has been overcoming significantly impaired CNS penetration.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> There has been a myriad of inhibitor classes that exhibit excellent BACE1 potency but struggle to achieve in vivo efficacy at clinically viable doses because they fail to adequately cross the blood–brain barrier (BBB). A key factor underlying this common problem is that the strategy that has been employed to engage the two aspartates in the catalytic site of BACE1 has generally been to design inhibitors that contain a basic amine, which engages these residues either directly or through a water-mediated hydrogen bond interaction.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9, 10)</a> This amine can be deleterious to brain penetration, as it often contains two hydrogen bond donors, and its impact can be further exacerbated by a basic p<i>K</i><sub>a</sub>, as both of these characteristics contribute to recognition by P-glycoprotein (P-gp) efflux transporters.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In this light, the recent report of compound <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) advancing to the clinic as an efficacious BACE1 inhibitor with a well-balanced absorption, distribution, metabolism, and excretion (ADME) profile is quite notable.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Unfortunately, clinical examination of <b>1</b> has been discontinued due to retinal toxicity observed in preclinical species.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> We and others postulated that such ocular toxicity was potentially due to the off-target inhibition of cathepsin D (CatD), a related aspartyl protease that has significant regulatory function in the eye.<a onclick="showRef(event, 'ref13 cit13b'); return false;" href="javascript:void(0);" class="ref ref13 cit13b">(13, 13b)</a> In its initial disclosure, <b>1</b> was described to have ∼100 times selectivity between BACE1 and CatD inhibition (250 nM and 25 μM IC<sub>50</sub>, respectively).<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In similarly run cell-free fluorescence polarization (FP) assays for BACE1 and CatD, however, <b>1</b> exhibited only a 6-fold selectivity for BACE1 over CatD (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><div class="NLM_p">In contrast, there is a plethora of BACE inhibitors reported to have significant CatD selectivity, including thioamidine <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This class of inhibitors is characterized by the presence of an amide moiety that occupies the S1/S3 pockets of BACE1 and engages Gly-230 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a), which has been a successful strategy to significantly increase BACE1 potency and improve selectivity over CatD. However, this structural motif imparts a significant P-gp mediated efflux liability [MDR efflux ratio (MDR) = 5.3], presumably due to the third hydrogen bond donor and increased molecular weight (320 → 369) of <b>2</b>. This efflux liability translates to the substantially impaired brain penetration observed in rodents (<i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub> = 0.07).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Such impairment requires a significantly increased body burden of inhibitor in order to achieve the same degree of central efficacy, resulting in lower safety therapeutic indices relative to an equivalent inhibitor with good CNS penetration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0013.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature thioamidine-derived BACE1 inhibitors and properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Thus, our objective herein was to efficiently improve CatD selectivity without simultaneously impacting CNS penetration. We have adopted a reductionist approach to this challenge, truncating back to a minimally required pharmacophore within this series and evaluating opportunities to improve selectivity using structure-based drug design. It was recognized that paring back in this fragment-like approach would generate a significant loss in BACE1 potency that would need to be addressed. Although this strategy allows for selective reconstruction in an efficient manner, it requires a committed investment to build inhibitors back into reasonable potency space without disruption of the balanced ADME properties. This approach is particularly attractive when considering the observed interplay between molecular weight (MW), p<i>K</i><sub>a</sub>, the number of hydrogen bond donors (HBDs), and their coordinated impact on P-gp mediated efflux liabilities.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> As the thioamidine inherently contains two hydrogen bond donors, diligence in design is required throughout to introduce additional molecular weight only where necessary, at the same time remaining cognizant of any impact on p<i>K</i><sub>a</sub>, in order to mitigate efflux concerns.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We initiated our design strategy by truncating the pyrimidine of <b>1</b> that occupies the S3 pocket to prepare fragment-like <b>6</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> the synthesis of which can be quickly accomplished via simple acid-catalyzed cyclization of intermediate <b>5</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-bromobut-3-en-1-yl 4-methylbenzenesulfonate, (Ph<sub>3</sub>P)<sub>4</sub>Pd, CsF, THF, 70 °C, 90%. (b) Thiourea, CH<sub>3</sub>CN, 75 °C, 83%; (c) 6 N HCl, 95 °C, 17%, then chiral separation.</p></p></figure><div class="NLM_p">As expected, <b>6</b> is only weakly potent at BACE1 (IC<sub>50</sub> = 36 μM) and has no measurable activity at CatD (up to 100 μM). A cocrystal structure of <b>6</b> bound to BACE1 was obtained and the binding of <b>6</b> to CatD was modeled, in an effort to identify opportunities to impart selectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The BACE1 structure reveals that the amidine group engages in hydrogen bonds with the catalytic aspartic acid residues 228 and 32, with the difluorophenyl ring occupying the S1 pocket. Analyses of the BACE1 crystal structure and CatD-bound model of <b>6</b> afford three potential points of differentiation that could be exploited to gain selectivity (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a). First, an Arg–Asp salt bridge is present in CatD in the S3 pocket, but absent in BACE1 (region I). Thus, molecules that fit deeply into the S3 pocket are likely to disrupt the salt bridge, explaining the selectivity of molecules similar to <b>2</b>. Second, the fold of the Phe-108 loop of BACE1 is significantly different from the corresponding region of CatD (region II). In particular, the residues that correspond to Phe-108 and Phe-109 of BACE1 are Ile and Thr, respectively, in CatD. More importantly, the residue that would correspond to the backbone carbonyl acceptor Phe-108 in BACE1 does not present its carbonyl to the S1 pocket in CatD. This is consistent with the structure and activity relationship of previous spiropiperidine series, where engagement with the Phe-108 backbone carbonyl significantly improved selectivity over CatD.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Third, although the flap loop conformation represented by BACE1 Tyr-71 and Trp-76 is similar to that in CatD, the substitution of Trp-76 by Leu (CatD) in the flap loop prevents hydrogen bond formation to Tyr-78 (by Trp). Instead, Tyr-78 engages Trp-40, which is not within the flap loop, likely rigidifying this region in CatD (region III). Thus, it was anticipated that building toward the flap in BACE1 would be better tolerated than the corresponding perturbation to the CatD flap region. This analysis suggested three subtle, but key, structural differences that could potentially be exploited to design in selectivity over CatD.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0014.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray crystal structure of <b>6</b> with BACE1 (green ball and stick/light blue ribbon) with a model of <b>6</b> in cathepsin D (orange ball and stick/yellow ribbon). Residues in the areas of interest are labeled with BACE1 residue names and numbers (light blue) following by the corresponding CatD residue names (yellow). (b) Potential regions to exploit for BACE1 vs cathepsin D selectivity. (c) Strategic construction to explore S2′.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Investigation of each of these key regions of differentiation delineated three potential strategies (regions I–III, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b) for series progression. In an effort to rank the efficiency of these strategies, the distances between the center of <b>6</b> to the corresponding key residues for each of the regions outlined above that are expected to impart selectivity were measured (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b). Of these, the S2′ pocket (region III) clearly provides the closest opportunity, suggesting that filling this pocket would be preferred from an “efficient selectivity” perspective. In contrast, disruption of the S3 salt bridge (region I) would require a substantial molecular weight increase; additionally, the most efficient method in the literature for building in this direction introduced the aforementioned third HBD, significantly increasing the risk of impaired brain penetration. Building toward region II can be deprioritized as well, given that optimal interactions with the Phe-108 carbonyl would also require a third HBD. Thus, the strategy of building efficiently toward the S2′ pocket was selected as our preferred approach to enhance selectivity for BACE1 over CatD.</div><div class="NLM_p">The crystal structure of <b>6</b> and BACE1 suggested that access to the S2′ pocket could be achieved by building from the C-5 position of the thioamidine ring in <b>I</b>, as outlined in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c. A methoxymethyl group in this position was initially selected to target the desired region without a dramatic increase in lipophilicity. We chose a strategy that could broaden the potential range of the SAR and simplify the initial synthesis. We used Ellman imine technology to control the absolute stereochemistry of the quaternary carbon at pro-C-4 but left the eventual C-5 substituent stereochemistry unrestrained, providing both diastereomers in the P2′ region.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We expected that separation would be straightforward at a late stage in the synthesis and a more selective synthesis was not necessary at this point. The key late steps of the synthesis are depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Thioamidine ring formation stemmed from the differentially protected propanediol <b>7</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) equipped with a (<i>S</i>)-2-methylpropane-2-sulfinimine functionality. Lewis acid-mediated addition of lithio-5-bromo-2,4-difluorophenyl anion provided <b>8</b> with the (<i>S</i>)-configuration at pro-C4 and as a 1:1 mixture of diastereomers at pro-C-5. Concomitant hydrolysis of the sulfinamide and removal of the silyl protecting group revealed the amino alcohol <b>9</b> as a mixture of optically active diastereomers, which was easily acylated by benzoyl isothiocyanate. The thiourea <b>10</b> was cyclized to the thioamidine <b>11</b> as a 1:1 mixture at C-5 by selective activation of the alcohol with triflic anhydride at −20 °C. The protecting group was exchanged for <i>t</i>-BOC and the diastereomers <b>13a</b> and <b>13b</b> were chromatographically separated at this point. Incorporation of the versatile bromide offered a viable route to SAR extension. For our initial two targets, the bromide was removed through halogen–metal exchange and protonation, followed by acidic removal of the BOC group. The sequence provides compounds <b>14a</b> and <b>14b</b> in a 1:3 ratio.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,5-dibromo-2,4-difluorobenzene, <i>n</i>-BuLi, AlMe<sub>3</sub>, −70 °C, tol. (b) HCl in dioxane, rt. (c) PhC(O)NCS, THF, rt. (d) Tf<sub>2</sub>O, pyridine, −20 °C, CH<sub>2</sub>Cl<sub>2</sub>. (e) DBU, MeOH, 80 °C. (f) <i>t</i>-BOC<sub>2</sub>O, aq NaHCO<sub>3</sub>–THF, rt, then chromatography. (g) <b>13a</b> and <b>13b</b> separately: <i>n</i>-BuLi, −78 °C, THF then TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, analog <b>14a</b>, which has a trans-relationship between the methoxymethyl and difluorophenyl substituents, maintains some potency in both the FP and whole-cell (WCA) BACE1 assays but remains inactive at CatD and thus indicates a productive direction for further exploration. The diminished activity observed for <b>14b</b> reinforces the relevance of stereochemistry in this series. Although clearly some benefit accrued from growing in this direction, the multiple degrees of freedom retained by the simple methoxy substituent in <b>14a</b> may be problematic. First, this relatively small substituent lacks sufficient bulk to enforce a ring conformation placing the aryl group in the crucial axial position, which is required for binding. It was supposed that a significant population exists in the inactive ring conformation, leading to the observed suboptimal potency. Second, the methoxymethyl group itself has no conformational bias to orient specifically toward S2′, again limiting the population of the most active conformation</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Data for <b>14a</b>/<b>14b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE1 FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CatD FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a> (fold)</th><th class="colsep0 rowsep0" align="center">BACE1 WCA IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">MDR Er<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">LipE</th><th class="colsep0 rowsep0" align="center">LE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14a</b></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">>100 (5.5×)</td><td class="colsep0 rowsep0" align="left">850</td><td class="colsep0 rowsep0" align="left">1.95</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">3.8</td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">88</td><td class="colsep0 rowsep0" align="left">>100</td><td class="colsep0 rowsep0" align="left">3940</td><td class="colsep0 rowsep0" align="left">1.71</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">2.7</td><td class="colsep0 rowsep0" align="left">0.30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 FP assay.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values obtained from the CatD FP assay.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 whole-cell assay (WCA).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Hepatic clearance predicted from an in vitro human microsomal stability study.</p></div></div></div><div class="NLM_p">It was envisaged that the two conformational challenges identified above could be overcome by fashioning the two alkyl substituents into a THF or THP ring, as fused bicyclic variants of thioamidine <b>6</b> (<b>II</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This would necessarily lock the aryl group into an axial orientation with respect to the thioamidine ring and provide a template for further precise elaboration toward S2′ from the newly constructed ring; this was anticipated to exploit the flap differences outlined above. We settled on a synthetic strategy that would accommodate an examination of ring size, as well as facile control of multiple C sp<sup>3</sup> stereocenters, in order to further probe the S2′ regions of the protein. An approach that performed well for this class of inhibitor involved early ring construction via an intramolecular [3 + 2] cycloaddition to form a [3.3.0] or [4.3.0] fused ring system whose constraints enforce stereocontrol along the ring fusion (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). In these early cases, we also decided to use chiral chromatography to separate enantiomers for testing in biological screens. Introduction of the aryl function occurs predominantly on the convex face, with excellent stereocontrol; this was followed by ring expansion to the thioamidine. In the forward sense, allylic or homoallylic alcohols are elaborated to the oxime <b>18a,b</b>, one of several possible precursors to a nitrile oxide. Nitrile oxide cycloaddition occurs in a straightforward fashion for either the fused tetrahydrofuran or tetrahydropyran ring, with a small amount of accompanying nitrile oxide dimer or intermolecular isoxazoline formation. Subsequent addition of the (2,4-difluoro)phenyl anion was very sensitive to the conditions employed: at a minimum, the process required imine activation with BF<sub>3</sub>–OEt<sub>2</sub> and low temperature to avoid benzyne formation from the (2,4-difluoro)phenyl anion. We also noticed that variable quantities of unreacted isoxazoline often remained following the addition, presumably due to deprotonation of the isoxazoline ring. The optimal conditions involved formation of the anion at −78 °C, followed by dropwise addition of BF<sub>3</sub>–OEt<sub>2</sub> and the isoxazoline while the reaction temperature was maintained below −73 °C. As expected, these reactions were highly stereoselective for the cis-ring fusion, with no detectable formation of the trans-isomer. The thioamidine ring formation was initiated after reductive cleavage of the N–O bond of <b>20a,b</b> with zinc metal and acylation with a suitable isothiocyanate. The resulting thiourea <b>22a,b</b> could be cyclized to the thioamidine by the novel use of the Ghosez reagent,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> which selectively activated the primary alcohol, or by treatment with aqueous acid, with loss of water. The FMOC or benzoyl protecting groups were removed by standard methods to afford the target compounds <b>24a</b> and <b>24b</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i> = 1:<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> HOCH<sub>2</sub>CH<sub>2</sub>OH, KOH, THF, 60 °C; <i>n</i> = 2, BrCH<sub>2</sub>CH(OEt)<sub>2</sub>, NaH, THF, 0 °C then 68 °C. (b) <i>n</i> = 1: (COCl)<sub>2</sub>, DMSO, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C. <i>n</i> = 2: aq HCl, THF, 70 °C. (c) <i>n</i> = 1, 2: NH<sub>2</sub>OH–HCl, NaOAc, EtOH–H<sub>2</sub>O, 60 °C. (d) <i>n</i> = 1, 2: NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt. <i>n</i> = 2: then chiral HPLC. (e) <i>n</i> = 1, 2: <i>n</i>-BuLi, 1-bromo-2,4-difluorobenzene, THF–tol 1:3, −78 °C then BF<sub>3</sub>–OEt<sub>2</sub>, <b>19a,b</b>, toluene, −78 °C to rt. (f) <i>n</i> = 1, 2: Zn, AcOH, rt. (g) <i>n</i> = 1: BzNCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. <i>n</i> = 2: FMOC-isothiocyanate, CH<sub>2</sub>Cl<sub>2</sub>, rt. (h) <i>n</i> = 1: Ghosez reagent, tol, 70 °C. <i>n</i> = 2: concd HCl (aq), MeOH, 70 °C. (i) <i>n</i> = 1: DBU, MeOH, 60 °C, then chiral HPLC. <i>n</i> = 2: MeCN, piperidine, rt.</p></p></figure><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, these compounds indeed show improved selectivity over CatD. The tetrahydrofuran derivative <b>24a</b> exhibits only modest improvements in BACE1 potency to 17.2 μM, whereas the pyran-containing <b>24b</b> is >20× selective for BACE1 over CatD, driven by a significant increase in BACE potency. Moreover, <b>24b</b> exhibits a lipophilic efficiency (LipE) improvement over <b>14a</b>, suggesting that building in this direction is indeed a productive direction, rather than a simple improvement in potency due to increased lipophilicity. A modest increase in ligand efficiency hinted that the substituent may partially be influencing the population of active conformations for <b>24b</b>, relative to the unsubstituted <b>14a</b>. Additionally, the compounds maintain preferred ADME properties (MDR Er < 2.5, HLM <10), reaffirming our strategy and providing an excellent starting point for further functionalization.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Data for <b>24a/24b</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">BACE1 FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CatD FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (fold)</th><th class="colsep0 rowsep0" align="center">BACE1 WCA IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">MDR Er<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">LipE</th><th class="colsep0 rowsep0" align="center">LE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24a</b></td><td class="colsep0 rowsep0" align="left">17.2</td><td class="colsep0 rowsep0" align="left">>100 (>7×)</td><td class="colsep0 rowsep0" align="left">375</td><td class="colsep0 rowsep0" align="left">1.48</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="left">5.8</td><td class="colsep0 rowsep0" align="left">>100 (>20×)</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">1.23</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">0.38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 FP assay.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values obtained from the CatD FP assay.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 whole-cell assay (WCA).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Hepatic clearance predicted from an in vitro human microsomal stability study.</p></div></div></div><div class="NLM_p">An X-ray crystal structure of <b>24b</b> bound in the BACE1 active site reveals a significant difference compared to what had been observed previously with <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In this structure, Tyr-71 has rotated, forced into a lower energy conformation by the addition of the fused ring system. The hydrogen bond that had existed between Tyr-71 and Trp-76 is now replaced by a water-mediated hydrogen bond from Trp-76 to the THP oxygen (the red water, Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In addition, this significant conformational change reveals a pocket adjacent to the space occupied by the THP ring. Analysis using HydroSite<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> suggests that there is a high-energy, unstable water exposed in this pocket (the cyan water). It was proposed that the introduction of small alkyl substituents into this lipophilic pocket should displace this calculated water, likely enhancing BACE1 potency.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal of <b>24b</b> (magenta) in BACE1 in comparison with <b>6</b> (green). Tyr-71 has rotated to a different rotameric conformation, to accommodate the THP ring. A crystallographically observed water is making a hydrogen bond to the oxygen of the THP. A computationally predicted “unstable” water molecule is shown in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To direct substituents from the fused THP system into the S2′ pocket, our synthetic strategy targeted the creation of versatile nonracemic homoallylic alcohols that would ultimately set the remaining stereocenters in the molecule and provide a handle for late-stage modification. This strategy, in combination with the [3 + 2] cycloaddition approach described above, resulted in the synthesis of chiral, late-stage intermediates required for analog generation in a stereoselective manner (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). To prepare the initial analogs, addition of nucleophiles to chiral epoxides or aldehydes was first explored. The first and most versatile R substituent was derived from (<i>R</i>)-(−)-glycidyl benzyl ether. Copper-catalyzed addition of vinylmagnesium bromide afforded the desired (<i>R</i>)-homoallylic alcohol <b>25a</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) bearing the versatile hydroxymethyl substituent in a protected form.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Alternatively, when desired substituents could not be generated late in the synthetic sequence, these groups were introduced, beginning with aldehydes. In the case where R is cyclopropyl, we found that addition of allylmagnesium bromide to cyclopropyl carboxaldehyde was the most efficient approach to this homoallylic substrate, albeit initially in racemic form (<b>25b</b>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Retrosynthetic Analysis for Analog Generation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The alcohol was elaborated as previously described to afford the oxime intermediate <b>28a,b</b> as a direct precursor to a nitrile oxide. Subsequent [3 + 2] cycloaddition was controlled by establishment of an equatorial R group and proceeded with excellent diastereoselectivity to afford an intermediate in which the benzyloxymethyl group (or cyclopropyl) of <b>29a,b</b> was trans to the ring junction of the newly formed fused isoxazoline ring system (confirmed by 2D NMR; see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for details). Introduction of the final chiral center through Lewis acid-catalyzed anion addition occurred with complete selectivity to form a cis ring junction in modest to good yields. Thioamidine ring formation was initiated by N–O bond reduction of <b>30a,b</b> using zinc in acetic acid to afford <b>31a,b</b>. Thiourea formation by reaction with a suitable isothiocyanate was straightforward and was followed by thioamidine cyclization. Two complementary methods were used for this purpose. The free alcohol of thiourea <b>32a</b> and the cyclopropyl THP <b>32b</b> were each activated with triflic anhydride at −60 °C, followed by spontaneous thioamidine cyclization to <b>33a,b</b>. Alternatively, <b>32a</b>′ was transformed with aqueous acid in methanol at elevated temperature to afford the thioamidine <b>33a</b>′. Following routine final transformations, this versatile route afforded thioamidines <b>34</b>, <b>35</b>, and <b>35</b>′ equipped with three chiral centers and versatile protecting groups to accommodate later transformation in the sequence.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0010.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R = CH<sub>2</sub>OBn: vinylMgBr, CuI–Et<sub>2</sub>O, THF −78 °C to rt. R = c-C<sub>3</sub>H<sub>5</sub>: ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>. (b) BrCH<sub>2</sub>CH(OEt)<sub>2</sub>, NaH, THF, 0 °C then 68 °C. (c) aq HCl, THF, 40–70 °C. (d) NH<sub>2</sub>OH–HCl, NaOAc, EtOH–H<sub>2</sub>O, 60 °C. (e) aq NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt. (f) BF<sub>3</sub>–OEt<sub>2</sub>, IPE–tol 1:1, or tol, −78 °C, then 1-bromo-2,4-difluorobenzene, <i>n</i>-BuLi, −78 °C to rt. (g) Zn, AcOH, rt. (h) R = CH<sub>2</sub>OBn: FMOC-NCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. Alternatively, R = CH<sub>2</sub>OBn: Bz-NCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. R = c-C<sub>3</sub>H<sub>5</sub>: BzNCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. (i) P = FMOC, R = CH<sub>2</sub>OBn: concd HCl, aq, MeOH, 70 °C. P = Bz, R = CH<sub>2</sub>OBn: Tf<sub>2</sub>O, pyr, CH<sub>2</sub>Cl<sub>2</sub>, −60 °C. R = c-C<sub>3</sub>H<sub>5</sub>: Tf<sub>2</sub>O, pyr, CH<sub>2</sub>Cl<sub>2</sub>, −50 °C. (j) R = c-C<sub>3</sub>H<sub>5</sub>: DBU, MeOH, 60 °C, then chiral HPLC. (k) P = FMOC, R = CH<sub>2</sub>OBn: concd HCl, 120 °C followed by piperidine, DMF, rt then <i>t</i>-BOC)<sub>2</sub>O, Et<sub>3</sub>N, THF/MeOH, rt. P = Bz, R = CH<sub>2</sub>OBn: NaBrO<sub>3</sub>, EtOAc–H<sub>2</sub>O, 0 °C.</p></p></figure><div class="NLM_p">The versatile intermediate <b>35</b> was transformed into a variety of substituents aimed at exploring the S2′ binding pocket. The alcohol group was immediately converted to the fluoride (<b>36</b>) using (diethylamino)sulfur trifluoride (DAST) or to the methoxy group with methyl iodide (<b>43</b>) (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>); alternatively, the alcohol can be deoxygenated in two steps via chloride formation followed by Superhydride reduction (<b>42</b>). Alcohol <b>35</b> can be reliably transformed into the aldehyde, which becomes a precursor for alkyl substituents via a Wittig reaction followed by hydrogenation (<b>39</b>, <b>40</b>). The stereochemistry of <b>39</b> was confirmed through 2-D NMR studies, and the configuration of the three chiral centers of <b>36</b> was confirmed by single crystal X-ray analysis (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The aldehyde also underwent difluorination with DAST to provide <b>38</b>.</div><figure id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) P = <i>t</i>-BOC: DAST, pentane–CH<sub>2</sub>Cl<sub>2</sub> 1:1, rt, 51%, then TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 74%. (b) P = Bz: MeI, NaH, THF, 40 °C, 69% then DBU, MeOH, 70 °C, 72%. (c) P = Bz: SO<sub>3</sub>–Pyr, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 71%. (d) DAST, CH<sub>2</sub>Cl<sub>2</sub>, −20 °C, 58%, then DBU, MeOH, 60 °C, 96%. (e) Ph<sub>3</sub>P<sup>+</sup>Me Br<sup>–</sup>, <i>t</i>-BuOK, THF, −15 °C to rt, 82% then H<sub>2</sub>, Pd/C, MeOH, rt, 100%, then DBU, MeOH, 80°, 58%. (f) SOCl<sub>2</sub>, tol, 80 °C, 90%. (g) LiEt<sub>3</sub>BH, THF, 0 °C, 81%, then DBU, MeOH, 80 °C, 81%. (h) Ph<sub>3</sub>P<sup>+</sup><i>i</i>-Pr Br<sup>–</sup>, <i>n</i>-BuLi, THF, 0 °C to rt, 38% then H<sub>2</sub>, Pd/C, MeOH, rt, 26%, then DBU, MeOH, 60 °C, 52%.</p></p></figure><div class="NLM_p">In all cases, the effect of small substituents on the THP ring improves the desired selectivity over CatD by significantly enhancing BACE1 potency, relative to <b>24b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The introduction of even a simple methyl group (<b>42</b>) improves BACE1 potency 7-fold in both the FP and WCA assays. In addition, <b>42</b> maintains the excellent balance of ADME properties, with low clearance, good permeability, and no predicted P-gp efflux. Increasing the bulk of the alkyl group further improves potency in most cases, but begins to impact the balanced profile of these compounds. The methyl ether (<b>43</b>) introduces a new site of metabolism, as evidenced by a significant increase in HLM despite a decrease in log <i>D</i>, relative to the ethyl derivative <b>39</b> (HLM Cl<sub>,int,app</sub> 67 vs <8). Larger alkyl substituents (<b>40</b>) tend to improve potency, but a trend of increasing P-gp efflux suggests a potential to encounter lower brain availability in this direction. The cyclopropyl-substituted analog (<b>34</b>) offers a nice balance of potency, clearance, and MDR, but unfortunately suffers from significant inhibition of CYP2D6 (IC<sub>50</sub> = 1.4 μM). It does, however, raise the possibility that modifying the electronics of the substituent could further aid in P-gp efflux liability. Gratifyingly, the fluorine-containing compounds <b>36</b> and <b>38</b> maintain similar potency and selectivity, at the same time retaining good predicted brain penetration (MDR BA/AB ratio of 0.9 for each). Moreover, all of these compounds exhibit a significant increase in CatD selectivity relative to <b>1</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. In Vitro Data for Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">BACE1 FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CatD FP IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (fold)</th><th class="colsep0 rowsep0" align="center">BACE1 WCA IC<sub><b>50</b></sub> (nM)<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">MDR Er<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> (mL/min/kg)</th><th class="colsep0 rowsep0" align="center">LipE</th><th class="colsep0 rowsep0" align="center">LE</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">>100 (>19.6×)</td><td class="colsep0 rowsep0" align="left">265</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">72.0 (102×)</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">0.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OMe</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">>91.4 (107×)</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">0.47</td><td class="colsep0 rowsep0" align="left">63 (134×)</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">c-Pr</td><td class="colsep0 rowsep0" align="left">0.28</td><td class="colsep0 rowsep0" align="left">45 (161 ×)</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.9</td><td class="colsep0 rowsep0" align="left">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left"><i>i</i>-Bu</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">25.1 (167×)</td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">2.82</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">0.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">CHF<sub>2</sub></td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="left">83.1 (124×)</td><td class="colsep0 rowsep0" align="left">59</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>F</td><td class="colsep0 rowsep0" align="left">1.07</td><td class="colsep0 rowsep0" align="left">>81 (>76×)</td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">0.38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 FP assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">IC<sub>50</sub> values obtained from the CatD FP assay.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">IC<sub>50</sub> values obtained from the BACE1 whole-cell assay (WCA).</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">Hepatic clearance predicted from an in vitro human microsomal stability study.</p></div></div></div><div class="NLM_p">The consistent increase in LipE for these compounds relative to the unsubstituted <b>24b</b> suggests that productive BACE1–ligand interactions are indeed introduced through exploration of this vector. Moreover, the constant or improved LE through the THP substitution reinforces that relative potency was garnered for the resultant increases in MW. A crystal structure of <b>36</b> and BACE1 (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) confirms that the fluoromethyl substituent is directed toward the lipophilic pocket revealed by the rotation of Tyr-71 and, further, overlays with the unstable water predicted from the structure of <b>24b</b>. As expected, the bound compound maintains a low-energy conformation that places the fluoromethyl substituent in a favorable equatorial orientation on the THP ring. Thus, displacement of the calculated, unstable water resulted in a significant (5–7×) improvement in BACE1 potency, as well as improvements in ligand and lipophilic efficiency.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>36</b> and BACE1. The fluoromethyl substituent is directed toward the lipophilic pocket revealed by the rotation of Tyr-71.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the improved CatD selectivity and balanced ADME profile, the ADME properties of compounds <b>38</b>, <b>42</b>, and <b>36</b> were examined in more detail. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, all three compounds exhibit low in vitro clearance in human liver microsomes. Further examination across hepatocytes derived from rodent, dog, and nonhuman primate suggests a low rate of clearance in all species. In addition to high passive permeability (RRCK > 10), all analogs showed excellent CNS penetration (<i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub> > 0.9) in mouse with no predicted P-gp efflux. In addition, <b>36</b> was further profiled in a dog neuropharmacokinetic study and showed a similar <i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub> ratio of 0.78, suggesting confidence in translating the brain availability across multiple species.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. In Vitro and in Vivo Pharmacokinetic Properties of Representative Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK properties</th><th class="colsep0 rowsep0" align="center"><b>42</b></th><th class="colsep0 rowsep0" align="center"><b>36</b></th><th class="colsep0 rowsep0" align="center"><b>38</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">In vitro h-Cl<sub>h</sub> (mL min<sup>-1</sup> kg<sup>-1</sup>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left"><8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">In vitro r-Cl<sub>h</sub> (mL min<sup>-1</sup> kg<sup>-1</sup>)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left"><14</td><td class="colsep0 rowsep0" align="left"><14</td><td class="colsep0 rowsep0" align="left"><14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RRCK AB<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MDR BA/AB<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P (mouse)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">3.90</td><td class="colsep0 rowsep0" align="left">9.2</td><td class="colsep0 rowsep0" align="left">3.51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub><b>u</b></sub> (plasma)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>u</sub> (brain)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">0.10</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>u,b</sub>/<i>C</i><sub>u,p</sub><a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">1.42</td><td class="colsep0 rowsep0" align="left">1.20</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Hepatic clearance predicted from an in vitro human microsomal stability study.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Hepatic clearance predicted from an in vitro rat microsomal stability study.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">RRCK cells with low transporter activity were isolated from Madine–Darby canine kidney cells and were used to estimate intrinsic absorptive permeability.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Ratio from the MS-based quantification of apical/basal and basal/apical transfer rates of a test compound at 2 μM across contiguous monolayers from MDR1-transfected MDCK cells.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Determined from plasma and brain exposures in mice 60 min after 10 mg/kg subcutaneous dosing.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Determined from equilibrium dialysis.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">As assessed in CD-1 mice.</p></div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> In Vivo Pharmacology</h3><div class="NLM_p">To assess whether the improved pharmacokinetic properties of this class of thioamidines translate into a pharmacodynamic (PD) response in vivo, acute BACE1 inhibition was examined in male wild-type 129/sve mice following an acute subcutaneous administration of <b>36</b> at a dose of 30 or 150 mg/kg. Aβ lowering was measured in brain, cerebrospinal fluid (CSF), and plasma over a time course from 1 to 30 h postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The corresponding exposures were also measured in these three compartments in order to delineate the PK/PD relationship for BACE1 inhibition. From a PD perspective, a significant reduction of Aβ was seen in all three compartments. There also appears to be a threshold of maximum inhibition in rodent brain that cannot be breached despite the higher exposures achieved with the 150 mg/kg dose.</div><div class="NLM_p">Although the time and degree of maximal inhibition was equivalent for the two doses, the decay in inhibition back to baseline was significantly delayed for the 150 mg/kg dose. In brain, a sustained maximum reduction of Aβx-40 and Aβx-42 was observed at 3–5 h postdose, 69% and 72%, respectively. Efficacy in CSF was more robust with a maximum inhibition of 85%, while the weakest efficacy was observed in plasma, with 54% inhibition. Hysteresis is also clearly demonstrated, with a delay in peak efficacy (3 h) from <i>C</i><sub>max</sub> (1 h). Utilization of previously described methods allowed for a <i>C</i><sub>eff</sub> determination of 371 nM (free brain).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0001.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course effect of <b>36</b> on brain, plasma, and CSF Aβ following acute administration in mouse. Compound <b>36</b> was dosed at 30 or 150 mg/kg sc at time = 0. Data are the mean ± SEM, <i>n</i> = 5/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to demonstrating brain, plasma, and CSF lowering of Aβ in mice, the efficacy of <b>36</b> was also confirmed in biomarker compartments of higher-order species. Using cisterna magna-cannulated beagle dogs, the acute effect of <b>36</b> was evaluated in serial CSF and plasma samples collected over a 60 h period (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Administration of an 18 mg/kg po dose of <b>36</b> produced a sustained reduction in CSF concentrations of Aβx-40 and Aβx-42, with a maximum decrease of 74% compared to vehicle, but at a <i>T</i><sub>max</sub> of 8 h, right-shifted from that seen in mouse. A decrease was also observed in plasma Aβx-40 (45% at <i>T</i><sub>max</sub> = 4 h postdose).</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0002.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time course of effect of <b>36</b> on plasma and CSF Aβ following acute 18 mg/kg po administration in beagle dogs. Compound <b>36</b> was dosed at 18 mg/kg po at time = 0. Data are the mean ± SEM, <i>n</i> = 4/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Evaluation of the efficacy of <b>36</b> in PS1/APP mice with respect to plaque burden modulation was examined following 2 months of chronic treatment at 100 mg/kg (po) using two-photon excitation microscopy.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Two-photon imaging provides the advantage of being able to follow changes in individual plaques over time, with each mouse acting as its own control versus prior baseline measurements. Thinned-skull cranial windows were created over the somatosensory cortex of PS1(G384A)APPSWE mice for imaging amyloid plaques by intravital two-photon microscopy.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Images were acquired at baseline and at 1 and 2 months after initiating compound treatment. The total plaque load in the imaged region was increased by 51 ± 13% over the 2 month period in vehicle-treated animals, suggesting a steady growth of plaques in these mice at the age of 6.5–8.5 months. The change rate of individual plaques displayed significant variability, from no detectable difference to a several-fold increase. Surprisingly, 2-month treatment with <b>36</b> led to a significant regression of total plaque burden, with an average decrease of 26.8% (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>, <i>n</i> = 6; <i>p</i> < 0.05). These results suggest that BACE1 inhibition was effective not only in halting amyloid plaque load increase but also in regressing plaque burden when administered during the plaque growth phase. Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a> illustrates representative images of preexisting parenchymal amyloid plaques and subsequent reductions following 2 month treatment with <b>36</b>.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0003.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>36</b> on amyloid-plaque-lowering efficacy in 8.5-month-old PS1/APP mice. Fluorescence intensity was quantitated from a defined cortical region (600 × 600 × 200 μm) at baseline (6.5 months of age) and after 2 months of treatment (8.5 months of age) with vehicle or <b>36</b>. Data are the mean ± SEM; <i>n</i> = 14 for vehicle and <i>n</i> = 6 for compound <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0004.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative two-photon imaging of preexisting amyloid plaques and subsequent reductions following 2 months of chronic treatment (po) with vehicle or compound <b>36</b>. (A, B) The same cortical region (600 × 600 × 200 μm) was imaged at baseline (A) and after 2-month vehicle treatment (B). (C) Examples of plaques that had increased volume with higher magnification (boxed region in A, B). (A′, B′) A significant percentage of parenchymal plaques showed volume reduction after 2-month BACE1 inhibitor (<b>36</b>) treatment. (C′) Examples of plaque regression (boxed region in A′, B′).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The demonstration of reduced amyloid deposition in the form of extractable brain Aβ as well as reduction of plaque load and plaque number, following chronic BACE1 inhibitor treatment in amyloid mouse models, has been reported.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> However, to our knowledge, this is the first definitive evidence that treatment with a BACE1 inhibitor has resulted in inhibition of de novo plaque formation, since two-photon imaging enables the tracking of individual plaque growth in a live mouse with time. This enzymatic inhibition, preventing the formation of Aβ from APP, does not rule out the possibility that other mechanisms or processes such as enhanced clearance could be responsible for diminishment of amyloid plaques in this model. One recent report<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> has shown that diminishment of BACE1 activity, either genetically or pharmacologically, enhanced clearance of axonal and myelin debris, as well as accelerated axonal regeneration following peripheral nerve axotomy in mice, opening up the possibility of BACE1 inhibition as a therapeutic approach for peripheral nerve damage.</div><div class="NLM_p">Additionally, the Aβ-lowering efficacy of <b>36</b> in CSF and plasma was examined in 8–9-month-old PS1/APP mice following a single subcutaneous dose at 30 mg/kg. The age of the mice was chosen to be in close alignment with that of the two-photon-imaged animals of the 2-month plaque assessment above. Brain efficacy assessment was not measured acutely, since the large Aβ brain load in these mice in the form of amyloid plaques would mask any inhibition that could be obtained following guanidine extraction of the total brain pool of Aβ (data not shown). However, proof that central biomarkers were modulated due to BACE inhibitor treatment can be obtained via Aβ assessment in the CSF compartment. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, robust lowering of CSF Aβx-40 and Aβx-42 was observed, with 79% and 72% inhibition, respectively, at <i>T</i><sub>max</sub> of 2 h postdose. Plasma Aβ inhibition was also robust, with a <i>T</i><sub>max</sub> of 2 h postdose (Aβx-40 89% inhibition; Aβx-42, 71% inhibition). The inhibitory effect was sustained, such that 50% inhibition was still evident at 7 h postdose.</div><figure id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0005.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Time course data for the acute effect of <b>36</b> on CSF and plasma Aβ concentrations in 8–9-month-old PS1/APP mice. Compound <b>36</b> was dosed at 30 mg/kg (sc) at time = 0. Data are the mean ± SEM, <i>n</i> = 2–5/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Taken together, these data demonstrate that <b>36</b> is a potent, orally available, brain-permeable BACE1 inhibitor. Compound <b>36</b> possesses central efficacy in Aβ lowering in wild-type mouse, PS1/APP mouse, and dog, as well as showing plaque regression in a mouse model of Alzheimer’s disease.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Toxicology Assessment in Rat</h3><div class="NLM_p last">Having demonstrated a sufficient PK profile and robust efficacy in vivo, <b>36</b> was evaluated in a 14-day repeat-dose rat toxicology study. At two doses (75 and 25 mg/kg, respectively) no changes were attributable to <b>36</b>, including, most importantly, no accumulation of autofluorescent material in retinal pigment epithelium (RPE), as evaluated microscopically by H&E staining. Thus, at reasonable multiples (up to 12× the AUC-derived <i>C</i><sub>eff</sub>) for 14 days, no ocular toxicity was observed. In contrast, accumulation of autofluorescent material could be observed after only 7 days with 150 mg/kg of compound <b>1</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> This study thus supports the hypothesis that minimizing CatD liability should mitigate the ocular toxicity previously reported for this series.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65401" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65401" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">A series of brain-penetrant, orally efficacious, thioamidine-derived BACE1 inhibitors are described herein. Truncating older BACE1 inhibitors back to a minimal pharmacophore and rationally building toward the flap by appending a fused THP ring induced a conformational change in the BACE1 active site, revealing a subpocket near S2′. The introduction of small substituents efficiently engaged this pocket, resulting in significant LipE improvements without sacrificing a balanced ADME profile. The reaction sequence effectively created up to three chiral centers and allowed timely exploration of the P2′ pocket from versatile late-stage intermediates. The route was amenable to the synthesis of bulk quantities of material for extended in vivo studies, as in the case of <b>36</b>. These compounds consistently exhibited good brain penetration and well-behaved pharmacokinetics. Robust efficacy in lowering both peripheral and central Aβ loads was observed in vivo both in mice and dog models. Moreover, chronic dosing of <b>36</b> for 2 months revealed that these compounds can lower the plaque load in mice, as assessed by two-photon analysis. Robust central efficacy led to the selection of <b>36</b> for evaluation in a 2-week rat exploratory toxicology study; there were no ocular findings, supporting the hypothesis that enhanced selectivity for BACE1 over CatD indeed imparts an improved ocular safety profile. Subsequent evolution of this series will require a substantial improvement in potency to lower the efficacious concentration, as well as critical examination of the selectivity over CatD that is required to maintain the clean safety profile described above. These efforts will be described in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58473" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58473" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biology</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> In Vitro Pharmacology</h4><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> sAPPβ Whole-Cell Assay (WCA)</h5><div class="NLM_p last">sAPPβ, the primary cleavage product of BACE1, was determined in H4 human neuroglioma cells overexpressing the wild-type human APP<sub>695</sub>. Cells were treated for 18 h with compound in a final concentration of 1% DMSO. sAPPβ levels were measured by ELISA with a capture APP N-terminal antibody (Affinity BioReagents, OMA1-03132), wild-type sAPPβ-specific reporter antibody p192 (Elan), and tertiary anti-rabbit-HRP (GE Healthcare). The colorimetric reaction was read by an EnVision (PerkinElmer) plate reader.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> BACE1 Enzyme Cell-Free Assay (FP)</h5><div class="NLM_p last">β-Secretase-1 activity was assessed with soluble BACE1 and the synthetic APP substrate biotin–GLTNIKTEEISEISYEVEFR-C[Oregon Green]KK–OH in the presence of compounds in a fluorescence polarization (FP) in vitro assay. Enzyme, substrate, and test compounds were incubated in 15 μL of 100 mM sodium acetate (pH 4.5) buffer containing 0.001% Tween-20 for 3 h at 37 °C. Following the addition of saturating immunopure streptavidin, fluorescence polarization was measured with a PerkinElmer EnVision plate reader (Ex485 nm/Em530 nm).</div></div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> In Vivo Experiments</h4><div class="NLM_p">All procedures were carried out in compliance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1985), under approval of an Institutional Animal Care and Use Committee (IACUC).</div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> Acute Treatment in Mice</h5><div class="NLM_p last">Male 129/SVE wild-type mice (20–25 g) were in a nonfasted state prior to subcutaneous dosing with vehicle or 30 or 150 mg/kg <b>36</b>, using a dosing volume of 10 mL/kg in 5:5:90 DMSO:Cremophor:saline vehicle. Mice (<i>n</i> = 5 per group) were sacrificed at 1, 3, 5, 7, 14, 20, and 30 h postdose. Whole blood samples (0.5–1.0 mL) were collected by cardiac puncture into ethylenediaminetetraacetic acid (EDTA)-containing tubes, and plasma was separated by centrifugation (1500<i>g</i> for 10 min at 4 °C). The generated plasma was distributed into separate tubes on wet ice for exposure measurements (50 μL) and Aβ analysis (remainder). CSF samples (8–12 μL) were obtained by cisterna magna puncture using a sterile 25 gauge needle and collected with a P-20 Eppendorff pipet. CSF samples were distributed into separate tubes on dry ice for exposure measurements (3 μL) and Aβ analysis (remainder). Whole brain was removed and divided for exposure measurements (cerebellum) and Aβ analysis (left and right hemispheres), weighed, and frozen on dry ice. All samples were stored at −80 °C prior to assay.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> Measurement of Rodent Amyloid-β</h5><div class="NLM_p">Frozen mouse hemibrains were homogenized (10% w/v) in 5 M guanidine HCl, using a Qiagen TissueLyser. Each sample was homogenized with a 5 mm stainless steel bead, four times, at a shaking rate of 24 times/s for 90 s, incubated at 25 °C for 3 h, and ultracentrifuged at 125 000<i>g</i> for 1 h at 4 °C. The resulting supernatant was removed and stored in a 96-well polypropylene deep-well plate at −80 °C. The Aβ peptides were further purified through solid-phase extraction using Waters Oasis reversed-phase HLB 96-well column plates (60 mg). Column eluates in ammonium hydroxide from 500 to 800 μL of original brain supernatant were evaporated to complete dryness and stored at −80 °C until assay. For plasma analysis, 140–175 μL of mouse plasma was treated 1:1 with 5 M guanidine HCl and incubated overnight with rotation at 4 °C. The entire volume was then purified through solid-phase extraction as indicated above.</div><div class="NLM_p">Samples were analyzed using a dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) platform enzyme-linked immunosorbent assay (ELISA). Configuration of the antibodies used in determining the level of Aβx-40 and Aβx-42 utilizes a common detection antibody (4G8) in combination with specific C-terminal antibodies for the 40 and 42 cleavage sites. For the Aβx-40 assay, a 384-well black Nunc Maxisorp plate was coated with 15 μL/well (4 μg/mL) of capture antibody (Rinat 1219) in 0.1 M sodium bicarbonate coating buffer (pH 8.2). For the Aβx-42 assay, 15 μL/well (8 μg/mL) of capture antibody (Rinat 10G3) was used. The plates were sealed and incubated at 4 °C overnight. Plates were washed with phosphate-buffered saline containing 0.05% Tween-20 (PBS-T) and blocked with 75 μL of blocking buffer (1% BSA in PBS-T) for 2 h at 25 °C.</div><div class="NLM_p last">After washing the plates with PBS-T, rodent Aβx-40 (California Peptide) or Aβx-42 (California Peptide) standard was serially diluted in blocking buffer and 15 μL was applied to the plate in quadruplicate. Dried brain samples were reconstituted in 120 μL of blocking buffer, which corresponds to a 4.16–6.67-fold concentration. Then, 15 μL of undiluted brain sample was added to the Aβx-42 assay plate in triplicate, or 15 μL of a 1:2 diluted brain sample was added to the Aβx-40 assay plate in triplicate. Dried plasma samples were reconstituted in 40 μL of blocking buffer, which corresponds to a 3.5–4.38-fold concentration, and 15 μL was added to the Aβx-40 assay plate in duplicate. CSF samples were diluted 1:8 in blocking buffer, and 15 μL was added to the Aβx-40 assay plate in duplicate. Plates were incubated with sample or standards for 2 h at 25 °C. The plates were washed with PBS-T, and 15 μL of detection antibody (4G8–biotin, Covance), 200 ng/mL in blocking buffer, was added to each well for a 2 h incubation at 25 °C. The plates were then washed with PBS-T, and 15 μL of europium-labeled streptavidin (PerkinElmer), 50 ng/mL in blocking buffer, was added for a 1 h incubation in the dark at 25 °C. The plates were washed with PBS-T, and 15 μL of PerkinElmer enhancement solution was added to each well with 20 min incubation at rt. Plates were read on an EnVision plate reader using DELFIA time-resolved fluorimetry (Exc340/Em615), and samples were extrapolated against the standard curve using four-parameter logistics. Measurement of human amyloid-β in plasma and CSF from PS1/APP mice utilizes the same capture and detect antibodies used for wild-type mice. Vehicle-treated samples from plasma and CSF were serially diluted to optimize sample dilution to the linear phase of an Aβ peptide standard curve. Aβ levels were measured using DELFIA ELISA.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Acute Treatment in Dog</h5><div class="NLM_p">Three naïve male beagle dogs (<i>Canis lupus familiaris</i>) were surgically prepared with indwelling cannulae inserted into the cisterna magna and connected to a subcutaneous access port to permit cerebrospinal fluid sampling. Animals were allowed a minimum 14-day recovery period, during which the catheter was checked for patency. The animals were individually housed in a climate-controlled room with a 12 h light–dark cycle (on 06:00, off 18:00).</div><div class="NLM_p">For systemic administration, dogs were dosed orally with 20% β-hydroxypropyl cyclodextrin (vehicle) or 18 mg/kg of <b>36</b> dissolved in vehicle. Dose formulations were made the day before each day of dosing, sterile-filtered into a sterile vial, and stored at 2–8 °C. Animals were fasted overnight prior to dosing and were fed approximately 4 h after the start of dosing. Each dog was dosed over a 2-week period in a crossover study design, with each dose condition represented on each day of dosing. All animals were weighed before each day of dosing and each dose was separated by a wash-out period of at least 7 days.</div><div class="NLM_p last">CSF and plasma samples were obtained at −24 (day −1), 0, 2, 4, 8, 12, 24, 32, 48, and 56 h relative to the start of dose administration on each day of dosing. The −24 and 0 h time points served as predose baseline controls. Whole blood samples of approximately 2 mL were collected from the jugular vein into EDTA-containing tubes and then placed on wet ice. Plasma was separated out by centrifugation at 3000 rpm for 10 min at 4 °C. The resulting plasma samples, approximately 1 mL each, were then stored at −80 °C until shipped on dry ice for analysis. CSF samples (6 drops, approximately 0.30 mL) were obtained using a sterile Huber needle inserted into the subcutaneous port. The CSF was not withdrawn through the needle but allowed to flow naturally and was collected as it dripped from the needle hub. A small amount of CSF (2 drops, approximately 0.1 mL of dead volume) was initially collected and discarded prior to each sampling point. The CSF was placed on dry ice upon collection and later stored at −80 °C until shipped on dry ice for analysis.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Measurement of Dog Amyloid-β</h5><div class="NLM_p">Samples were analyzed using a DELFIA platform ELISA. For the detection of Aβ, 96-well plates were coated with 50 μL per well of capture antibody in coating buffer (0.1 M NaHCO<sub>3</sub>, pH 8.2). The capture antibody for the Aβx-40 assay was Rinat RN1219. The capture antibody for the Aβx-42 assay was Rinat 10G3. The capture antibody for the Aβ total assay was Covance 6E10. Plates with coating antibody were covered with foil seals and incubated overnight at 4 °C.</div><div class="NLM_p">Coated plates were washed four times with phosphate-buffered saline (PBS) with 0.05% Tween-20 (PBS-T), and then 130 μL of blocking buffer [PBS-T, 1% bovine serum albumin (BSA)] was added to each well before incubation for 2 h at rt. Plates were washed four times with PBS-T, and 50 μL of diluted sample or standards was added to the plate in duplicate. For dog plasma analysis of Aβx-40 and Aβ total, 120 μL of plasma was added to 120 μL of blocking buffer, which were mixed for a 1:2 dilution. For dog CSF analysis of Aβx-42, 40 μL of CSF was added to 160 μL of blocking buffer, which were mixed for a 1:5 dilution. For CSF analysis of Aβx-40, 80 μL of the 1:5 diluted CSF was added to 80 μL of blocking buffer, which were mixed for a 1:10 dilution. For CSF analysis of Aβ total, 40 μL of the 1:10 diluted CSF was added to 80 μL of blocking buffer, which were mixed for a 1:30 dilution. To prepare standard curves, human Aβ1–40 for the Aβx-40 or Aβ total assay (California Peptide) or Aβ1–42 for the Aβ42 assay (American Peptide) was serially diluted in blocking buffer using a 1:2 dilution series from 256 to 0.25 pg/well, while blocking buffer without peptide addition was used as a 0 pg/well control. Sample or standards were applied to plates at 50 μL/well, and plates were sealed with foil lids before incubation overnight at 4 °C.</div><div class="NLM_p last">Plates were washed four times with PBS-T and incubated with 50 μL of Covance 4G8–biotin detection antibody (0.2 mg/mL in blocking buffer) for 2 h at rt. Plates were washed an additional four times with PBS-T, and 50 μL of PerkinElmer europium–streptavidin (diluted 1:1000 in blocking buffer to a concentration of 0.1 μg/mL with 20 μM EDTA supplement) was added to the plates, which incubated at rt for 1 h. Plates were washed four times with PBS-T, and 50 μL per well of PerkinElmer enhancement solution warmed to rt was added to the plates for a 30 min incubation with rocking at rt. Europium counts were read on an EnVision plate reader using DELFIA time-resolved fluorimetry (Exc340/Em615), and samples were extrapolated against the standard curve using four-parameter logistics.</div></div><div id="sec4_1_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> Two-Photon Imaging Assessment of Mouse Brain Amyloid Plaques</h5><div class="NLM_p last">PS1-APP mice (∼6.5 month old at the beginning of the study) were utilized for intravital two-photon imaging studies. Briefly, PS1-APP mice were injected with 10 mg/kg (ip) methoxy X-04 to label amyloid plaques 24–48 h before each imaging view. Mice were deeply anaesthetized (80 mg/kg ketamine and 12 mg/kg xylazine), and then the skull over the somatosensory cortex region was thinned to ∼20 μm in thickness using a dental drill.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The brain vasculature was labeled following iv administration of 10 kDa rhodamine dextran (10 mg/kg) immediately before the animal was secured on the stage of a multiphoton microscope. Utilizing a two-photon laser that was mode-locked at 840 nm, images were captured with a 20× water immersion objective (Olympus, model XLUMPLFLN20XW, N/A = 1.00). The laser power at the sample was less than 40 mW. A <i>z</i>-stack image series was acquired from the pial surface to a depth of ∼200 μm into the cortex. These same regions were imaged once every month. Each stack consisted of one color channel to capture amyloid and one color channel to capture vascular structures. The image acquisition and data quantification were blinded with regard to the animal treatment paradigm. The plaques were quantified by a custom analysis package.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Image stacks were first Gaussian filtered, and then the volume of each individual plaque was calculated by 3D reconstruction. All images were aligned to the baseline image using rigid body registration.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> After alignment, individual plaques imaged at each time point were quantified and compared. Vascular plaques were identified on the basis of their proximity to the vasculature defined by unique characteristics and wrapping morphology. The change in CAA was quantified as the ratio between total vascular plaque loads at different time points. Plaque load was represented as the sum of all the quantified plaques within the imaged area. A plaque was counted as “increased” or “decreased” only when its volume changed by more than 30%. New plaque formation was calculated as <i>N</i><sub>new</sub>/<i>N</i><sub>total</sub> × 100, where <i>N</i><sub>new</sub> is the number of new plaques and <i>N</i><sub>total</sub> is the total number of plaques captured in the first imaging session.</div></div><div id="sec4_1_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> Pharmacokinetic Studies in Male Wistar Han Rats</h5><div class="NLM_p last">The in-life and bioanalytical portions of these studies were conducted at BioDuro, Pharmaceutical Product Development Inc. (Beijing, China). Male Wistar Han rats (obtained from Vital River, 200–250 g) underwent jugular vein cannulation surgery at BioDuro. Rats received either a 1 mg/kg intravenous (iv) dose or a 5 mg/kg oral (po) dose of compound <b>36</b>, <b>38</b>, or <b>42</b>. The doses were prepared in 20% (w/v) sulfobutyl ether β-cyclodextrin and delivered in a volume of 1 mL/kg (iv) or 10 mL/kg (po). Animals were sacrificed in a CO<sub>2</sub> chamber. Blood samples were collected in K<sub>2</sub>EDTA-treated tubes at designated times between 2 min and 24 h via jugular vein cannula. Plasma was isolated after centrifugation. The plasma samples were stored at −80 °C prior to analysis.</div></div><div id="sec4_1_2_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i24" class="anchor-spacer"></div><h5 class="article-section__title" id="_i24"> Neuropharmacokinetic Studies in Male CD-1 Mice</h5><div class="NLM_p last">The in-life and bioanalytical portions of these studies were conducted at BioDuro, Pharmaceutical Product Development Inc. (Beijing, China). Male CD-1 mice were obtained from PUMC. Mice received a 10 mg/kg subcutaneous (sc) dose of compound <b>36</b>, <b>38</b>, or <b>42</b>. The doses were prepared in 5% DMSO/95% (0.5% methylcellulose) and delivered in a volume of 5 mL/kg. Animals were sacrificed in a CO<sub>2</sub> chamber. Blood, brain, and CSF samples were collected at 1, 4, and 7 h postdosing. Plasma was isolated after centrifugation. The plasma, brain, and CSF samples were stored at −80 °C prior to analysis.</div></div><div id="sec4_1_2_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Measurement of Fractions Unbound in Brain</h5><div class="NLM_p last">The unbound fraction of each compound was determined in brain tissue homogenate using the 96-well equilibrium dialysis method described by Kalvass et al.,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> with the following exceptions. Brain homogenates were prepared from freshly harvested rat brains following dilution with a 4-fold volume of phosphate buffer and spiked with 1 μM compound. The homogenates were dialyzed against an equal volume (150 μL) of phosphate buffer at 37 °C for 6 h. Following the incubation, equal volumes (50 μL) of brain homogenate and buffer samples were collected and mixed with 50 μL of buffer or control homogenate, respectively, for preparation of mixed matrix samples. All samples were then precipitated with internal standard in acetonitrile (200 μL), vortexed, and centrifuged. Supernatants were analyzed using an LC–MS/MS assay. A dilution factor of 5 was applied to the calculation of brain fraction unbound.</div></div><div id="sec4_1_2_9" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Generic Liquid Chromatography Tandem Mass Spectrometry (LC–MS/MS) Assay for Exposure Measurements in Plasma, Brain, and CSF</h5><div class="NLM_p last">Plasma, brain, and CSF were collected as described above and frozen at −80 °C until analysis by LC–MS/MS. Standard curves were prepared in respective matrix via serial dilution at a concentration of 1.0–2000 ng/mL (plasma and CSF) or 0.5–2000 ng/g (brain). For plasma, a 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min and then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. Frozen brain tissue was weighed and a 2-propanol:water (60:40) volume equivalent to 4 times the mass was added before homogenization in a bead beater (BioSpec Products Inc., Bartlesville, OK). A 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min and then centrifuged at 3000 rpm for 10 min. The supernatant was transferred to a 96-well plate. For CSF, a 50 mL aliquot of sample was precipitated with 500 mL of MTBE containing an internal standard. Samples were vortexed for 1 min and then centrifuged at 3000 rpm for 10 min. The supernatant (300 mL) was transferred to a 96-well plate. LC–MS/MS analysis was carried out using a high-performance liquid chromatography system consisting of tertiary Shimadzu LC20AD pumps (Shimadzu Scientific Instruments, Columbia, MD) with a CTC PAL autosampler (Leap Technologies, Carrboro, NC) interfaced to an API 4000 LC–MS/MS quadrupole tandem mass spectrometer (AB Sciex Inc., Ontario, Canada). The mobile phase consisted of solvent A (water with 0.1% formic acid) and solvent B (acetonitrile with 0.1% formic acid). The gradient was as follows: solvent B was held at 5% for 0.4 min, linearly ramped from 5% to 95% in 0.5 min, held at 90% for 0.6 min, and then stepped to 5% over 0.01 min. The mass spectrometer was operated using positive electrospray ionization. All raw data were processed using Analyst Software ver. 1.4.2 (AB Sciex Inc., Ontario, Canada).</div></div><div id="sec4_1_2_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i27" class="anchor-spacer"></div><h5 class="article-section__title" id="_i27"> Crystallization of BACE</h5><div class="NLM_p last">Crystals of BACE were prepared as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>24B</b> was soaked into crystals grown using protein expressed and refolded according to the procedure described in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>a, while compounds <b>6</b> and <b>36</b> were soaked into crystals grown using the procedure described in ref <a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">34</a>b, with several modifications to the protein purification scheme. Ni<sup>2+</sup>-affinity and size exclusion chromatography were used as the initial purification steps, yielding homogeneous BACE and eliminating the need for a peptide affinity column. Following removal of the prodomain by furin (0.0375 U/mg BACE), anion exchange chromatography (GE Healthcare 1 mL Q HP) was used as a final purification step. Crystals were soaked at 0.6 mM for 1 h (compounds <b>6</b> and <b>36</b>) or 3 mM overnight (compound <b>24B</b>). Crystals of <b>6</b> and <b>36</b> were transferred to a cryoprotectant comprised of 80% mother liquor/20% glycerol, while the specimen containing <b>24B</b> was harvested directly from the soaking solution. Crystals were then flash cooled in liquid nitrogen. X-ray diffraction data for compounds <b>6</b> and <b>36</b> were collected at sector 17ID at the Advanced Photon Source (Argonne National Laboratory, Argonne, IL) on a Pilatus 6 M detector at −170 °C. Data for compound <b>24B</b> was collected in-house on a Rigaku FRE rotating-anode X-ray generator equipped with a Rigaku Saturn 944 CCD detector. All data were processed using AUTOPROC<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and XDS,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and subsequent data manipulation was performed using the CCP4 suite of programs.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Initial structures were determined by rigid body refinement of a reference BACE structure, followed by restrained positional refinement in REFMAC.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Ligands were automatically fit to difference maps calculated after refinement in AUTOBUSTER,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and all further refinement was performed in AUTOBUSTER. Data and refinement statistics are reported in Table S1 of the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Molecular Dynamics</h4><div class="NLM_p last">In order to refine protein–ligand interactions and to test the stability of the modeling of compound <b>6</b> to CatD (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA">1LYA</a>), a molecular dynamics (MD) simulation was performed. The binary complex was first optimized with Protein Preparation Wizard in Maestro V9.1.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> A default quick relaxation protocol was used to minimize the MD system with the Desmond program.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Two rounds of steepest descent minimization were performed with a maximum of 2000 steps with and without restrains (force constant of 50 kcal/mol/Å on all solute atoms) keeping the aspartic acid residues (Asp-32 and Asp-228) in the active site fixed throughout all the calculations. The default protocol within Desmond was applied as the first step of relaxation for the MD simulation. After this step, a total of 15 ns of MD simulation was performed, applying the OPLS 2005 force field<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> at a constant pressure of 1 bar and a temperature of 300 K, using the Nosé–Hoover chain method.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The short-range and long-range Coulombic interactions were calculated with a cutoff radius of 9 Å and with the smooth particle mesh method.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Time step scheduling was used as follows: the multistep RESPA integrator<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> with an inner time step of 2.0 fs for bonded forces and nonbonded near forces within the short-range cutoff and an outer time step of 6.0 fs for nonbonded far forces beyond the cutoff.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Chemistry</h3></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> General Methods</h3><div class="NLM_p last">Solvents and reagents were of reagent grade and were used as supplied by the manufacturer. All reactions were run under a N<sub>2</sub> atmosphere. Organic extracts were routinely dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>. Concentration refers to rotary evaporation under reduced pressure. Chromatography refers to flash chromatography using disposable RediSep R<sub>f</sub> 4–120 g silica columns or Biotage disposable columns on a CombiFlash Companion or Biotage Horizon automatic purification system. Microwave reactions were carried out in a SmithCreator microwave reactor from Personal Chemistry. Purification by mass-triggered HPLC was carried out using Waters XTerra PrepMS C<sub>18</sub> columns, 5 μm, 30 × 100 mm. Compounds were presalted as TFA salts and diluted with 1 mL dimethyl sulfoxide. Samples were purified by mass-triggered collection using a mobile phase of 0.1% trifluoroacetic acid in water and acetonitrile with a gradient of 100% aqueous to 100% acetonitrile over 10 min, at a flow rate of 20 mL/min. LC–MS analyses were performed on a Waters Acquity UPLC–MS system with a Waters Aquity HSS T3, 1.7 μm C18 column (50 × 2.1 mm). UPLC conditions: solvent A = 0.1% formic acid in water (v/v), solvent B = 0.1% formic acid in acetonitrile; flow rate =1.25 mL/min; compounds were eluted with a gradient of 5% B/A to 95% B/A for 1.1 min. Optical rotations were run on a JASCO P-2000 polarimeter. Elemental analyses were performed by QTI, Whitehouse, NJ. All target compounds were analyzed using ultrahigh-performance liquid chromatography/ultraviolet/evaporative light-scattering detection coupled to time-of-flight mass spectrometry (UHPLC/UV/ELSD/TOFMS). Unless otherwise noted, all tested compounds were found to be <i>></i>95% pure by this method.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> UHPLC/MS Analysis</h3><div class="NLM_p last">The UHPLC was performed on a Waters ACQUITY UHPLC system (Waters, Milford, MA), which was equipped with a binary solvent delivery manager, column manager, and sample manager coupled to ELSD and UV detectors (Waters, Milford, MA). Detection was performed on a Waters LCT premier XE mass spectrometer (Waters, Milford, MA). The instrument was fitted with an Acquity BEH (Bridged Ethane Hybrid) C18 column (30 × 2.1 mm, 1.7 μm particle size, Waters, Milford, MA) operated at 60 °C.</div></div><div id="sec4_2_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 3-(2,4-Difluorophenyl)but-3-en-1-yl 4-methylbenzenesulfonate (<b>4</b>)</h3><div class="NLM_p last">To an oven-dried, 2 dram vial equipped with a stir bar was added 100 mg (0.328 mmol) of 3-bromobut-3-en-1-yl 4-methylbenzenesulfonate followed by 2,4-difluorophenylboronic acid (104 mg, 0.656 mmol) and anhydrous THF (4 mL) (THF was previously deoxygenated by bubbling N<sub>2</sub> gas via a needle for 20 min). Cesium fluoride (199 mg, 1.31 mmol) was then added and to that heterogeneous solution was added palladium tetrakis(triphenylphosphine) (38.5 mg, 0.0330 mmol). The vessel was capped and heated to 70 °C for 16 h. Analysis by LC/MS revealed product formation (M + NH<sub>4</sub> = 356 <i>m</i>/<i>z</i>). The reaction mixture was cooled to rt. The cap of the vial was removed and the mixture stirred in air at rt for 1 h. To the solution was added brine (1 mL) followed by vigorous stirring at rt for 5 min. The aqueous layer was removed and extracted with Et<sub>2</sub>O (2 × 1 mL). The combined organic extract was dried over sodium sulfate, filtered, and concentrated in vacuo. The resulting crude material (100 mg, 90% yield) was employed without purification in the next step.</div></div><div id="sec4_2_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 3-(2,4-Difluorophenyl)but-3-en-1-yl carbamimidothioate (<b>5</b>)</h3><div class="NLM_p last">To a 2 dram vial equipped with a stir bar were introduced 3-(2,4-difluorophenyl)but-3-en-1-yl 4-methylbenzenesulfonate (<b>4</b>) (100 mg, 0.30 mmol) and thiourea (45.4 mg, 0.596 mmol) followed by 0.2 mL of acetonitrile. The resulting thick slurry was capped, heated to 75 °C, and stirred gently for 18 h. The cap of the vial was removed and the slurry was heated to 80 °C for 0.5 h to remove most of the acetonitrile. The resulting gum was employed crude in the next step (60 mg, 83% yield).</div></div><div id="sec4_2_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-(2,4-Difluorophenyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>6</b>)</h3><div class="NLM_p last">To a 2 dram vial, equipped with a stir bar, containing 3-(2,4-difluorophenyl)but-3-en-1-yl carbamimidothioate (59 mg, 0.24 mmol) was added 0.5 mL of 6 N HCl. The resulting slurry was capped and heated to 95 °C for 6 h. To the gum was added dropwise 2 N NaOH until pH ∼10 was reached (∼1.2 mL). The solution was extracted with EtOAc (2 × 1.5 mL). The combined extracts were dried in vacuo to a gum. The resulting crude material was purified by flash chromatography [SiO<sub>2</sub>, 12 g, 0–100% gradient of (89% CH<sub>2</sub>Cl<sub>2</sub>/10% MeOH/1% NH<sub>4</sub>OH)/CH<sub>2</sub>Cl<sub>2</sub>]. After evaporation the product was isolated as a gum (10 mg, 17% yield): LC–MS <i>m</i>/<i>z</i> 243 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.27 (dt, <i>J</i> = 6.6, 9.4 Hz, 1H), 6.85–6.95 (m, 2H), 3.27 (td, <i>J</i> = 1.6, 3.3 Hz, 2H), 2.91 (ddd, <i>J</i> = 3.6, 5.7, 12.5 Hz, 1H), 2.46–2.58 (m, 2H), 1.77 (ddd, <i>J</i> = 3.7, 11.9, 14.1 Hz, 1H), 1.56 (d, <i>J</i> = 1.4 Hz, 3H).</div></div><div id="sec4_2_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-<i>N</i>-((2<i>S</i>)-2-(5-bromo-2,4-difluorophenyl)-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-(methoxymethyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>8</b>)</h3><div class="NLM_p last">To a solution of (<i>S</i>)-<i>N</i>-((<i>Z</i>)-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-(methoxymethyl)butan-2-ylidene)-2-methylpropane-2-sulfinamide (<b>7</b>)<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> (26 g, 74.5 mmol) in toluene (250 mL) at −70 °C was added 2.0 M AlMe<sub>3</sub> in toluene (41 mL, 82 mmol) dropwise while the internal temp was maintained at −70 °C. In a separate flask, a solution of 1,5-dibromo-2,4-difluorobenzene (30.4 g, 111.75 mmol) in toluene (250 mL) was treated with 2.5 M <i>n</i>-BuLi in hexanes (49 mL, 122.92 mmol) in a dropwise manner while the internal temp was maintained at −70 °C. After the addition, the mixture was stirred at −70 °C for 1 h. At this time point, the solution of (<i>S</i>)-<i>N</i>-((<i>Z</i>)-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-(methoxymethyl)butan-2-ylidene)-2-methylpropane-2-sulfinamide and trimethylaluminum in toluene was added slowly via cannula to the solution of 1-lithio-5-bromo-2,4-difluorobenzene in toluene while the internal temp was maintained at −70 °C. After the addition, the mixture was stirred at −70 °C for 1 h and then warmed to 40 °C and stirred for 18 h. Analysis by LC–MS showed that the reaction was complete. The mixture was quenched with saturated aqueous NH<sub>4</sub>Cl solution and then extracted with EtOAc (2 × 200 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by column chromatography to give (<i>S</i>)-<i>N</i>-((2<i>S</i>)-2-(5-bromo-2,4-difluorophenyl)-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-(methoxymethyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>8</b>) (10 g, 24.7%) as a yellow oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.21–8.32 (m, 1H), 6.83 (dd, <i>J</i> = 7.9, 11.4 Hz, 1H), 3.80 (dd, <i>J</i> = 2.3, 10.3 Hz, 1H), 3.53–3.65 (m, 2H), 3.33 (s, 3H), 3.23 (s, 1H), 2.17–2.28 (m, 1H), 1.78 (d, <i>J</i> = 0.8 Hz, 3H), 1.16–1.32 (m, 9H), 0.76–0.92 (m, 9H), 0.00 (s, 3H), −0.11 to −0.03 (m, 3H)</div></div><div id="sec4_2_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (3<i>S</i>)-3-Amino-3-(5-bromo-2,4-difluorophenyl)-2-(methoxymethyl)butan-1-ol (<b>9</b>)</h3><div class="NLM_p last">A mixture of (S)-N-((2S)-2-(5-bromo-2,4-difluorophenyl)-4-((<i>tert</i>-butyldimethylsilyl)oxy)-3-(methoxymethyl)butan-2-yl)-2-methylpropane-2-sulfinamide (<b>8</b>) (10 g, 18.4 mmol) in 4.0 N HCl/dioxane (100 mL) was stirred at room temperature for 18 h. Analysis by LC–MS showed the reaction was complete. The mixture was concentrated in vacuo and H<sub>2</sub>O (30 mL) was added. The mixture was basified with solid NaOH until the solution was found to be at pH 8 and then extracted with EtOAc (30 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to afford crude (3<i>S</i>)-3-amino-3-(5-bromo-2,4-difluorophenyl)-2-(methoxymethyl)butan-1-ol (<b>9</b>) (4.5 g, 75.5%), which was used in next step without further purification.</div></div><div id="sec4_2_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-{[(2<i>S</i>)-2-(5-Bromo-2,4-difluorophenyl)-4-hydroxy-3-(methoxymethyl)butan-2-yl]carbamothioyl}benzamide (<b>10</b>)</h3><div class="NLM_p last">To a solution of (3<i>S</i>)-3-amino-3-(5-bromo-2,4-difluorophenyl)-2-(methoxymethyl)butan-1-ol (<b>9</b>) (4.5 g, 13.88 mmol) in THF (40 mL) was added benzoyl isothiocyanate (3.4 g, 20.82 mmol) in one portion. The mixture was stirred at room temperature for 2 h. Analysis by TLC (EtOAc) showed that the reaction was completed. Water (30 mL) was added, the mixture was extracted with EtOAc (2 × 20 mL), and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by CombiFlash (EtOAc) to give <i>N</i>-{[(2<i>S</i>)-2-(5-bromo-2,4-difluorophenyl)-4-hydroxy-3-(methoxymethyl)butan-2-yl]carbamothioyl}benzamide (<b>10</b>) (5.2 g, 77%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.65 (s, 1H), 8.77 (s, 1H), 7.88–7.79 (m, 2H), 7.65–7.60 (m, 1H), 7.56–7.51 (m, 3H), 6.88–6.83 (m, 1H), 4.11–4.00 (m, 1H), 3.78–3.70 (m, 2H), 3.43–3.26 (s, 3H), 2.54–2.52 (m, 1H), 2.20 (s, 3H), 2.10–1.97 (m, 1H).</div></div><div id="sec4_2_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[(4<i>S</i>)-4-(5-Bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]benzamide (<b>11</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-{[(2<i>S</i>)-2-(5-bromo-2,4-difluorophenyl)-4-hydroxy-3-(methoxymethyl)butan-2-yl]carbamothioyl}benzamide (<b>10</b>) (5.2 g, 10.67 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) at −20 °C was added pyridine (2.5 g, 32 mmol), followed by dropwise addition of triflic anhydride (4.5 g, 16 mmol). After the addition, the mixture was stirred at −10 °C for 30 min. Analysis by TLC (EtOAc) showed that the reaction was complete. The reaction mixture was treated with H<sub>2</sub>O (50 mL) and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 20 mL) and washed with brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo to give crude <i>N</i>-[(4<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]benzamide (<b>11</b>) (5.5 g, quant) as a light brown oil, which was used in the next step without further purification.</div></div><div id="sec4_2_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (4<i>S</i>)-4-(5-Bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>12</b>)</h3><div class="NLM_p last">A solution of crude <i>N</i>-[(4<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]benzamide (<b>11</b>) (5.5 g, 11.7 mmol) in CH<sub>3</sub>OH (150 mL) was treated with DBU (5.3 g, 35.1 mmol), and the mixture was heated under reflux for 5 h. Analysis by TLC (EtOAc) showed that the reaction was complete. The mixture was concentrated in vacuo, the residue was dissolved in EtOAc (100 mL) and washed with brine, and the organic layer was concentrated in vacuo to give crude (4<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>12</b>) (9 g) as a brown oil, which was used in the next step without further purification.</div></div><div id="sec4_2_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>tert</i>-Butyl [(4<i>S</i>,5<i>S</i>)-4-(5-Bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13a</b>) and <i>tert</i>-Butyl [(4<i>S</i>,5<i>R</i>)-4-(5-Bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13b</b>)</h3><div class="NLM_p">To a solution of crude (4<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>12</b>) (9 g) in THF (50 mL) was added sat. NaHCO<sub>3</sub> solution (20 mL) and BOC<sub>2</sub>O (21.4 g, 98.3 mmol); after the addition, the mixture was stirred at room temperature overnight. TLC (EtOAc) showed that the reaction was complete. The mixture was extracted with EtOAc (2 × 30 mL), the organic layer was concentrated in vacuo, and the residue was purified by column chromatography on silica gel to give <i>tert</i>-butyl [(4<i>S</i>,5<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13a</b>) (800 mg, 16.2%) as a yellow solid: LC–MS <i>m</i>/<i>z</i> 466 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 7.9 Hz, 1H), 6.86 (dd, <i>J</i> = 7.8, 11.5 Hz, 1H), 3.49–3.60 (m, <i>J</i> = 4.8 Hz, 1H), 3.40–3.49 (m, 1H), 3.31 (s, 3H), 2.92 (dd, <i>J</i> = 4.5, 12.8 Hz, 1H), 2.76–2.86 (m, 1H), 2.63 (dd, <i>J</i> = 3.4, 12.7 Hz, 1H), 1.59 (s, 3H), 1.45 (s, 9H).</div><div class="NLM_p last"><i>tert</i>-Butyl [(4<i>S</i>,5<i>R</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13b</b>) (2.1 g, 42.4%) was isolated as a white solid: LC–MS <i>m</i>/<i>z</i> 466 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.75–7.92 (m, 1H), 6.80 (dd, <i>J</i> = 8.2, 11.4 Hz, 1H), 3.23–3.38 (m, <i>J</i> = 3.8 Hz, 1H), 2.97–3.17 (m, 5H), 2.58–2.74 (m, 2H), 1.39–1.53 (m, 12H).</div></div><div id="sec4_2_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (4<i>S</i>,5<i>S</i>)-4-(2,4-Difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>14a</b>)</h3><div class="NLM_p">A solution of <i>tert</i>-butyl [(4<i>S</i>,5<i>S</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13a</b>) (80 mg, 0.17 mmol) in anhydrous THF (1.7 mL) was cooled to −78 °C. <i>n</i>-BuLi (0.18 mL, 0.40 mmol) was added dropwise and the reaction mixture was stirred for 10 min. The mixture was then poured into aqueous NH<sub>4</sub>Cl and separated. The aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic layers were washed with brine (25 mL), dried over sodium sulfate, and concentrated to yield <i>tert</i>-butyl [(4<i>S</i>,5<i>S</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate as a crude product that was used without purification: yield 60 mg, 0.16 mmol, 90%; LC–MS <i>m</i>/<i>z</i> 387.5 [M + 1].</div><div class="NLM_p last">A solution of <i>tert</i>-butyl [(4<i>S</i>,5<i>S</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (60 mg, 0.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.776 mL) was treated with trifluoroacetic acid (0.059 mL, 0.776 mmol). The reaction turned red immediately and was stirred at rt for 45 min. The reaction mixture was concentrated and then taken up in EtOAc and aqueous saturated NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc (3×). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuo to afford 21 mg (47% yield) of (4<i>S</i>,5<i>S</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>14a</b>): LC–MS <i>m</i>/<i>z</i> 287 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ d 7.19 (dt, <i>J</i> = 6.2, 9.0 Hz, 1H), 6.78–6.94 (m, 2H), 3.63 (dd, <i>J</i> = 4.4, 9.5 Hz, 1H), 3.46 (t, <i>J</i> = 9.4 Hz, 1H), 3.39 (s, 3H), 3.13 (dd, <i>J</i> = 4.1, 12.3 Hz, 1H), 2.94 (dd, <i>J</i> = 4.3, 9.2 Hz, 1H), 2.74 (dd, <i>J</i> = 3.5, 12.3 Hz, 1H), 1.70 (s, 3H); [α]<sub class="stack">D</sub><sup class="stack">27</sup> = −201.5° (<i>c</i> 0.32, MeOH).</div></div><div id="sec4_2_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (4<i>S</i>,5<i>R</i>)-4-(2,4-Difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>14b</b>)</h3><div class="NLM_p">A solution of <i>tert</i>-butyl [(4<i>S</i>,5<i>R</i>)-4-(5-bromo-2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (<b>13b</b>) (140 mg, 0.30 mmol) in anhydrous THF (3.0 mL) was cooled to −78 °C. <i>n</i>-BuLi (0.26 mL, 0.66 mmol) was added dropwise and the reaction was stirred for 10 min. The reaction was then poured into aqueous NH<sub>4</sub>Cl and separated. The aqueous layer was extracted with EtOAc (2 × 25 mL). The combined organic layers were washed with brine (25 mL), dried over sodium sulfate, and concentrated to yield <i>tert</i>-butyl [(4<i>S</i>,5<i>R</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate as a crude product: yield 110 mg, 0.28 mmol, 95%; LC–MS <i>m</i>/<i>z</i> 387.5 [M + 1].</div><div class="NLM_p last">A solution of <i>tert</i>-butyl [(4<i>S</i>,5<i>R</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-yl]carbamate (110 mg, 0.285 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.2 M) was treated with trifluoroacetic acid (0.109 mL, 1.42 mmol, 5 equiv). The reaction turned red immediately and was stirred at rt for 45 min. The reaction was then concentrated in vacuo and the residue partitioned between EtOAc and aqueous saturated NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc (3×). The organic layers were combined and dried over Na<sub>2</sub>SO<sub>4</sub> to afford 63 mg (77% yield) of (4<i>S</i>,5<i>R</i>)-4-(2,4-difluorophenyl)-5-(methoxymethyl)-4-methyl-5,6-dihydro-4<i>H</i>-1,3-thiazin-2-amine (<b>14b</b>): LC–MS <i>m</i>/<i>z</i> 287 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (dt, <i>J</i> = 7.0, 9.1 Hz, 1H), 6.81–6.88 (m, 1H), 6.77 (ddd, <i>J</i> = 2.7, 9.0, 12.0 Hz, 1H), 4.30 (br s, 2H), 3.40–3.48 (m, 1H), 3.21–3.29 (m, 1H), 3.09–3.19 (m, 4H), 2.64–2.76 (m, 2H), 1.53 (d, <i>J</i> = 1.8 Hz, 3H); [α]<sub class="stack">D</sub><sup class="stack">26</sup> = −7.35° (<i>c</i> 0.26, MeOH).</div></div><div id="sec4_2_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 4-(2,2-Diethoxyethoxy)but-1-ene (<b>16b</b>)</h3><div class="NLM_p last">A solution of but-3-en-1-ol (96%, 28.0 mL, 312 mmol) in tetrahydrofuran (150 mL) was added to a suspension of sodium hydride (60% in mineral oil, 59.9 g, 1.50 mol) in tetrahydrofuran (700 mL) at 0 °C. After the reaction mixture had stirred for 30 min at this temperature, a solution of 2-bromo-1,1-diethoxyethane (97%, 72.6 mL, 468 mmol) in tetrahydrofuran (150 mL) was added at 0 °C, and the reaction mixture was then heated to 68 °C for 66 h. The reaction mixture was cooled to 0 °C, slowly quenched with water (150 mL), and concentrated in vacuo. After three extractions with EtOAc, the combined organic layers were dried over magnesium sulfate, filtered, and concentrated in vacuo to afford 77 g of <b>16b</b> as an oil, which was taken directly to the following step: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (product peaks only) δ 1.23 (t, <i>J</i> = 7.0 Hz, 6H), 2.32–2.38 (m, 2H), 3.50 (d, <i>J</i> = 5.3 Hz, 2H), 3.53–3.62 (m, 4H), 3.67–3.75 (m, 2H), 4.63 (t, <i>J</i> = 5.3 Hz, 1H), 5.02–5.06 (m, 1H), 5.07–5.13 (m, 1H), 5.77–5.88 (m, 1H).</div></div><div id="sec4_2_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (But-3-en-1-yloxy)acetaldehyde (<b>17b</b>)</h3><div class="NLM_p last">A solution of <b>16b</b> (77 g, 312 mmol) in tetrahydrofuran (515 mL) was treated with aqueous hydrochloric acid (2 M, 105 mL); the reaction mixture was then brought to 70 °C and maintained at that temperature for 30 min. After cooling to room temperature, removal of solvents in vacuo afforded 40 g of the product as an amber oil, which was taken directly to the following step.</div></div><div id="sec4_2_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2-(But-3-en-1-yloxy)acetaldehyde Oxime (<b>18b</b>)</h3><div class="NLM_p last">(But-3-en-1-yloxy)acetaldehyde (<b>17b</b>) (40 g from the preceding step, 312 mmol) was dissolved in a 2:1 mixture of ethanol and water (700 mL). Sodium acetate (128 g, 1560 mmol) was added, and the mixture was stirred for 20 min. Hydroxylamine hydrochloride (98%, 66.4 g, 936 mmol) was then added, and the reaction mixture was heated to 60 °C for 18 h, at which point it was cooled to room temperature and concentrated under reduced pressure to remove ethanol. The aqueous residue was poured into water (500 mL) and extracted with EtOAc (4×). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, concentrated in vacuo, and purified by flash chromatography (SiO<sub>2</sub>, 0%–40% gradient of EtOAc in heptane) to afford 24 g (60% yield) of <b>18b</b> as an oil, presumed from the <sup>1</sup>H NMR spectrum to be a mixture of <i>E</i>- and <i>Z</i>-oximes: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ [7.51 (t, <i>J</i> = 5.6 Hz), and 6.92 (t, <i>J</i> = 3.7 Hz) total 1H], 5.89–5.76 (m, 1H), 5.16–5.04 (m, 2H), [4.36 (d, <i>J</i> = 3.7 Hz) and 4.11 (d, <i>J</i> = 5.7 Hz), total 2H], 3.57–3.51 (m, 2H), 2.41–2.33 (m, 2H).</div></div><div id="sec4_2_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (3a<i>R</i>)-3,3a,4,5-Tetrahydro-7<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>19b</b>)</h3><div class="NLM_p">To a solution of 2-(but-3-en-1-yloxy)acetaldehyde oxime (<b>18b</b>, 10.1 g, 78.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (495 mL) in a water bath at rt was added triethylamine (817 μL, 5.86 mmol). The solution was treated with bleach (95 mL, 6.15% NaOCl, 78.4 mmol) in a dropwise introduction via an addition funnel. The internal temp of the reaction mixture was monitored and rose from 18 to 22.4 °C. The reaction mixture was stirred at rt. At the end of the addition, the reaction mixture was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The organic phase was dried over MgSO<sub>4</sub>, filtered and concentrated in vacuo to provide 8.5 g (85% yield) of <i><b>rac-</b></i><b>19b</b> as an amber oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.70 (br d, <i>J</i> = 13 Hz, 1H), 4.62 (dd, <i>J</i> = 10.2, 8.0 Hz, 1H), 4.12 (dd, <i>J</i> = 13.5, 1.2 Hz, 1H), 4.09–4.03 (m, 1H), 3.79 (dd, <i>J</i> = 11.6, 8.1 Hz, 1H), 3.50 (ddd, <i>J</i> = 12.3, 12.1, 2.0 Hz, 1H), 3.45–3.34 (m, 1H), 2.20–2.13 (m, 1H), 1.84–1.73 (m, 1H).</div><div class="NLM_p last">The enantiomers of 3,3a,4,5-tetrahydro-7<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<i><b>rac-</b></i><b>19b</b>) (4.1 g, 32 mmol) were separated using supercritical-fluid chromatography (column, Chiralpak AS-H, 5 μm; eluent, 95:5 CO<sub>2</sub>/2-propanol). The second-eluting enantiomer afforded 1.2 g (9.4 mmol) of <b>19b</b> as an oil: LC–MS <i>m</i>/<i>z</i> 128.0 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 4.61–4.52 (m, 2H), 4.16 (dd, <i>J</i> = 13.3, 1.2 Hz, 1H), 4.02–3.96 (m, 1H), 3.73 (dd, <i>J</i> = 11.5, 8.0 Hz, 1H), 3.54 (ddd, <i>J</i> = 12.3, 12.3, 1.9 Hz, 1H), 3.53–3.44 (m, 1H), 2.22–2.15 (m, 1H), 1.75–1.63 (m, 1H).</div></div><div id="sec4_2_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>rac-</i>(3a<i>S</i>,6a<i>S</i>)-6a-(2,4-Difluorophenyl)tetrahydro-1<i>H</i>,3<i>H</i>-furo[3,4-<i>c</i>][1,2]oxazole (<b>20a</b>)</h3><div class="NLM_p last">To a stirred solution of 2,4-difluoro-1-iodobenzene (6.58 g, 27.4 mmol) in toluene (110.0 mL) and tetrahydrofuran (11.0 mL) under N<sub>2</sub> at −70 °C (internal temp) was added boron trifluoride etherate (3.17 mL, 25.7 mmol) (no exotherm) followed by dropwise addition of <i>n</i>-BuLi in hexane (10.2 mL, 25.5 mmol, 2.5 M). The reaction mixture’s internal temp was not allowed to rise above −70 °C throughout the addition. Once the <i>n</i>-BuLi addition was complete, the resulting dark yellow/amber homogeneous solution was stirred at −75 °C (internal temp) for 30 min. To this solution was added 3a,4-dihydro-3<i>H</i>,6<i>H</i>-furo[3,4-<i>c</i>][1,2]oxazole (<b>19a</b>, 2.0 g, 18 mmol) in toluene (10.0 mL) and tetrahydrofuran (1.0 mL). The resulting amber solution was stirred at −76 °C (internal temp) for 60 min. The reaction mixture was quenched with saturated NH<sub>4</sub>Cl (200 mL) and warmed to rt. The resulting organic crude was partitioned between H<sub>2</sub>O (100 mL) and EtOAc (300 mL). The resulting organic layer was isolated and washed with brine (100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield a dark amber oily residue that was redissolved in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and adsorbed on silica gel (25 g of SNAP). The resulting solid was loaded on CombiFlash R<sub>f</sub> for purification [120 g high-performance RediSep Gold column, 0–50% of EtOAc in heptanes, 16 column volumes (CV)]. Fractions containing the new major spot (∼25% EtOAc) were combined and concentrated under reduced pressure to yield a pale yellow, waxy solid that was suspended in heptane (∼5 mL) and then filtered and evaporated in vacuo to afford <i><b>rac</b></i><b>-20a</b> (2.42 g, 60%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89–7.81 (m, 1H), 6.95–6.76 (m, 2H), 5.10 (s, 1H), 4.53 (t, <i>J</i> = 8.3 Hz, 1H), 4.19–4.07 (m, 1H), 3.98 (d, <i>J</i> = 9.4 Hz, 1H), 3.92–3.76 (m, 2H), 3.57 (t, <i>J</i> = 7.3 Hz, 1H), 3.37 (q, <i>J</i> = 7.6 Hz, 1H).</div></div><div id="sec4_2_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (3a<i>R</i>,7a<i>S</i>)-7a-(2,4-Difluorophenyl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>20b</b>)</h3><div class="NLM_p last"><i>n</i>-Butyllithium (2.5 M solution in hexanes, 3.95 mL, 9.88 mmol) was added to a solution of 1-bromo-2,4-difluorobenzene (0.558 mL, 4.94 mmol) in a 1:3 mixture of tetrahydrofuran and toluene (25 mL) at −78 °C, and the reaction mixture was stirred at this temperature for 1 h. In a separate flask, a solution of <b>19b</b> (628 mg, 4.94 mmol) in toluene (15 mL) was cooled to −78 °C and treated with boron trifluoride diethyl etherate (1.22 mL, 9.88 mmol); this mixture was also allowed to stir at −78 °C for 1 h and then added via cannula to the aryllithium solution. The reaction mixture was stirred for 1 h and was then quenched with saturated aqueous ammonium chloride solution. After dilution with EtOAc, the layers were separated, and the organic layer was washed with saturated aqueous sodium chloride solution, dried over magnesium sulfate, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 40%) provided 610 mg (51% yield) of <b>20b</b>: LC–MS <i>m</i>/<i>z</i> 242.0 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.92–7.84 (m, 1H), 7.00–6.93 (m, 2H), 4.03 (dd, <i>J</i> = 12.5, 1.8 Hz, 1H), 4.02–3.95 (br m, 1H), 3.76–3.53 (m, 4H), 3.10–3.03 (m, 1H), 1.93–1.75 (m, 2H).</div></div><div id="sec4_2_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>rac-</i>[(3<i>R</i>,4<i>S</i>)-4-Amino-4-(2,4-difluorophenyl)tetrahydrofuran-3-yl]methanol (<b>21a</b>)</h3><div class="NLM_p last">To a stirring solution of <i><b>rac</b></i><b>-20a</b> (1.2 g, 5.28 mmol) in glacial acetic acid (25.0 mL, <i>c</i> = 0.211 M) was added zinc dust (<10 μm, 4.5 g, 68.8 mmol). The resulting gray heterogeneous solution was stirred at rt for 18 h. The reaction was filtered through a small plug of Celite followed by a rinse with EtOAc (60 mL). The filtrate was concentrated in vacuo and the resulting oily residue was partitioned between saturated NaHCO<sub>3</sub> (50 mL) and EtOAc (100 mL). The lower aqueous layer was washed with additional EtOAc (2 × 50 mL). The combined organic extracts were washed with brine (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford <i><b>rac</b></i><b>-21a</b> (975 mg, solid, 80.5%) as a white solid. This product was used directly in the next step: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (dt, <i>J</i> = 6.2, 9.05 Hz, 1H), 6.94–6.79 (m, 2H), 4.13–4.00 (m, 2H), 3.97–3.87 (m, 3H), 3.86–3.77 (m, 1H), 2.89–2.74 (m, 1H).</div></div><div id="sec4_2_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> [(3<i>S</i>,4<i>R</i>)-3-Amino-3-(2,4-difluorophenyl)tetrahydro-2<i>H</i>-pyran-4-yl]methanol (<b>21b</b>)</h3><div class="NLM_p last">To a mixture of <b>20b</b> (1.06 g, 4.39 mmol) in acetic acid (10 mL) was added zinc powder (3.74 g, 57.2 mmol), and the resulting mixture was stirred for 18 h. Insoluble material was removed via filtration, and the filtrate was concentrated in vacuo. The resulting paste was dissolved in EtOAc, washed with saturated sodium bicarbonate and with saturated sodium chloride, and dried over MgSO<sub>4</sub>. Filtration and concentration in vacuo provided 900 mg (84% yield) of the product <b>21b</b>: LC–MS <i>m</i>/<i>z</i> 244 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.71–7.64 (m, 1H), 7.05–6.96 (m, 2H), 4.15–4.09 (m, 1H), 4.01 (dd, <i>J</i> = 11.3, 2.0 Hz, 1H), 3.62 (ddd, <i>J</i> = 12.7, 11.5, 2.7 Hz, 1H), 3.50 (d, <i>J</i> = 11.5 Hz, 1H), 3.40–3.37 (m, 2H), 2.48–2.40 (m, 1H), 2.12–2.00 (m, 1H), 1.71–1.78 (m, 1H).</div></div><div id="sec4_2_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>rac</i>-<i>N</i>-{[(3<i>S</i>,4<i>R</i>)-3-(2,4-Difluorophenyl)-4-(hydroxymethyl)tetrahydrofuran-3-yl]carbamothioyl}benzamide (<b>22a</b>)</h3><div class="NLM_p last">To a very fine suspension of <i><b>rac-</b></i><b>21a</b> (950 mg, 4.14 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40.0 mL, <i>c </i>= 0.104 M) rapidly stirring under an atmosphere of nitrogen was added benzoyl isothiocyanate (649 mg, 3.98 mmol, 0.535 mL) in one portion. The resulting yellow solution was stirred at rt for 1.5 h. The reaction mixture was concentrated under reduced pressure to yield a sticky yellow solid, which was purified by flash chromatography (SiO<sub>2</sub>, 40 g RediSep Gold column, EtOAc/heptane gradient from 0 to 20% over 16 CV) to afford 1.48 g (91%) of <i><b>rac-</b></i><b>22a</b> as an off-white solid: LC–MS <i>m</i>/<i>z</i> 393 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.80 (s, 1H), 8.86 (s, 1H), 7.79–7.91 (m, 2H), 7.59–7.76 (m, 2H), 7.47–7.57 (m, 2H), 6.85–6.95 (m, 1H), 6.79 (ddd, <i>J</i> = 2.5, 8.8, 11.7 Hz, 1H), 4.67 (d, <i>J</i> = 9.8 Hz, 1H), 4.39 (dd, <i>J</i> = 1.6, 9.8 Hz, 1H), 4.13 (t, <i>J</i> = 8.5 Hz, 1H), 3.97–4.07 (m, 1H), 3.91 (ddd, <i>J</i> = 4.4, 7.1, 11.8 Hz, 1H), 3.78 (dd, <i>J</i> = 7.0, 9.0 Hz, 1H), 3.08–3.22 (m, 1H), 2.80 (dd, <i>J</i> = 4.7, 7.0 Hz, 1H).</div></div><div id="sec4_2_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 9<i>H</i>-Fluoren-9-ylmethyl [(3<i>S</i>,4<i>R</i>)-3-(2,4-Difluorophenyl)-4-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl]carbamothioyl}carbamate (<b>22b</b>)</h3><div class="NLM_p last">To a solution of <b>21b</b> (650 mg, 2.67 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was added 9<i>H</i>-fluoren-9-ylmethyl carbonizothiocyanatidate (FMOC-isothiocyanate) (827 mg, 2.94 mmol), and the reaction mixture was stirred for 4 h at room temperature. The mixture was then concentrated in vacuo to provide a paste that was purified by flash chromatography (SiO<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0% to 5%) to afford 1.17 g (84% yield) of the product <b>22b</b>: LC–MS <i>m</i>/<i>z</i> 525.2 [M + 1].</div></div><div id="sec4_2_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>rac-N</i>-[(4a<i>S</i>,7a<i>S</i>)-7a-(2,4-Difluorophenyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>23a</b>)</h3><div class="NLM_p last">A rapidly stirred suspension of <i><b>rac-</b></i><b>22a</b> (492 mg, 1.25 mmol) in toluene (10.0 mL) under an atmosphere of nitrogen was heated to 90 °C in an oil bath, during which time it became a homogeneous solution. Ghosez’s reagent (0.303 g, 2.27 mmol, 0.300 mL) was added in one portion to the hot solution. The resulting homogeneous solution continued to be heated at 90 °C for 15 min. The reaction mixture was cooled, concentrated in vacuo, and purified by flash chromatography (SiO<sub>2</sub>, 24 g high-performance RediSep Gold column, EtOAc/heptanes gradient from 0 to 80% over 16 CV) to afford 456 mg (97%) of <b>23a</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 375 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (d, <i>J</i> = 6.8 Hz, 2H), 7.36–7.57 (m, 4H), 6.84–7.00 (m, 2H), 4.41 (d, <i>J</i> = 9.2 Hz, 1H), 4.21 (d, <i>J</i> = 7.6 Hz, 2H), 4.01 (d, <i>J</i> = 7.8 Hz, 1H), 3.27–3.40 (m, <i>J</i> = 4.5 Hz, 1H), 3.18 (dd, <i>J</i> = 3.5, 13.5 Hz, 1H), 2.90 (dd, <i>J</i> = 5.2, 13.6 Hz, 1H).</div></div><div id="sec4_2_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (4a<i>S</i>,7a<i>S</i>)-7a-(2,4-Difluorophenyl)-4a,5,7,7a-tetrahydro-4<i>H</i>-furo[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>24a</b>)</h3><div class="NLM_p last">To a solution of <b>23a</b> (450.0 mg, 1.20 mmol) in methanol (8.0 mL) was added DBU (101.8 mg, 0.668 mmol, 100.0 μL). The reaction mixture was stirred and heated in a tightly capped 20 mL vial at 60 °C (external) for 16 h. The solution was then cooled to rt and concentrated in vacuo. The residue was partitioned between EtOAc (35 mL) and H<sub>2</sub>O (10 mL). After extraction, the organic phase was washed with H<sub>2</sub>O (2 × 10 mL). The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and purified by flash chromatography (SiO<sub>2</sub>, 12 g RediSepGold column, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0 to 10% over 35 CV) to afford 261 mg (80% yield) of <i><b>rac-</b></i><b>24a</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 271 [M + 1]. Enantiomer separation was carried out using a Lux Cellulose-2 250 × 21.2 mm, 5 μm column eluting with 70% CO<sub>2</sub> and 30% MeOH (isocratic) with 0.2% NH<sub>4</sub><sup>+</sup> buffer at a flow rate of 80 mL/min (120 bar backpressure) with detection at 210 nm. The desired enantiomer eluted at 8.40 min (peak 2): LC–MS <i>m</i>/<i>z</i> 271 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.44 (dt, <i>J</i> = 6.6, 9.00 Hz, 1H), 6.76–6.90 (m, 2H), 4.43 (dd, <i>J</i> = 1.4, 8.8 Hz, 1H), 4.01–4.16 (m, 2H), 3.79 (dd, <i>J</i> = 2.2, 8.8 Hz, 1H), 2.99–3.07 (m, 1H), 2.91–2.99 (m, 1H), 2.79–2.88 (m, 1H); [α]<sub class="stack">D</sub><sup class="stack">27.39</sup> = −2.06° (<i>c</i> = 0.785, MeOH).</div></div><div id="sec4_2_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (4a<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>24b</b>)</h3><div class="NLM_p last">A suspension of <b>22b</b> (1.42 g, 2.70 mmol) in MeOH (20 mL) was treated with concentrated HCl (0.675 mL, 8.10 mmol) and heated to 70 °C for 2 h. The reaction mixture was then concentrated in vacuo, dissolved in CH<sub>2</sub>Cl<sub>2</sub>, and washed with saturated sodium bicarbonate. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in acetonitrile (20 mL), treated with piperidine (2 mL), stirred at rt for 18 h, and then concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0 to 7%) provided 281 mg (37%) of <b>24b</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 285.0 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.35 (ddd, <i>J</i> = 9.5, 8.7, 6.7 Hz, 1H), 7.00–6.92 (m, 2H), 4.05–3.99 (m, 2H), 3.70–3.62 (m, 1H), 3.63 (br d, <i>J</i> = 10.9 Hz, 1H), 2.90–2.82 (m, 2H), 2.73–2.67 (m, 1H), 2.12–1.99 (m, 1H), 1.52–1.45 (m, 1H).</div></div><div id="sec4_2_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (2<i>R</i>)-1-(Benzyloxy)pent-4-en-2-ol (<b>25a</b>)</h3><div class="NLM_p last">A mixture of (2<i>R</i>)-2-[(benzyloxy)methyl]oxirane (9.8 g, 60 mmol) and copper(I) iodide (648 mg, 3.40 mmol) in diethyl ether (150 mL) was cooled to −78 °C. Vinylmagnesium chloride (1.6 M in THF, 41.0 mL, 65.6 mmol) was added dropwise, and the reaction mixture was allowed to warm slowly to rt and stir for 18 h. Ice and saturated aq NH<sub>4</sub>Cl were added to the reaction mixture, which was then extracted with EtOAc. The combined organic layers were washed with saturated aq NH<sub>4</sub>Cl, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo. This material was used in the following step without further purification: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) (product peaks only) δ 7.4–7.3 (m, 5H), 5.89–5.78 (m, 1H), 5.16–5.09 (m, 2H), 4.57 (s, 2H), 3.93–3.87 (m, 1H), 3.53 (dd, <i>J</i> = 9.5, 3.4 Hz, 1H), 3.39 (dd, <i>J</i> = 9.4, 7.4 Hz, 1H), 2.25–2.31 (m, 2H).</div></div><div id="sec4_2_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> ({[(2<i>R</i>)-2-(2,2-Diethoxyethoxy)pent-4-en-1-yl]oxy}methyl)benzene (<b>26a</b>)</h3><div class="NLM_p last">A solution of (2<i>R</i>)-1-(benzyloxy)pent-4-en-2-ol (<b>25a</b>) (material from the previous step, 60 mmol) in THF (50 mL) was added dropwise to a suspension of sodium hydride (60% in mineral oil, 11.0 g, 275 mmol) in THF (100 mL) at 0 °C. After the reaction mixture had stirred for 30 min at this temperature, a solution of 2-bromo-1,1-diethoxyethane (97%, 13.3 mL, 85.8 mmol) in THF (50 mL) was added at 0 °C, and the reaction mixture was then heated to reflux for 18 h. Additional 2-bromo-1,1-diethoxyethane (11 mL, 71 mmol) was added, and heating was continued for a further 24 h. The reaction mixture was cooled to 0 °C, quenched with water, and extracted with EtOAc (3×). The combined organic layers were washed with water and with saturated aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 15%) afforded 11.04 g (60% yield over two steps) of <b>26a</b> as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38–7.27 (m, 5H), 5.90–5.78 (m, 1H), 5.12–5.02 (m, 2H), 4.61 (t, <i>J</i> = 5.3 Hz, 1H), 4.55 (s, 2H), 3.74–3.49 (m, 9H), 2.36–2.31 (m, 2H), 1.22 (t, <i>J</i> = 7.0 Hz, 3H), 1.21 (t, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_2_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> [1-(2,2-Diethoxyethoxy)but-3-en-1-yl]cyclopropane (<b>26b</b>)</h3><div class="NLM_p last">1-Cyclopropylbut-3-en-1-ol<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (<b>25b</b>, 92%, 8.1 g, 66 mmol) was added to a suspension of sodium hydride (60% in mineral oil, 8.25 g, 206 mmol) in THF (105 mL) at 0 °C. The cooling bath was removed and the suspension was stirred until the internal temp reached 21 °C. The reaction mixture was then cooled in an ice bath, and 2-bromo-1,1-diethoxyethane (97%, 18.5 mL, 119 mmol) was added dropwise at a rate that maintained the internal temp below 5 °C. After warming to rt, the reaction mixture was heated to 58 °C (internal temp) for 27 h. Sodium hydride (60% in mineral oil, 3.3 g, 83 mmol) and 2-bromo-1,1-diethoxyethane (97%, 10 mL, 64 mmol) were added again, and the reaction mixture was heated at mild reflux for 14 h. The reaction mixture was then cooled to 0 °C, slowly quenched with water (100 mL), and extracted with diethyl ether (3 × 200 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification via flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 10%) afforded 12.1 g (80% yield) of <b>26b</b> as a colorless oil: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.98–5.87 (m, 1H), 5.11–5.05 (m, 1H), 5.04–5.00 (m, 1H), 4.61 (t, <i>J</i> = 5.3 Hz, 1H), 3.75–3.66 (m, 3H), 3.62–3.54 (m, 2H), 3.47 (dd, <i>J</i> = 10.3, 5.5 Hz, 1H), 2.70 (dt, <i>J</i> = 8.4, 6.0 Hz, 1H), 2.41–2.36 (m, 2H), 1.22 (t, <i>J</i> = 7.0 Hz, 3H), 0.90–0.80 (m, 1H), 0.62–0.54 (m, 1H), 0.50–0.35 (m, 2H), 0.14–0.07 (m, 1H).</div></div><div id="sec4_2_2_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> {[(2<i>R</i>)-1-(Benzyloxy)pent-4-en-2-yl]oxy}acetaldehyde (<b>27a</b>)</h3><div class="NLM_p last">To a solution of <b>26a</b> (10.14 g, 32.88 mmol) in THF (110 mL) was added aqueous HCl (2 M, 19.5 mL, 39.0 mmol), and the reaction mixture was then heated to 75 °C for 1 h. The reaction was concentrated to approximately half its original volume and then partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc, and the combined organic layers were washed with saturated aq sodium chloride, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo, to afford 7.76 g (87% yield) of <b>27a</b> as a colorless oil, which was used directly in the following step: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.72 (t, <i>J</i> = 1.0 Hz, 1H), 7.39–7.27 (m, 5H), 5.89–5.78 (m, 1H), 5.15–5.06 (m, 2H), 4.53 (br s, 2H), 4.28–4.18 (m, 2H), 3.68–3.62 (m, 1H), 3.57–3.54 (m, 2H), 2.42–2.28 (m, 2H).</div></div><div id="sec4_2_2_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> [(1-Cyclopropylbut-3-en-1-yl)oxy]acetaldehyde (<b>27b</b>)</h3><div class="NLM_p last">A mixture of <b>26b</b> (2.97 g, 13.0 mmol), aqueous HCl (1 M, 39 mL, 39 mmol), and THF (39 mL) was stirred at rt for 12.5 h and then heated to 40 °C for 3 h. The reaction mixture was cooled to rt and slowly transferred into a stirring biphasic mixture of saturated aqueous sodium bicarbonate (200 mL) and diethyl ether (200 mL). The aqueous layer was extracted with diethyl ether (2 × 100 mL), and the combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo (900 mbar, 60 °C) to afford 3.63 g (81% yield) of <b>27b</b> as a colorless oil, which contained residual diethyl ether and THF by <sup>1</sup>H NMR analysis. This material was taken directly into the following step: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.78–9.76 (m, 1H), 5.98–5.86 (m, 1H), 5.15–5.04 (m, 2H), 4.15 (br AB quartet, <i>J</i><sub>AB</sub> = 17.8 Hz, Δν<sub>AB</sub> = 22.8 Hz, 2H), 2.71 (dt, <i>J</i> = 8.8, 5.9 Hz, 1H), 2.47–2.41 (m, 2H), 0.91–0.81 (m, 1H), 0.66–0.58 (m, 1H), 0.57–0.49 (m, 1H), 0.38–0.31 (m, 1H), 0.15–0.08 (m, 1H).</div></div><div id="sec4_2_2_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-{[(2<i>R</i>)-1-(Benzyloxy)pent-4-en-2-yl]oxy}-<i>N</i>-hydroxyethanimine (<b>28a</b>)</h3><div class="NLM_p last">To a solution of <b>27a</b> (7.76 g, 32.9 mmol) in a 2:1 mixture of ethanol and water (127 mL) was added sodium acetate (13.6 g, 166 mmol), and the mixture was stirred for 15 min. Hydroxylamine hydrochloride (98%, 7.05 g, 99.4 mmol) was then added, and the reaction mixture was heated to 60 °C for 18 h. The reaction mixture was partitioned between EtOAc and water, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with saturated aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 30%) afforded 7.12 g (87% yield over two steps) of <b>28a</b> as a colorless oil, presumed from the <sup>1</sup>H NMR spectrum to be a mixture of <i>E-</i> and <i>Z</i>-oximes: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.27 (m, 5H), 7.55–7.47 and 7.01–6.93 (2 br m, total 1H), 5.87–5.75 (m, 1H), 5.14–5.05 (m, 2H), 4.56 and 4.55 (2 s, total 2H), 4.49–4.45 (br m) and [4.25 (dd, half of ABX pattern, <i>J</i> = 12.9, 5.6 Hz) and 4.20 (dd, half of ABX pattern, <i>J</i> = 12.9, 5.8 Hz), total 2H], 3.65–3.47 (m, 3H), 2.37–2.30 (m, 2H).</div></div><div id="sec4_2_2_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-[(1-Cyclopropylbut-3-en-1-yl)oxy]-<i>N</i>-hydroxyethanimine (<b>28b</b>)</h3><div class="NLM_p last">To a solution of <b>27b</b> (3.63 g from the previous step, <13.0 mmol) in a 2:1 mixture of ethanol and water (39 mL) was added sodium acetate (5.32 g, 64.9 mmol). After the reaction mixture had been stirred for 15 min, hydroxylamine hydrochloride (98%, 2.76 g, 38.9 mmol) was added, and the reaction mixture was heated to 60 °C for 5 min, at which time water (4 × 1 mL) was added until a solution resulted. After the mixture had stirred for 1 h at 60 °C, it was cooled to rt, concentrated in vacuo to remove ethanol, and diluted with saturated aqueous NaCl (100 mL). The mixture was extracted with diethyl ether (3 × 100 mL), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo at 22 °C. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 25%) provided 1.77 g (81%) of <b>28b</b> as a thick, opaque oil. By <sup>1</sup>H NMR analysis, this material consisted of a roughly 1:1 mixture of <i>E-</i> and <i>Z</i>-oxime isomers: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ [7.50 (dd, <i>J</i> = 5.7 and 5.6 Hz) and 6.99–6.92 (m), total 1H], 5.97–5.84 (m, 1H), 5.15–5.03 (m, 2H), [4.53 (dd, half of ABX pattern, <i>J</i> = 16.4 and 3.5 Hz) and 4.41 (dd, half of ABX pattern, <i>J</i> = 16.4 and 3.6 Hz)] and [4.27 (dd, half of ABX pattern, <i>J</i> = 12.9 and 5.5 Hz) and 4.16 (dd, half of ABX pattern, <i>J</i> = 12.9 and 5.8 Hz), total 2H], 2.74–2.65 (m, 1H), 2.44–2.37 (m, 2H), 0.91–0.81 (m, 1H), 0.68–0.59 (m, 1H), 0.56–0.47 (m, 1H), 0.44–0.35 (m, 1H), 0.15–0.07 (m, 1H).</div></div><div id="sec4_2_2_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (3a<i>R</i>,5<i>R</i>)-5-[(Benzyloxy)methyl]-3,3a,4,5-tetrahydro-7<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>29a</b>)</h3><div class="NLM_p last">A solution of <b>28a</b> (7.12 g, 28.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (168 mL) was placed in a rt water bath. Triethylamine (0.299 mL, 2.14 mmol) was added, followed by addition of bleach (aqueous sodium hypochlorite solution, 6.15%, 71 mL, 59 mmol) at a rate slow enough to maintain the internal reaction temperature between 22 and 25.5 °C. Upon completion of the addition, the reaction mixture was diluted with water and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic extracts were washed with saturated aqueous NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 35%) provided 5.65 g (80% yield) of <b>29a</b> as a yellow oil. The indicated relative stereochemistry was assigned on the basis of nuclear Overhauser enhancement studies, which revealed an interaction between the methine protons on carbons 3a and 5: LC–MS <i>m</i>/<i>z</i> 248.1 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39–7.27 (m, 5H), 4.77 (d, <i>J</i> = 13.5 Hz, 1H), 4.65–4.54 (m, 3H), 4.23 (dd, <i>J</i> = 13.5 and 1.2 Hz, 1H), 3.79 (dd, <i>J</i> = 11.8 and 8.1 Hz, 1H), 3.77–3.68 (m, 1H), 3.57 (dd, half of ABX pattern, <i>J</i> = 10.2 and 5.8 Hz, 1H), 3.49 (dd, half of ABX pattern, <i>J</i> = 10.2 and 4.2 Hz, 1H), 3.52–3.40 (m, 1H), 2.24–2.17 (m, 1H), 1.63–1.51 (m, 1H).</div></div><div id="sec4_2_2_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>rel</i>-(3a<i>R</i>,5<i>R</i>)-5-Cyclopropyl-3,3a,4,5-tetrahydro-7<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>29b</b>)</h3><div class="NLM_p last">An aqueous solution of sodium hypochlorite (6.15% solution, 27.1 mL, 22.4 mmol) was added dropwise over 24 min to a solution of <b>28b</b> (1.85 g, 10.9 mmol) and triethylamine (0.114 mL, 0.818 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (64 mL) that was immersed in a rt water bath. The rate of addition was adjusted to maintain the internal temp of the reaction between 19.5 and 22.8 °C. After completion of the addition, the reaction mixture was diluted with water (50 mL) and the aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 50 mL). The combined organic layers were washed with saturated aq NaCl (50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo (300 mbar, 40 °C) to provide 1.73 g (94% yield) of <b>29b</b> as a pale yellow oil. The indicated relative stereochemistry was assigned on the basis of nuclear Overhauser enhancement studies, which revealed an interaction between the methine protons on carbons 3a and 5: GC–MS <i>m</i>/<i>z</i> 167 [M<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 4.73 (d, <i>J</i> = 13.5 Hz, 1H), 4.61 (dd, <i>J</i> = 10.2 and 8.0 Hz, 1H), 4.14 (dd, <i>J</i> = 13.5 and 1.0 Hz, 1H), 3.80 (dd, <i>J</i> = 11.5 and 8.0 Hz, 1H), 3.48–3.36 (m, 1H), 2.83 (ddd, <i>J</i> = 11.0, 8.0, and 1.8 Hz, 1H), 2.31 (ddd, <i>J</i> = 13.0, 6.5, and 1.5 Hz, 1H), 1.64 (ddd, <i>J</i> = 12.8, 11.4, and 1.5 Hz, 1H), 0.98–0.89 (m, 1H), 0.64–0.51 (m, 2H), 0.45–0.38 (m, 1H), 0.28–0.21 (m, 1H).</div></div><div id="sec4_2_2_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (3a<i>R</i>,5<i>R</i>,7a<i>S</i>)-5-[(Benzyloxy)methyl]-7a-(2,4-difluorophenyl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>30a</b>)</h3><div class="NLM_p last">Boron trifluoride diethyl etherate (60.1 mL, 226 mmol) was added to a solution of <b>29a</b> (50 g, 202 mmol) in a 1:1 mixture of toluene and isopropyl ether (2000 mL total volume) at −78 °C. An emulsion was formed instantly and it remained through the course of the reaction. The reaction mixture was stirred at this temperature for 30 min and then treated with 2,4-difluoro-1-iodobenzene (27.1 mL, 226 mmol). <i>n</i>-Butyllithium (2.5 M in hexanes, 85.7 mL, 214 mmol) was slowly added while the reaction temperature was maintained at −78 to −73 °C. The resulting yellow emulsion mixture was allowed to stir at −78 °C for 1 h 20 min. An aliquot of the reaction mixture was quenched with NH<sub>4</sub>Cl (aq, saturated), and the organics were extracted with EtOAc. Analysis by TLC of the organic layer (40:60 EtOAc/heptanes) showed a minor (only visible when stained in KMnO<sub>4</sub>) amount of starting material together with the major product spot. The reaction was then quenched with saturated aqueous NH<sub>4</sub>Cl and water (1000 mL). The resulting heterogeneous solution was partitioned between H<sub>2</sub>O (1000 mL) and EtOAc (750 mL), and the now heterogeneous mixture was allowed to warm up to rt. The organic layer was isolated and the aqueous layer was back-extracted with EtOAc (3 × 250 mL). The combined organics were washed with brine (550 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to yield a yellow oily residue. The residue was redissolved in EtOAc, adsorbed on silica gel and loaded on CombiFlash 1 (330 g RediSep column, 25 CV, gradient from 0 to 70% of EtOAc in heptanes) for purification purposes. Fractions that contained the product spot were combined and concentrated under reduced pressure to afford <b>30a</b> as a yellow oily residue: yield 46.9 g, 64%; LC–MS <i>m</i>/<i>z</i> 362.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.93 (ddd, <i>J</i> = 9.1, 9.0, and 6.8 Hz, 1H), 7.40–7.28 (m, 5H), 6.93–6.87 (m, 1H), 6.80 (ddd, <i>J</i> = 11.9, 8.6, and 2.5 Hz, 1H), 4.60 (AB quartet, <i>J</i><sub>AB</sub> = 12.1 Hz 2H), 4.14 (dd, <i>J</i> = 12.7 and 1.8 Hz, 1H), 3.90–3.82 (m, 2H), 3.72 (br d, <i>J</i> = 7 Hz, 1H), 3.59–3.53 (m, 2H), 3.50 (dd, half of ABX pattern, <i>J</i> = 10.2 and 4.1 Hz, 1H), 3.12–3.04 (m, 1H), 1.90–1.82 (m, 1H), 1.60–1.48 (m, 1H, assumed, partially obscured by water peak).</div></div><div id="sec4_2_2_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>rel</i>-(3a<i>R</i>,5<i>R</i>,7a<i>S</i>)-5-Cyclopropyl-7a-(2,4-difluorophenyl)hexahydro-1<i>H</i>-pyrano[3,4-<i>c</i>][1,2]oxazole (<b>30b</b>)</h3><div class="NLM_p last">Boron trifluoride diethyl etherate (2.97 mL, 24.1 mmol) was added dropwise to a solution of <b>29b</b> (1.67 g, 9.99 mmol) in toluene (150 mL) at an internal temp of −72.5 °C. The reaction mixture was stirred at −73 to −76 °C for 30 min and then treated with 2,4-difluoro-1-iodobenzene (98%, 1.37 mL, 11.2 mmol) in one portion. While the reaction temperature was maintained below −73 °C, <i>n</i>-BuLi (2.5 M in hexanes, 4.24 mL, 10.6 mmol) was added in a dropwise manner over 15 min. The reaction mixture was stirred at −73 to −75 °C for 1 h and then was quenched with saturated aq NH<sub>4</sub>Cl (350 mL) at −74 °C and allowed to warm to rt. The resulting mixture was extracted with EtOAc (400 mL), and the aqueous layer was extracted with additional EtOAc (250 and 100 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 30%) afforded 2.16 g (77% yield) of <b>30b</b> as a white solid after azeotroping with CH<sub>2</sub>Cl<sub>2</sub>: GC–MS <i>m</i>/<i>z</i> 281 [M<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.98–7.88 (m, 1H), 6.93–6.84 (m, 1H), 6.79 (ddd, <i>J</i> = 11.9, 8.6, and 2.4 Hz, 1H), 6.34 (br s, 1H), 4.04 (br d, <i>J</i> = 12.7 Hz, 1H), 3.83 (d, <i>J</i> = 12.5 Hz, 1H), 3.72 (d, <i>J</i> = 7.0 Hz, 1H), 3.54 (dd, <i>J</i> = 6.8 and 5.1 Hz, 1H), 3.08–2.99 (m, 1H), 2.95–2.86 (m, 1H), 1.99 (br dd, <i>J</i> = 13.8 and 6.8 Hz, 1H), 1.68–1.56 (m, 1H), 1.00–0.88 (m, 1H), 0.64–0.51 (m, 2H), 0.47–0.37 (m, 1H), 0.33–0.24 (m, 1H).</div></div><div id="sec4_2_2_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> [(2<i>R</i>,4<i>R</i>,5<i>S</i>)-5-Amino-2-[(benzyloxy)methyl]-5-(2,4-difluorophenyl)tetrahydro-2<i>H</i>-pyran-4-yl]methanol (<b>31a</b>)</h3><div class="NLM_p last">To a mixture of <b>30a</b> (46.9 g, 130 mmol) in acetic acid (430 mL) was added zinc powder (110 g, 1690 mmol), and the reaction mixture was stirred for 18 h. Analysis by TLC (30% EtOAc/heptane) indicated that all starting material had been consumed. The insoluble material was removed via filtration, and the solids were washed with EtOAc. The combined filtrates were washed with saturated 1 N KOH, and the aqueous layer was extracted with EtOAc. The combined organic layers were washed with saturated aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford 49.5 g (quantitative yield) of <b>31a</b> as an opaque oil, which was used in the following reaction without additional purification: LC–MS <i>m</i>/<i>z</i> 364.4 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.79–7.62 (br m, 1H), 7.40–7.27 (m, 5H), 7.05–6.92 (br m, 1H), 6.83 (ddd, <i>J</i> = 12.6, 8.6, and 2.6 Hz, 1H), 4.61 (AB quartet, upfield signals are broadened, <i>J</i><sub>AB</sub> = 12.1 Hz, 2H), 4.22 (dd, <i>J</i> = 11.5 and 2.3 Hz, 1H), 3.92–3.82 (br m, 1H), 3.73–3.60 (br m, 1H), 3.60–3.42 (m, 3H), 3.41–3.32 (m, 1H), 2.41–2.24 (br m, 1H), 2.16–1.98 (br m, 1H), 1.65 (ddd, <i>J</i> = 14.0, 4.3, and 2.6 Hz, 1H).</div></div><div id="sec4_2_2_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>rel-</i>[(2<i>R</i>,4<i>R</i>,5<i>S</i>)-5-Amino-2-cyclopropyl-5-(2,4-difluorophenyl)tetrahydro-2<i>H</i>-pyran-4-yl]methanol (<b>31b</b>)</h3><div class="NLM_p last">To a solution of <b>30b</b> (1.19 g, 4.23 mmol) in glacial acetic acid (12 mL) stirred at room temperature was added zinc powder (3.51 g, 53.7 mmol) in one portion. During the 15 min after the zinc addition, a gradual internal exotherm from 22 °C initially to 38 °C at its peak was observed. After the exotherm peaked at 38 °C, it took ∼15 min for it to gradually subside back to 29 °C. After 1 h, the reaction mixture’s internal temp was 22 °C. The reaction mixture was stirred at rt for 18 h. The reaction mixture was filtered through a small plug of Celite, followed by an additional rinse with EtOAc (100 mL). The filtrate was slowly poured over stirring saturated aq NaHCO<sub>3</sub> (250 mL) and EtOAc (200 mL). The mixture was extracted and separated. The lower aq layer was washed with additional EtOAc (2 × 150 mL). The combined upper extracts were washed with brine (200 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo, to afford 1.22 g of <b>31b</b> as a thick, pale amber gum (1.22 g), which was taken directly to the following step without additional purification: LC–MS <i>m</i>/<i>z</i> 284.1 [M + H<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.61–7.77 (br m, 1H), 6.90–7.05 (br m, 1H), 6.82 (ddd, <i>J</i> = 12.7, 8.6, and 2.6 Hz, 1H), 4.13 (dd, <i>J</i> = 11.5 and 2.5 Hz, 1H), 3.55 (br dd, <i>J</i> = 11 and 2 Hz, 1H), 3.49–3.32 (br m, 2H), 2.89 (ddd, <i>J</i> = 11.3, 8.2, and 2.5 Hz, 1H), 2.34–2.03 (br m, 2H), 1.81 (ddd, <i>J</i> = 14.0, 4.0, and 2.6 Hz, 1H), 1.13–1.01 (br m, 1H), 0.65–0.53 (m, 2H), 0.48–0.41 (m, 1H), 0.32–0.24 (m, 1H).</div></div><div id="sec4_2_2_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-{[(3<i>S</i>,4<i>R</i>,6<i>R</i>)-6-[(Benzyloxy)methyl]-3-(2,4-difluorophenyl)-4-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl]carbamothioyl}benzamide (<b>32a</b>)</h3><div class="NLM_p last">To a solution of [(2<i>R</i>,4<i>R</i>,5<i>S</i>)-5-amino-2-[(benzyloxy)methyl]-5-(2,4-difluorophenyl)tetrahydro-2<i>H</i>-pyran-4-yl]methanol (<b>31a</b>) (50.1 g, 138 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1380 mL) was added benzoyl isothiocyanate (22.3 g, 18.4 mL, 137 mmol) and the reaction mixture was stirred at rt for 18 h. An aliquot of the reaction mixture was analyzed by LC–MS, which showed complete consumption of the starting material and major product mass. The reaction mixture was concentrated under reduced pressure to yield 73 g (100%) of an orange oily residue (<b>32a</b>). This material was used in the next step without purification.</div></div><div id="sec4_2_2_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-{[(3<i>S</i>,4<i>R</i>,6<i>R</i>)-6-[(Benzyloxy)methyl]-3-(2,4-difluorophenyl)-4-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl]carbamothioyl}-2-(9<i>H</i>-fluoren-9-yl)acetamide (<b>32a</b>′)</h3><div class="NLM_p last">A solution of 49.5 g (136 mmol) of <b>31a</b> in 1.4 L of anhydrous CH<sub>2</sub>Cl<sub>2</sub> was treated with 42.2 g (150 mmol) of FMOC-isothiocyanate. The reaction mixture was stirred at rt for 18 h. Analysis by TLC (1:1 EtOAc/heptanes) indicated that starting material was consumed and a new less polar spot had appeared. The reaction mixture was concentrated to dryness and the residue was chromatographed (SIM) on an 330 g column eluting with 0–30% EtOAc/heptanes. Some of the early fractions were rechromatographed on a 330 g column eluting with 0–30% EtOAc/heptanes. After evaporation of the solvent, there was obtained <b>32a</b>′ as a pink solid. This material was contaminated with a small amount of less polar cyclized material <b>33a</b>′ and a very minor impurity that was highly colored. The material was used directly in the next transformation: yield 91.4 g (quant.); LC–MS <i>m</i>/<i>z</i> 645.2 [M + 1].</div></div><div id="sec4_2_2_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>rel</i>-<i>N</i>-[(3<i>S</i>,4<i>R</i>,6<i>R</i>)-6-Cyclopropyl-3-(2,4-difluorophenyl)-4-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl]carbamothioyl}benzamide (<b>32b</b>)</h3><div class="NLM_p last">To a solution of <b>31b</b> (1.20 g, 4.23 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (45 mL) was added benzoyl isothiocyanate (0.540 mL, 4.02 mmol). After the reaction mixture had stirred at rt for 15 h, it was partitioned between aqueous HCl (0.1 M, 20 mL) and CH<sub>2</sub>Cl<sub>2</sub> (35 mL). The organic layer was washed with saturated aqueous sodium bicarbonate (25 mL) and with saturated aqueous NaCl (25 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 45%) provided 1.69 g (89% yield) of <b>32b</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 447.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ 11.64 (br s, 1H), 9.28 (br s, 1H), 7.93–7.89 (m, 2H), 7.69–7.64 (m, 1H), 7.58–7.52 (m, 2H), 7.58–7.44 (br m, 1H), 6.99–6.86 (m, 2H), 3.86–3.48 (br m, 2H), 3.47–3.35 (m, 1H), 3.01 (ddd, <i>J</i> = 11.3, 7.6, and 2.7 Hz, 1H), 3.0–2.89 (br m, 1H), 2.6–2.3 (br m, 1H), 2.03–1.96 (m, 1H), 1.9–1.7 (br m, 1H), 1.00–0.90 (m, 1H), 0.53–0.44 (m, 2H), 0.40–0.34 (m, 1H), 0.31–0.26 (m, 1H).</div></div><div id="sec4_2_2_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-[(Benzyloxy)methyl]-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>33a</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-{[(3<i>S</i>,4<i>R</i>,6<i>R</i>)-6-[(benzyloxy)methyl]-3-(2,4-difluorophenyl)-4-(hydroxymethyl)tetrahydro-2<i>H</i>-pyran-3-yl]carbamothioyl}benzamide (<b>32a</b>) (5.17 g, 9.82 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (89 mL) was added pyridine (3 mL, 37.3 mmol). The solution was cooled to −60 °C (dry ice/acetone) and then triflic anhydride (3.3 mL, 19.6 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (17 mL) was added dropwise. The reaction mixture turned from clear to yellow. The reaction was gradually warmed to −5 °C over 3 h. Water was then added and the mixture extracted. The aqueous layer was washed once more with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, 80 g, EtOAc/heptane gradient from 0 to 30%) afforded 2.58 g (52% yield) of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-[(benzyloxy)methyl]-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>33a</b>) as a white solid: LC–MS <i>m</i>/<i>z</i> 509.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 7.4 Hz, 2H), 7.52 (d, <i>J</i> = 7.4 Hz, 1H), 7.39–7.49 (m, 3H), 7.27–7.34 (m, 2H), 7.16–7.27 (m, 3H), 7.00–7.11 (m, 2H), 4.50–4.63 (m, 2H), 4.13 (m, 1H), 3.89 (m, 2H), 3.54–3.66 (m, 2H), 3.13–3.24 (m, 1H), 2.93 (m, <i>J</i> = 4.1 Hz, 1H), 2.74 (m, <i>J</i> = 13.1, 2.9 Hz, 1H), 1.88–2.00 (m, 1H), 1.66–1.75 (m, 1H).</div></div><div id="sec4_2_2_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-[(Benzyloxy)methyl]-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]-2-(9<i>H</i>-fluoren-9-yl)acetamide (<b>33a</b>′)</h3><div class="NLM_p last">The material for this reaction was split in half for the cyclization, but combined for workup: In two 2-L round-bottom flasks was dissolved <b>32a</b>′ (45.7 g, 71.0 mmol) in MeOH (958 mL). The solution was treated with 18.5 mL of concd HCl and the reaction mixture was heated to 70 °C for 3 h. Analysis by LC–MS and TLC (1:1 EtOAc/heptane) indicated that starting material was consumed. The reaction mixture was concentrated to a paste. The residues from the two reactions were dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with saturated aqueous NaHCO<sub>3</sub>. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×). The combined CH<sub>2</sub>Cl<sub>2</sub> extracts were washed with brine, and then the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. Compound <b>33a</b>′ was recovered as a pale yellow foam: yield 83.9 g, 95%; LC–MS <i>m</i>/<i>z</i> 627.1 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (d, <i>J</i> = 7.6 Hz, 2H), 7.70 (t, <i>J</i> = 6.7 Hz, 2H), 7.37–7.43 (m, 2H), 7.26–7.36 (m, 8H), 6.94 (m, <i>J</i> = 6.7, 6.7 Hz, 1H), 6.81–6.90 (m, 1H), 4.50–4.64 (m, 2H), 4.36–4.43 (m, 2H), 4.28–4.35 (m, 1H), 4.13 (d, <i>J</i> = 12.3 Hz, 1H), 3.84–3.95 (m, 1H), 3.75 (br s, 1H), 3.62 (dd, <i>J</i> = 10.0, 6.3 Hz, 1H), 3.48 (dd, <i>J</i> = 10.0, 4.4 Hz, 1H), 3.09 (br s, 1H) 2.95 (dd, <i>J</i> = 12.8, 3.8 Hz, 1H), 2.60 (m, <i>J</i> = 11.30 Hz, 1H), 1.90 (m, <i>J</i> = 12.90 Hz, 1H), 1.66 (d, <i>J</i> = 12.29 Hz, 1H).</div></div><div id="sec4_2_2_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>rel</i>-<i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-Cyclopropyl-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>33b</b>)</h3><div class="NLM_p last">To a magnetically stirred solution of <b>32b</b> (1680 mg, 3.76 mmol) and pyridine (1.09 mL, 13.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (67 mL, anhydrous) at −50 °C (xylenes/dry ice bath, internal temp) was added trifluoromethanesulfonic anhydride (1.27 mL, 7.52 mmol) in a dropwise fashion, and then the reaction mixture was gradually warmed to 0 °C over 90 min. The reaction mixture was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and water (100 mL). The phases were separated, and the lower organic layer was washed with water (2 × 75 mL) followed by brine (1 × 75 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and purified by flash chromatography (SiO<sub>2</sub>, 80 g RediSep Gold column, EtOAc/heptane gradient from 0 to 35% over 23 CV, 60 mL/min) to afford 1.42 g (88% yield) of <b>33b</b> as a solid: LC–MS <i>m</i>/<i>z</i> 429.1 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.7–12.5 (v br s, 1H), 8.24 (br d, <i>J</i> = 7.6 Hz, 2H), 7.54–7.48 (m, 1H), 7.48–7.38 (m, 3H), 6.97–6.82 (m, 2H), 4.08 (br dd, <i>J</i> = 12.4 and 1.3 Hz, 1H), 3.80 (d, <i>J</i> = 12.3 Hz, 1H), 3.13–3.05 (m, 1H), 3.04–2.93 (m, 2H), 2.64 (dd, <i>J</i> = 12.8 and 2.6 Hz, 1H), 2.18–2.05 (m, 1H), 1.83–1.75 (m, 1H), 1.06–0.96 (m, 1H), 0.62–0.50 (m, 2H), 0.46–0.40 (m, 1H), 0.29–0.22 (m, 1H).</div></div><div id="sec4_2_2_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-Cyclopropyl-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>34</b>)</h3><div class="NLM_p last">To a solution of <b>33b</b> (480 mg, 1.12 mmol) in methanol (20 mL) was added DBU (95%, 130 μL, 0.83 mmol) and the mixture was heated to 80 °C for 9 h. The reaction mixture was cooled, concentrated in vacuo, and then partitioned between CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and water (40 mL). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified via flash chromatography (SiO<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub>, 0 to 15%) to provide <i><b>rac</b></i>-<b>34</b>, which was separated into its enantiomers using supercritical-fluid chromatography (column, Phenomenex Lux Cellulose-4, 5 μm; eluent, 7:3 carbon dioxide/methanol containing 0.2% isopropylamine). The first-eluting enantiomer provided 147 mg (40% yield) as a pale yellow solid. The indicated absolute stereochemistry was assigned to compound <b>34</b> on the basis of this compound’s biological activity; its enantiomer proved to be essentially inactive: yield 147 mg, 0.453 mmol, 40%; LC–MS <i>m</i>/<i>z</i> 325.2 [M + H<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36 (ddd, <i>J</i> = 9, 9, and 6.7 Hz, 1H), 6.89–6.82 (m, 1H), 6.78 (ddd, <i>J</i> = 12.4, 8.6, and 2.6 Hz, 1H), 4.01 (dd, <i>J</i> = 11.0 and 2.4 Hz, 1H), 3.79 (d, <i>J</i> = 11.2 Hz, 1H), 2.95 (dd, <i>J</i> = 12.2 and 4.2 Hz, 1H), 2.90–2.79 (m, 2H), 2.60 (dd, <i>J</i> = 12.3 and 2.7 Hz, 1H), 2.00–1.88 (m, 1H), 1.61 (ddd, <i>J</i> = 13.4, 4.1, and 2.2 Hz, 1H), 1.05–0.95 (m, 1H), 0.60–0.48 (m, 2H), 0.46–0.39 (m, 1H), 0.26–0.19 (m, 1H); [α]<sub class="stack">D</sub><sup class="stack">25.4</sup> = +19.6° (<i>c</i> = 0.355, MeOH).</div></div><div id="sec4_2_2_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-(hydroxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>35</b>)</h3><div class="NLM_p last">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-[(benzyloxy)methyl]-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>33a</b>) (255 mg, 0.501 mmol) in EtOAc (8 mL) was added sodium bromate (378 mg, 2.5 mmol in 7 mL of water). The reaction mixture was cooled to 0 °C and was then added dropwise to a vigorously stirred biphasic mixture of sodium dithionate (436 mg 2.5 mmol) in 12 mL of water over 10 min. The yellow/orange mixture was removed from the ice bath and stirred at rt for 1.5 h. The mixture was diluted with EtOAc (15 mL) and water (10 mL). The layers were separated, and the EtOAc phase was washed with saturated aq sodium thiosulfate (10 mL). The color was completely discharged, and then brine (15 mL) was added. The EtOAc phase was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concd in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, 12 g, EtOAc/heptane gradient from 0 to 100%) afforded 134 mg (64%) of <b>35</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 419.3 [M + 1H<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (d, <i>J</i> = 7.4 Hz, 2H) 7.34–7.54 (m, 4H) 6.83–6.95 (m, 2H) 4.16 (dd, <i>J</i> = 12.1, 1.6 Hz, 1H) 3.77–3.85 (m, 2H) 3.60–3.70 (m, 2H) 3.11–3.19 (m, 1H) 3.00 (dd, <i>J</i> = 13.0, 4.2 Hz, 1H) 2.63 (dd, <i>J</i> = 12.9, 2.7 Hz, 1H) 1.94–2.05 (m, 1H) 1.58 (ddd, <i>J</i> = 13.5, 4.3, 2.2 Hz, 1H).</div></div><div id="sec4_2_2_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>tert</i>-Butyl [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-(hydroxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]carbamate (<b>35</b>′)</h3><div class="NLM_p">A mixture of <b>33a</b>′ (83.9 g, 134 mmol) in concd HCl (1.2 L) was heated to 120 °C for 3 h. The reaction mixture was removed from heat and allowed to cool to rt. Analysis by TLC (1:1 EtOAc/heptane) indicated that two more polar substances were present. The major product was the desired debenzylated substance, together with a minor amount of doubly deprotected material, both of which precipitated from the aqueous phase. The aqueous HCl was decanted to afford a gum. The gum was taken up in EtOAc and carefully basified with saturated aq bicarbonate. The aqueous phase was extracted with EtOAc (three times). The combined EtOAc extracts were washed with H<sub>2</sub>O and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The organic phase was concentrated in vacuo to afford a yellow foam, which was used directly in the next step: yield 65.4 g, 91%; LC–MS <i>m</i>/<i>z</i> 537.6 [M + 1].</div><div class="NLM_p">The product (65.4 g 122 mmol) from the previous reaction was taken up in DMF (80 mL), followed by the addition of piperidine (40 mL). The reaction mixture was stirred at rt for 1 h. Analysis by TLC (1:1 EtOAc/heptane or 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) indicated that starting material had been consumed. The mixture was concentrated to a lesser volume and saturated aqueous sodium bicarbonate solution was added, followed by extraction with EtOAc (4×). The EtOAc extracts were combined and washed with H<sub>2</sub>O and with brine, followed by drying over Na<sub>2</sub>SO<sub>4</sub>. The organic phase was concentrated to dryness. The residue was triturated in CH<sub>2</sub>Cl<sub>2</sub> and then filtered, and the product was air-dried. [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-2-Amino-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-6-yl]methanol was recovered as a white solid: yield 29.5 g, 77%; LC–MS <i>m</i>/<i>z</i> 315.5 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (m, <i>J</i> = 8.8, 8.8, 6.9 Hz, 1H), 6.74–6.88 (m, 2H), 4.09 (m, 1H), 3.80 (d, <i>J</i> = 11.1 Hz, 1H), 3.70–3.78 (m, 1H), 3.58–3.69 (m, 2H), 2.87–2.98 (m, 2H), 2.56–2.63 (m, 1H), 1.79–1.91 (m, 1H), 1.35–1.43 (m, 1H).</div><div class="NLM_p last">To a solution of [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-2-amino-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-6-yl]methanol (29.5 g, 93.8 mmol) in a mixture of THF (295 mL) and MeOH (135 mL) was added triethylamine (21.1 mL, 150 mmol) followed by addition of <i>t</i>-BOC anhydride in one portion. The reaction mixture was stirred at rt for 18 h. Analysis by TLC (10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> or 1:1 EtOAc/hexane) indicated a new less polar spot, which was UV active. The reaction mixture was concentrated in vacuo and the residue was taken up in EtOAc and washed with H<sub>2</sub>O and saturated brine, and then the solution was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was triturated in a minimum volume of CH<sub>2</sub>Cl<sub>2</sub> and the product was isolated by filtration. The triturated material was still impure, containing a minor amount of less polar material and baseline material. The product was chromatographed (SIM) on a 12 g CombiFlash column eluting with a 50–100% EtOAc/heptane gradient. After evaporation of the eluent, <b>35</b>′ was obtained as a white solid: yield 32.3 g, 83%; LC–MS <i>m</i>/<i>z</i> 415.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.30–7.38 (m, 1H), 6.98–7.06 (m, 2H), 4.05–4.11 (m, 1H), 3.79 (d, <i>J</i> = 11.9 Hz, 1H), 3.67–3.75 (m, 1H), 3.56 (d, <i>J</i> = 5.1 Hz, 2H), 3.02–3.15 (m, 1H), 2.85–2.94 (m, 1H), 2.65–2.73 (m, 1H), 1.68–1.82 (m, 1H), 1.57–1.67 (m, 1H), 1.47–1.50 (m, 9H).</div></div><div id="sec4_2_2_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>36</b>)</h3><div class="NLM_p">(Diethylamino)sulfur trifluoride (DAST) (2.39 mL, 18.1 mmol) was dissolved in a mixture of pentane (78 mL) and CH<sub>2</sub>Cl<sub>2</sub> (49 mL) at room temperature in a 1000 mL round-bottomed flask equipped with an addition funnel and N<sub>2</sub> inlet. The alcohol <b>35</b>′ (5.0 g, 12 mmol) dissolved in a mixture of pentane (60 mL) and CH<sub>2</sub>Cl<sub>2</sub> (105 mL) was added dropwise to the DAST solution. The reaction was stirred at room temperature for 18 h. Analysis by TLC (1:1 EtOAc/heptane) showed a new less polar spot with no starting material evident at this point (however, a small amount of starting material was recovered at the end of the workup). The organic reaction mixture was treated with an equal volume of saturated aq bicarbonate solution followed by extraction with CH<sub>2</sub>Cl<sub>2</sub> (three times), and then the organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and evaporated in vacuo. The crude residue was chromatographed (SIM) on a 330 g RediSep Gold column eluting with a 0–25% EtOAc/heptane gradient. Evaporation of the eluent afforded <i>tert</i>-butyl [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]carbamate as a white solid: yield 2.54 g, 50.6%. For safety reasons in using DAST, five separate reactions on a 5.0 g scale were run using the preceding conditions and the products were combined to afford additional quantities of <i>tert</i>-butyl [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]carbamate: yield 12.7 g, 51%; LC–MS <i>m</i>/<i>z</i> 415.4 [M – 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), δ 7.36–7.28 (m, 1H), 6.96–6.89 (m, 1H), 6.85 (ddd, <i>J</i> = 12.4, 8.4, and 2.4 Hz, 1H), 4.50 (ddd, half of ABXY pattern, <i>J</i> = 47.7, 9.9, and 6.4 Hz, 1H), 4.42 (ddd, half of ABXY pattern, <i>J</i> = 46.7, 9.9, and 3.6 Hz, 1H), 4.15 (dd, <i>J</i> = 11.9 and 1.9 Hz, 1H), 3.91–4.03 (m, 1H), 3.79 (br d, <i>J</i> = 12 Hz, 1H), 3.10–3.01 (br m, 1H), 2.93 (dd, <i>J</i> = 12.9 and 3.8 Hz, 1H), 2.57 (dd, <i>J</i> = 12.9 and 2.8 Hz, 1H), 1.99–1.87 (m, 1H), 1.53 (s, 9H).</div><div class="NLM_p last">A solution of <i>tert</i>-butyl [(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(fluoromethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]carbamate (24.0 g, 57.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (696 mL) was cooled to 0 °C and treated with trifluoroacetic acid (TFA) (80 mL, 1100 mmol). The reaction mixture was allowed to warm to rt and was then stirred for 4 h. Analysis by TLC (1:1 EtOAc/heptane or 10% MeOH/CH<sub>2</sub>Cl<sub>2</sub>) indicated that starting material was consumed. The mixture was diluted with EtOAc and then carefully basified with sat.urated aq bicarbonate solution. It was found that the aqueous bicarbonate solution was not sufficiently basic to neutralize the TFA salt of the thioamidine, and thus, the aqueous layer was treated with solid NaOH until the pH of the aqueous phase was above 10. The mixture was separated and the aqueous layer was extracted twice more with EtOAc. The combined EtOAc extracts were washed with H<sub>2</sub>O and brine and then dried over Na<sub>2</sub>SO<sub>4</sub>. The organic phase was concentrated in vacuo. The product was chromatographed (SIM) on a 330 g RediSep Gold column eluting with a 0–10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient. Fractions containing the product were concentrated in vacuo to afford <b>36</b> as a white solid: yield 17.3 g, 95%; LC–MS <i>m</i>/<i>z</i> 317.2 [M + 1]; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.41–7.36 (m, 1H), 7.34–7.28 (m, 1H), 7.26–7.21 (m, 1H), 4.57–4.38 (m, 2H), 4.01–3.92 (m, 2H), 3.88 (d, half of AB quartet, <i>J</i> = 12.3 Hz, 1H), 3.21–3.14 (m, 1H), 3.02 (br d, <i>J</i> = 13 Hz, 1H), 2.88 (dd, <i>J</i> = 13.2 and 3.5 Hz, 1H), 1.66–1.72 (m, 1H), 1.56–1.64 (m, 1H); [α]<sub class="stack">D</sub><sup class="stack">25.4</sup> = −2.20° (<i>c</i> = 0.355, MeOH). The structure of this compound was further confirmed by generating a single-crystal X-ray structure (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec4_2_2_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-formyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>37</b>)</h3><div class="NLM_p last">To a solution of <b>35</b> (19 g, 45 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (908 mL) in a rt water bath was added triethylamine (75.9 mL, 545 mmol). After 5 min, dimethyl sulfoxide (45.2 mL, 636 mmol) was rapidly added, immediately followed by sulfur trioxide–pyridine complex (98%, 59.0 g, 363 mmol) in a single portion. The resulting solution was stirred at rt for 4 h, whereupon it was diluted with a 1:1 mixture of saturated aq NaCl and water and stirred for 10 min. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2×), and the combined organic layers were washed with water until the pH of the aqueous extract was pH 6–7 and then were washed with 0.2 N HCl (2×) and once with saturated aq NaCl. After being dried over Na<sub>2</sub>SO<sub>4</sub>, the organic layer was filtered and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 100%) provided 13.27 g (71% yield) of <b>37</b> as a pale yellow solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.71 (br s, 1H), 8.24–8.16 (m, 2H), 7.56–7.50 (m, 1H), 7.48–7.36 (m, 3H), 6.98–6.87 (m, 2H), 4.23 (dd, <i>J</i> = 12.2 and 1.6 Hz, 1H), 4.15–4.09 (m, 1H), 3.94 (d, <i>J</i> = 12.1 Hz, 1H), 3.22–3.13 (m, 1H), 3.04 (dd, <i>J</i> = 13.1 and 4.0 Hz, 1H), 2.69 (dd, <i>J</i> = 13.0 and 2.9 Hz, 1H), 2.15–2.02 (m, 1H), 1.99–1.92 (m, 1H).</div></div><div id="sec4_2_2_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-(Difluoromethyl)-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>38</b>)</h3><div class="NLM_p">To a solution of <b>37</b> (previously azeotroped twice with 5 mL of toluene; 3.30 g, 7.92 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (80 mL) cooled to −20 °C was added DAST (2.62 mL, 19.8 mmol) dropwise over 7 min and the reaction mixture was allowed to slowly warm to rt. After 5 h at rt, it was cooled to 0 °C, diluted with saturated aqueous sodium bicarbonate (45 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 40 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 80%) provided 2.03 g (58% yield) of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-(difluoromethyl)-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid: <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (br d, <i>J</i> = 7 Hz, 2H), 7.58–7.51 (m, 1H), 7.50–7.42 (m, 3H), 7.12–7.02 (m, 2H), 5.83 (td, <i>J</i> = 55.4 and 4.3 Hz, 1H), 4.17 (br d, <i>J</i> = 12 Hz, 1H), 3.95 (d, <i>J</i> = 12.1 Hz, 1H), 4.02–3.91 (m, 1H), 3.26–3.16 (m, 1H), 2.97 (dd, <i>J</i> = 13 and 4 Hz, 1H), 2.79 (dd, <i>J</i> = 12.9 and 2.7 Hz, 1H), 2.08–1.96 (m, 1H), 1.85–1.77 (m, 1H).</div><div class="NLM_p last">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-(difluoromethyl)-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (2000 mg, 4.56 mmol) in methanol (20 mL) was added DBU (718 μL, 4.56 mmol). The reaction mixture was heated to 68 °C for 18 h. The reaction mixture was then cooled slightly and concentrated in vacuo. The residue was purified using flash chromatography (SiO<sub>2</sub>, 40 g RediSep Gold column, EtOAc/heptanes gradient from 15 to 100%) to afford 1.46 g (96% yield) of <b>38</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 335.1 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.35 (ddd, <i>J</i> = 9, 9, and 7 Hz, 1H), 7.01–6.93 (m, 2H), 5.77 (td, <i>J</i> = 55.6 and 3.9 Hz, 1H), 4.11 (dd, <i>J</i> = 11.1 and 2.0 Hz, 1H), 3.92–3.81 (m, 1H), 3.73 (d, <i>J</i> = 11.0 Hz, 1H), 2.97–2.87 (m, 2H), 2.75–2.69 (m, 1H), 1.99–1.88 (m, 1H), 1.66–1.59 (m, 1H); [α]<sub class="stack">D</sub><sup class="stack">27</sup> = −2.13° (<i>c</i> 0.835, MeOH).</div></div><div id="sec4_2_2_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-ethyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>39</b>)</h3><div class="NLM_p">To a magnetically stirred suspension of methyltriphenylphosphonium bromide (547 mg, 1.5 mmol) in THF (9 mL, anhydrous) at rt under a nitrogen atmosphere was added <i>t</i>-BuOK (1.0 M in THF, 1.5 mL, 1.5 mmol) in a dropwise fashion. All solids dissolved and then the solution turned deep yellow/pale orange. A precipitate formed immediately thereafter and this mixture was stirred at rt for 1 h and was then cooled to −15 °C (internal temp). A solution of <b>37</b> (312 mg, 0.75 mmol) in THF (3 mL, anhydrous) was added in a dropwise fashion over 5 min. The internal temp never exceeded −12 °C. One minute after the addition was complete, the cooling bath was removed and the reaction was allowed to warm to rt over 20 min (21 °C internal temp). The reaction mixture was stirred at rt for 10 min and then cooled to 0 °C (external bath temp). The reaction was quenched by addition of saturated aq NH<sub>4</sub>Cl (15 mL) and the mixture was then extracted with EtOAc (2 × 25 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by flash chromatography (SiO<sub>2</sub>, 24 g RediSep Gold, EtOAc/heptane gradient from 0 to 25% over 20 CV, 35 mL/min) to afford 256 mg (82% yield) of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-vinyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid: LC–MS <i>m</i>/<i>z</i> 415 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (d, <i>J</i> = 7.4 Hz, 2H), 7.48–7.29 (m, 4H), 6.90–6.74 (m, 2H), 5.84 (ddd, <i>J</i> = 17.3, 10.7, and 5.7 Hz, 1H), 5.33–5.21 (m, 1H), 5.11 (td, <i>J</i> = 10.7 and 1.2 Hz, 1H), 4.11 (dd, <i>J</i> = 12.1 and 1.8 Hz, 2H), 3.76 (d, <i>J</i> = 12.1 Hz, 1H), 3.18–3.05 (m, 1H), 2.95 (dd, <i>J</i> = 12.7 and 4.1 Hz, 1H), 2.64–2.50 (m, 1H), 2.08–1.91 (m, 1H), 1.72–1.61 (m, 1H).</div><div class="NLM_p">A solution of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-vinyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (50 mg. 0.12 mmol) in MeOH (35 mL) was placed in a 250 mL Parr bottle. The solution was treated with solid palladium on activated carbon (10 wt % dry basis, wet Degussa type E101 NE/W, 50 mg). The vessel was sealed, evacuated, charged with H<sub>2</sub> (25 psi), and mechanically shaken for 90 min. The reaction vessel was then evacuated and recharged with N<sub>2</sub> gas. The mixture was then carefully filtered through Celite and the filter cake washed with MeOH (30 mL). The combined filtrate was concentrated in vacuo to afford 50 mg (quantitative yield) of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-ethyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as an off-white/pale yellow solid: LC–MS <i>m</i>/<i>z</i> 417 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (d, <i>J</i> = 7.0 Hz, 2H), 7.32–7.55 (m, 4H), 6.79–6.97 (m, 2H), 4.10 (d, <i>J</i> = 12.1 Hz, 1H), 3.76 (d, <i>J</i> = 11.9 Hz, 1H), 3.45–3.58 (m, 1H), 3.04–3.18 (m, <i>J</i> = 10.0 Hz, 1H), 2.99 (dd, <i>J</i> = 3.8, 13.0 Hz, 1H), 2.62 (d, <i>J</i> = 12.5 Hz, 1H), 1.81–1.95 (m, 1H), 1.56–1.72 (m, 2H), 1.45–1.56 (m, 1H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H).</div><div class="NLM_p last">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-ethyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (45 mg, 108 μmol) in MeOH (2 mL, anhydrous) was added DBU (13 μL, 82 μmol) in a sealed vial with magnetic stirring and heating to 80 °C. The mixture soon became a complete solution and the reaction was stirred at 80 °C for 18 h. The solvent was removed using N<sub>2</sub> flow and the residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (12 mL) and water (4 mL). The CH<sub>2</sub>Cl<sub>2</sub> layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered through cotton, and purified using flash chromatography (SiO<sub>2</sub>, 4 g RediSep Gold column, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0 to 15% over 15 min, 18 mL/min) to afford 20.2 mg (58% yield) of <b>39</b> as a white foam (20.2 mg, 58%): LC–MS <i>m</i>/<i>z</i> 313 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (dt, <i>J</i> = 9.0 and 6.6 Hz, 1H), 6.83–6.66 (m, 2H), 3.98 (dd, <i>J</i> = 11.0 and 2.5 Hz, 1H), 3.70 (d, <i>J</i> = 11.2 Hz, 1H), 3.46–3.35 (m, 1H), 2.88 (dd, <i>J</i> = 12.2 and 4.2 Hz, 1H), 2.84–2.75 (m, 1H), 2.52 (dd, <i>J</i> = 12.1 and 2.7 Hz, 1H), 1.71–1.51 (m, 2H), 1.50–1.37 (m, 2H), 0.96–0.85 (m, 3H).</div></div><div id="sec4_2_2_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-(2-methylpropyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>40</b>)</h3><div class="NLM_p">To a suspension of triphenyl(propan-2-yl)phosphonium iodide (1.08 g, 2.50 mmol) in THF (10 mL) at 0 °C was added <i>n</i>-BuLi (2.5 M in hexanes, 0.90 mL, 2.25 mmol) in a dropwise fashion. The resulting solution was stirred and allowed to warm to rt over 30 min, whereupon it was cooled to 0 °C. A solution of <b>37</b> (104 mg, 0.250 mmol) in THF (1 mL) was added, and stirring was continued at 0 °C for 1 h and then at rt for 3 h. The reaction mixture was diluted with EtOAc (20 mL), washed with saturated aq sodium bicarbonate (3 × 20 mL) and with water (20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane gradient from 0 to 30%) afforded 42 mg (38% yield) of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(2-methylprop-1-en-1-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid: LC–MS <i>m</i>/<i>z</i> 443.3 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.8 (v br s, 1H), 8.24 (d, <i>J</i> = 7.4 Hz, 2H), 7.55–7.38 (m, 4H), 6.97–6.85 (m, 2H), 5.27 (d, <i>J</i> = 8 Hz, 1H), 4.40–4.31 (m, 1H), 4.19 (d, <i>J</i> = 12.1 Hz, 1H), 3.80 (d, <i>J</i> = 12.1 Hz, 1H), 3.22–3.13 (m, 1H), 3.06–2.98 (m, 1H), 2.68–2.59 (m, 1H), 2.13–2.00 (m, 1H), 1.75 (s, 6H), 1.67–1.59 (m, 1H); [α]<sub class="stack">D</sub><sup class="stack">25.9</sup> = −5.59° (<i>c</i> = 0.340, MeOH).</div><div class="NLM_p">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(2-methylprop-1-en-1-yl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (42 mg, 95 μmol) in MeOH (28 mL) in a Parr bottle was added palladium on activated carbon [10% by weight (dry), 50% water, 224 mg, 105 μmol]. The reaction mixture was charged with hydrogen gas (35 psi) and mechanically shaken for 20 h. The reaction mixture was then filtered through Celite, and the filter pad was rinsed with MeOH (30 mL). The combined filtrates were concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, EtOAc/heptanes gradient from 0 to 30%) to afford 10.9 mg (26% yield) of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(2-methylpropyl)-4,4a,5,6,8,8a-hexahydro-pyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as an opaque semisolid: LC–MS <i>m</i>/<i>z</i> 445.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (br d, <i>J</i> = 8 Hz, 2H), 7.54–7.48 (m, 1H), 7.48–7.37 (m, 3H), 6.96–6.84 (m, 2H), 4.11 (dd, <i>J</i> = 12.2 and 1.5 Hz, 1H), 3.77 (d, <i>J</i> = 12.1 Hz and 1H), 3.72–3.64 (m, 1H), 3.17–3.09 (m, 1H), 3.01 (dd, <i>J</i> = 12.7 and 4.1 Hz, 1H), 2.63 (dd, <i>J</i> = 12.7 and 2.7 Hz, 1H), 1.97–1.86 (m, 1H), 1.87–1.76 (m, 1H), 1.65–1.55 (m, 2H), 1.31–1.23 (m,1H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H), 0.92 (d, <i>J</i> = 6.6 Hz, 3H).</div><div class="NLM_p last">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(2-methylpropyl)-4,4a,5,6,8,8a-hexahydro-pyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (10.5 mg, 23.6 μmol) in MeOH (0.4 mL) was added DBU (3.0 μL, 20 μmol) and the reaction mixture was heated to 60 °C for 18 h in a sealed vial. Solvent was removed under a stream of nitrogen, and the residue was partitioned between water (3 mL) and EtOAc (5 mL). The aqueous layer was extracted with EtOAc (5 mL), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by reversed-phase high-performance liquid chromatography [column, Waters XBridge C18, 5 μm; mobile phase A, 0.03% ammonium hydroxide in water (v/v); mobile phase B, 0.03% ammonium hydroxide in acetonitrile (v/v); gradient, 30–100% B] afforded 4.2 mg (51% yield) of <b>40</b>; LC–MS <i>m</i>/<i>z</i> 341.1 [M + 1]; <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.36–7.31 (m, 1H), 7.20–7.15 (m, 1H), 7.08 (ddd, <i>J</i> = 9, 8, and 2 Hz, 1H), 3.86 (dd, <i>J</i> = 10.5 and 1.8 Hz, 1H), 3.54 (d, <i>J</i> = 10.5 Hz, 1H), 3.56–3.50 (m, 1H), 2.73–2.62 (m, 3H), 1.79–1.71 (m, 1H), 1.60–1.52 (m, 1H), 1.50–1.45 (m, 1H), 1.40 (ddd, <i>J</i> = 14, 8, and 6 Hz, 1H), 1.21 (ddd, <i>J</i> = 14, 8, and 4.5 Hz, 1H), 0.89 (d, <i>J</i> = 6.1 Hz, 3H), 0.88 (d, <i>J</i> = 6.6 Hz, 3H).</div></div><div id="sec4_2_2_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-6-(Chloromethyl)-8a-(2,4-difluorophenyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (<b>41</b>)</h3><div class="NLM_p last">To a solution of <b>35</b> (2.0 g, 4.8 mmol) in toluene (68 mL) was added thionyl chloride (10.4 mL, 143 mmol), and the reaction mixture was heated to 80 °C for 18 h. After cooling to rt, it was concentrated in vacuo and azeotroped with CH<sub>2</sub>Cl<sub>2</sub> (3×). The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with saturated aq NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptanes gradient from 0 to 100%) provided 1.88 g (90% yield) of <b>41</b> as an off-white solid: LC–MS <i>m</i>/<i>z</i> 437.1 [M + H<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12–8.08 (m, 2H), 7.65–7.59 (m, 1H), 7.55–7.46 (m, 3H), 7.17–7.05 (m, 2H), 4.18 (dd, <i>J</i> = 12.2 and 1.3 Hz, 1H), 4.01 (d, <i>J</i> = 12.3 Hz, 1H), 3.98–3.91 (m, 1H), 3.69–3.61 (m, 2H), 3.3–3.26 (m, 1H, assumed, partially obscured by solvent peak), 3.07 (br dd, <i>J</i> = 13.3 and 3.7 Hz, 1H), 2.91 (br dd, <i>J</i> = 13.3 and 2.5 Hz, 1H), 1.93–1.86 (m, 2H).</div></div><div id="sec4_2_2_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> (4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-methyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>42</b>)</h3><div class="NLM_p">To a solution of <b>41</b> (1.88 g, 4.30 mmol) in THF cooled to 0 °C was added lithium triethylborohydride (1 M in tetrahydrofuran, 34.4 mL, 34.4 mmol) in a dropwise fashion, and the reaction mixture was allowed to warm to rt. After 18 h, the reaction mixture was partitioned between aqueous sodium bicarbonate solution and EtOAc. The aqueous layer was extracted twice with EtOAc, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification using flash chromatography (SiO<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0 to 10%) afforded 1.4 g (81% yield) of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-methyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid: LC–MS <i>m</i>/<i>z</i> 403.1 [M + 1]; <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 12.29 (br s, 1H), 8.30–8.19 (br m, 2H), 7.54–7.48 (m, 1H), 7.48–7.37 (m, 3H), 6.96–6.84 (m, 2H), 4.15 (dd, <i>J</i> = 12.2 and 2.0 Hz, 1H), 3.84–3.77 (m, 1H), 3.77 (d, <i>J</i> = 12.3 Hz, 1H), 3.19–3.09 (br m, 1H), 3.01 (dd, <i>J</i> = 12.9 and 4.1 Hz, 1H), 2.63 (dd, <i>J</i> = 12.8 and 2.8 Hz, 1H), 2.00–1.88 (m, 1H), 1.69–1.62 (m, 1H), 1.30 (d, <i>J</i> = 6.2 Hz, 3H).</div><div class="NLM_p last">To a suspension of <i>N</i>-[(4a<i>R</i>,6<i>S</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-methyl-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (1.40 g, 3.48 mmol) in MeOH (100 mL) was added DBU (0.5 mL, 3 mmol), and the resulting mixture was heated to 80 °C for 18 h. After concentration in vacuo, the residue was partitioned between saturated aqueous sodium bicarbonate and EtOAc, the aqueous layer was extracted with EtOAc, and the combined organic layers were washed with saturated aqueous NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification via flash chromatography (SiO<sub>2</sub>, EtOAc) afforded 840 mg (81% yield) of <b>42</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 299.2 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.38–7.30 (m, 1H), 7.00–6.92 (m, 2H), 4.08 (dd, <i>J</i> = 11.1 and 2.2 Hz, 1H), 3.78–3.69 (m, 1H), 3.65 (d, <i>J</i> = 11.1 Hz, 1H), 2.93–2.83 (m, 2H), 2.68–2.62 (m, 1H), 1.76–1.65 (m, 1H), 1.54 (ddd, <i>J</i> = 13.1, 4.1, and 2.4 Hz, 1H), 1.22 (d, <i>J</i> = 6.2 Hz, 3H); [α]<sub class="stack">D</sub><sup class="stack">27.4</sup> = −5.25° (<i>c</i> = 0.755, MeOH).</div></div><div id="sec4_2_2_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-Difluorophenyl)-6-(methoxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-amine (<b>43</b>)</h3><div class="NLM_p">A solution of <b>35</b> (300 mg, 0.717 mmol) in THF (2.5 mL) was added to a mixture of sodium hydride (60% in mineral oil, 60.2 mg, 1.51 mmol) in THF (5 mL), and the reaction mixture was stirred at rt for 25 min. To this was added iodomethane (44.7 μL, 0.717 mmol), and the reaction mixture was heated to 41 °C for 6 h, cooled back to rt, and quenched with saturated aqueous NH<sub>4</sub>Cl (15 mL). After extraction with EtOAc (3 × 20 mL), the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by flash chromatography (SiO<sub>2</sub>, EtOAc/heptane, 0 to 50%) provided 214 mg (69% yield) of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(methoxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide as a white solid: LC–MS <i>m</i>/<i>z</i> 329.0 [M + 1]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.12 (d, <i>J</i> = 7.0 Hz, 2H), 7.57–7.50 (m, <i>J</i> = 7.4 Hz, 1H), 7.49–7.38 (m, 3H), 7.12–6.99 (m, 2H), 4.16–4.09 (m, 1H), 3.94–3.80 (m, 2H), 3.58–3.40 (m, 2H), 3.37 (s, 3H), 3.23–3.11 (m, 1H), 3.01–2.90 (m, 1H), 2.74 (dd, <i>J</i> = 13.1 and 2.7 Hz, 1H), 1.94–1.79 (m, 1H), 1.75–1.64 (m, 1H).</div><div class="NLM_p last">To a solution of <i>N</i>-[(4a<i>R</i>,6<i>R</i>,8a<i>S</i>)-8a-(2,4-difluorophenyl)-6-(methoxymethyl)-4,4a,5,6,8,8a-hexahydropyrano[3,4-<i>d</i>][1,3]thiazin-2-yl]benzamide (214 mg, 0.494 mmol) in MeOH (12 mL) was added DBU (95%, 62 μL, 0.396 mmol) and the mixture heated to 72 °C for 18 h. The reaction mixture was concentrated in vacuo and purified by flash chromatography (SiO<sub>2</sub>, MeOH/CH<sub>2</sub>Cl<sub>2</sub> gradient from 0 to 10%), to afford 118 mg (72% yield) of <b>43</b> as a white solid: LC–MS <i>m</i>/<i>z</i> 329.0 [M + H<sup>+</sup>]; <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.34 (ddd, <i>J</i> = 9, 9, and 7 Hz, 1H), 7.00–6.93 (m, 2H), 4.08 (dd, <i>J</i> = 11.1 and 2.2 Hz, 1H), 3.84–3.77 (m, 1H), 3.69 (d, <i>J</i> = 11.1 Hz, 1H), 3.47 (dd, half of ABX pattern, <i>J</i> = 10.4 and 6.6 Hz, 1H), 3.41 (dd, half of ABX pattern, <i>J</i> = 10.4 and 4.0 Hz, 1H), 3.38 (s, 3H), 2.95–2.85 (m, 2H), 2.70–2.64 (m, 1H), 1.81–1.70 (m, 1H), 1.52 (ddd, <i>J</i> = 13.1, 4.1, and 2.4 Hz, 1H); [α]<sub class="stack">D</sub><sup class="stack">28.1</sup> = −1.08° (<i>c</i> = 0.365, MeOH).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i86"><a href="/doi/suppl/10.1021/jm501833t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76701" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76701" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Exposure data for in vivo mouse experiments, data collection and refinement statistics for crystal structures of BACE1 with <b>6</b>, <b>24b</b>, and <b>36</b>, and preparation of intermediate compound <b>7</b>.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501833t/suppl_file/jm501833t_si_001.pdf">jm501833t_si_001.pdf (1.35 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the following BACE cocrystal structures have been deposited with the RCSB: compound <b>6</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X2L">4X2L</a>), compound <b>24b</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY1">4WY1</a>), and compound <b>36</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY6">4WY6</a>). Single-Crystal X-ray Structural Data has been deposited with the CCDC: compound <b>13a</b> (CCDC ID: <a href="https://1052669" class="ext-link">1052669</a>), compound <b>36</b> (CCDC ID: <a href="https://1043880" class="ext-link">1043880</a>).</p><div class="testing" data-doi="10.1021/jm501833t" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87327" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87327" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Butler</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#610209130812150e110904134f134f0314150d0413211107081b04134f020e0c"><span class="__cf_email__" data-cfemail="90f3f8e2f9e3e4ffe0f8f5e2bee2bef2e5e4fcf5e2d0e0f6f9eaf5e2bef3fffd">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Brodney</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth M. Beck</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gabriela Barreiro</span> - <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles E. Nolan</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Feng Pan</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Vajdos</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Parris</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alison H. Varghese</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ricardo Lira</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn D. Doran</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Riddell</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leanne M. Buzon</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason K. Dutra</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luis A. Martinez-Alsina</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Ogilvie</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Murray</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph M. Young</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin Atchison</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ashley Robshaw</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cathleen Gonzales</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinlong Wang</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Zhang</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian T. O’Neill</span> - <span class="hlFld-Affiliation affiliation">†Neuroscience Worldwide Medicinal
Chemistry and ‡Neuroscience Research Unit, Pfizer Worldwide
Research and Development, 610 Main Street, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="hlFld-Affiliation affiliation">§Neuroscience Worldwide Medicinal
Chemistry, ∥Center of Chemistry Innovation
and Excellence, and ⊥Pharmacokinetics, Dynamics, and Metabolism, Pfizer Worldwide Research and Development, 445 Eastern Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Departamento
de Inovação, Eurofarma Laboratorios
S.A., Avenida Vereador
José Diniz, 3465, Campo Belo, São Paulo, Brasil</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec, 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d717e7264-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06334" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06334" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Subas Sakya and Ming Liu (WuXi AppTec) for their synthetic expertise, Brian Samas for X-ray crystallography, David Karanian for his toxicology expertise, and Bruce Rogers, Xinjun Hou, Katherine Brighty, and Pat Verhoest for helpful discussion in manuscript preparation. Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08075" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08075" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid Deposition as the Central Event in the Aetiology of Alzheimer’s Disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+Deposition+as+the+Central+Event+in+the+Aetiology+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520Deposition%2520as%2520the%2520Central%2520Event%2520in%2520the%2520Aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+Years+of+the+Alzheimer%E2%80%99s+Disease+Amyloid+Hypothesis%3A+A+Genetic+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520Years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Amyloid%2520Hypothesis%253A%2520A%2520Genetic%2520Perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+Proteolysis+in+Alzheimer+Disease%3A+A+Multifactorial+View+on+the+Disease+Process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0lhOeeE9_ycDAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520Proteolysis%2520in%2520Alzheimer%2520Disease%253A%2520A%2520Multifactorial%2520View%2520on%2520the%2520Disease%2520Process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The beta-Secretase Enzyme BACE in Health and Alzheimer’s Disease: Regulation, Cell Biology, Function, and Therapeutic Potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+beta-Secretase+Enzyme+BACE+in+Health+and+Alzheimer%E2%80%99s+Disease%3A+Regulation%2C+Cell+Biology%2C+Function%2C+and+Therapeutic+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0lhOeeE9_ycDAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520beta-Secretase%2520Enzyme%2520BACE%2520in%2520Health%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Regulation%252C%2520Cell%2520Biology%252C%2520Function%252C%2520and%2520Therapeutic%2520Potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, M. J.</span><span> </span><span class="NLM_article-title">BACE and gamma-Secretase Characterization and Their Sorting as Therapeutic Targets To Reduce Amyloidogenesis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+gamma-Secretase+Characterization+and+Their+Sorting+as+Therapeutic+Targets+To+Reduce+Amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0liqMm2VQoMlPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520gamma-Secretase%2520Characterization%2520and%2520Their%2520Sorting%2520as%2520Therapeutic%2520Targets%2520To%2520Reduce%2520Amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D181%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A Mutation in APP Protects against Alzheimer’s Disease and Age-Related Cognitive Decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x"> (</span><span class="NLM_issue">7409</span><span class="NLM_x">) </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-9&issue=7409&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+Mutation+in+APP+Protects+against+Alzheimer%E2%80%99s+Disease+and+Age-Related+Cognitive+Decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520Mutation%2520in%2520APP%2520Protects%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Age-Related%2520Cognitive%2520Decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26issue%3D7409%26spage%3D96%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hince, C.</span><span> </span><span class="NLM_article-title">BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1007%2Fs40266-013-0099-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=23842796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=755-764&author=G.+Evinauthor=C.+Hince&title=BACE1+as+a+Therapeutic+Target+in+Alzheimer%E2%80%99s+Disease%3A+Rationale+and+Current+Status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status</span></div><div class="casAuthors">Evin, Genevieve; Hince, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that causes dementia in a large percentage of the aged population and for which there are only symptomatic treatments.  Disease-modifying therapies that are currently being pursued are based on the amyloid cascade theory.  This states that accumulation of amyloid β (Aβ) in the brain triggers a cascade of cellular events leading to neurodegeneration.  Aβ, which is the major constituent of amyloid plaques, is a peptidic fragment derived from proteolytic processing of the amyloid precursor protein (APP) by sequential cleavages that involve β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase.  Targeting BACE1 is a rational approach as its cleavage of APP is the rate-limiting step in Aβ prodn. and this enzyme is elevated in the brain of patients with AD.  Furthermore, knocking out the BACE1 gene in mice showed little apparent consequences.  Ten years of intensive research has led to the design of efficacious BACE1 inhibitors with favorable pharmacol. properties.  Several drug candidates have shown promising results in animal models, as they reduce amyloid plaque pathol. in the brain and rescue cognitive deficits.  Phase I clin. trials indicate that these drugs are well tolerated, and the results from further trials in AD patients are now awaited eagerly.  Yet, recent novel information on BACE1 biol., and the discovery that BACE1 cleaves a selection of substrates involved in myelination, retinal homeostasis, brain circuitry, and synaptic function, alert us to potential side effects of BACE1 inhibitors that will require further evaluation to provide a safe therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEqXQKm8PabVg90H21EOLACvtfcHk0liTP6T4KaQBdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI&md5=356aae7bd5a2aeb1ea1c208be4b0a5f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0099-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0099-3%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DHince%26aufirst%3DC.%26atitle%3DBACE1%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Rationale%2520and%2520Current%2520Status%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D755%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-Based+Design+of+%CE%B2-Site+APP+Cleaving+Enzyme+1+%28BACE1%29+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-Based%2520Design%2520of%2520%25CE%25B2-Site%2520APP%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travagli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">BACE1 Inhibitors: A Head Group Scan on a Series of Amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-43&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+Inhibitors%3A+A+Head+Group+Scan+on+a+Series+of+Amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520Inhibitors%253A%2520A%2520Head%2520Group%2520Scan%2520on%2520a%2520Series%2520of%2520Amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambroise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies to Identify Centrally Efficacious Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9224</span><span class="NLM_x">–</span> <span class="NLM_lpage">9239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9224-9239&author=M.+A.+Brodneyauthor=G.+Barreiroauthor=K.+Ogilvieauthor=E.+Hajos-Korcsokauthor=J.+Murrayauthor=F.+Vajdosauthor=C.+Ambroiseauthor=C.+Christoffersenauthor=K.+Fisherauthor=L.+Lanyonauthor=J.+Liuauthor=C.+E.+Nolanauthor=J.+M.+Withkaauthor=K.+A.+Borzilleriauthor=I.+Efremovauthor=C.+E.+Oborskiauthor=A.+Vargheseauthor=B.+T.+O%E2%80%99Neill&title=Spirocyclic+Sulfamides+as+%CE%B2-Secretase+1+%28BACE-1%29+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Utilization+of+Structure+Based+Drug+Design%2C+WaterMap%2C+and+CNS+Penetration+Studies+to+Identify+Centrally+Efficacious+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm3009426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009426%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DVarghese%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DSpirocyclic%2520Sulfamides%2520as%2520%25CE%25B2-Secretase%25201%2520%2528BACE-1%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Utilization%2520of%2520Structure%2520Based%2520Drug%2520Design%252C%2520WaterMap%252C%2520and%2520CNS%2520Penetration%2520Studies%2520to%2520Identify%2520Centrally%2520Efficacious%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9224%26epage%3D9239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10<i>R</i>)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-Amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5Dbenzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+Macrocyclic+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+and+c-ros+Oncogene+1+%28ROS1%29+with+Preclinical+Brain+Exposure+and+Broad-Spectrum+Potency+against+ALK-Resistant+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255Dbenzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520Macrocyclic%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520and%2520c-ros%2520Oncogene%25201%2520%2528ROS1%2529%2520with%2520Preclinical%2520Brain%2520Exposure%2520and%2520Broad-Spectrum%2520Potency%2520against%2520ALK-Resistant%2520Mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust Central Reduction of Amyloid-beta in Humans with an Orally Available, Non-Peptidic beta-Secretase Inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+Central+Reduction+of+Amyloid-beta+in+Humans+with+an+Orally+Available%2C+Non-Peptidic+beta-Secretase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lizmusx8AXU3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520Central%2520Reduction%2520of%2520Amyloid-beta%2520in%2520Humans%2520with%2520an%2520Orally%2520Available%252C%2520Non-Peptidic%2520beta-Secretase%2520Inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennemärker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span> </span><span class="NLM_article-title">Specific Functions of Lysosomal Proteases in Endocytic and Autophagic Pathways</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.bbapap.2011.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21767668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=34-43&issue=1&author=S.+M%C3%BCllerauthor=J.+Dennem%C3%A4rkerauthor=T.+Reinheckel&title=Specific+Functions+of+Lysosomal+Proteases+in+Endocytic+and+Autophagic+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Specific functions of lysosomal proteases in endocytic and autophagic pathways</span></div><div class="casAuthors">Mueller, Sabrina; Dennemaerker, Julia; Reinheckel, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Endolysosomal vesicles form a highly dynamic multifunctional cellular compartment that contains multiple highly potent proteolytic enzymes.  Originally these proteases have been assigned to cooperate solely in executing the unselective 'bulk proteolysis' within the acidic milieu of the lysosome.  Although to some degree this notion still holds true, evidence is accumulating for specific and regulatory functions of individual 'acidic' proteases in many cellular processes linked to the endosomal/lysosomal compartment.  Here we summarize and discuss the functions of individual endolysosomal proteases in such diverse processes as the termination of growth factor signaling, lipoprotein particle degrdn., infection, antigen presentation, and autophagy.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzZ1LeFcrGbVg90H21EOLACvtfcHk0lizmusx8AXU3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rM&md5=fcb49bcadddced25d1d0aef37f266d9e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DDennem%25C3%25A4rker%26aufirst%3DJ.%26aulast%3DReinheckel%26aufirst%3DT.%26atitle%3DSpecific%2520Functions%2520of%2520Lysosomal%2520Proteases%2520in%2520Endocytic%2520and%2520Autophagic%2520Pathways%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2012%26volume%3D1824%26issue%3D1%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Steinfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraetzner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brück, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gärtner, J.</span><span> </span><span class="NLM_article-title">Cathepsin D Deficiency Is Associated with a Human Neurodegenerative Disorder</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1086%2F504159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16685649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVyks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=988-998&author=R.+Steinfeldauthor=K.+Reinhardtauthor=K.+Schreiberauthor=M.+Hillebrandauthor=R.+Kraetznerauthor=W.+Br%C3%BCckauthor=P.+Saftigauthor=J.+G%C3%A4rtner&title=Cathepsin+D+Deficiency+Is+Associated+with+a+Human+Neurodegenerative+Disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D deficiency is associated with a human neurodegenerative disorder</span></div><div class="casAuthors">Steinfeld, Robert; Reinhardt, Konstanze; Schreiber, Kathrin; Hillebrand, Merle; Kraetzner, Ralph; Brueck, Wolfgang; Saftig, Paul; Gaertner, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">988-998</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Cathepsin D is a ubiquitously expressed lysosomal protease that is involved in proteolytic degrdn., cell invasion, and apoptosis.  In mice and sheep, cathepsin D deficiency is known to cause a fatal neurodegenerative disease.  Here, we report a novel disorder in a child with early blindness and progressive psychomotor disability.  Two missense mutations in the CTSD gene, F229I and W383C, were identified and were found to cause markedly reduced proteolytic activity and a diminished amt. of cathepsin D in patient fibroblasts.  Expression of cathepsin D mutants in cathepsin D-/- mouse fibroblasts revealed disturbed posttranslational processing and intracellular targeting for W383C and diminished maximal enzyme velocity for F229I.  The structural effects of cathepsin D mutants were estd. by computer modeling, which suggested larger structural alterations for W383C than for F229I.  Our studies broaden the group of human neurodegenerative disorders and add new insight into the cellular functions of human cathepsin D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohf0ApK0eyVLVg90H21EOLACvtfcHk0ljnIFScY2_lWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVyks78%253D&md5=96a9bf74f1823244552ed50391eb5278</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1086%2F504159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F504159%26sid%3Dliteratum%253Aachs%26aulast%3DSteinfeld%26aufirst%3DR.%26aulast%3DReinhardt%26aufirst%3DK.%26aulast%3DSchreiber%26aufirst%3DK.%26aulast%3DHillebrand%26aufirst%3DM.%26aulast%3DKraetzner%26aufirst%3DR.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DG%25C3%25A4rtner%26aufirst%3DJ.%26atitle%3DCathepsin%2520D%2520Deficiency%2520Is%2520Associated%2520with%2520a%2520Human%2520Neurodegenerative%2520Disorder%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2006%26volume%3D78%26spage%3D988%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamura, Y.; Suzuki, S.; Tada, Y.; Yonezawa, S.; Fujikoshi, C.; Matsumoto, S.; Kooriyama, Y.; Ueno, T.</span><span> </span><span class="NLM_article-title">Aminodihydrothiazine Derivatives Substituted with a Cyclic Group</span>. U.S. Patent Application 2010/0075957 A1, March 25,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Tamura&author=S.+Suzuki&author=Y.+Tada&author=S.+Yonezawa&author=C.+Fujikoshi&author=S.+Matsumoto&author=Y.+Kooriyama&author=T.+Ueno&title=Aminodihydrothiazine+Derivatives+Substituted+with+a+Cyclic+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26atitle%3DAminodihydrothiazine%2520Derivatives%2520Substituted%2520with%2520a%2520Cyclic%2520Group%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The Evolution of Amidine-Based Brain Penetrant BACE1 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-45&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+Evolution+of+Amidine-Based+Brain+Penetrant+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0ljnIFScY2_lWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520Evolution%2520of%2520Amidine-Based%2520Brain%2520Penetrant%2520BACE1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-95&author=S.+A.+Hitchcock&title=Structural+Modifications+that+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520that%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving Beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-49&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgXAreIPsKf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lgXAreIPsKf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">A similar fragment was identified by the authors of ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a> that lacked the fluoro groups on the aryl group.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Hori, A.; Kato, T.</span> U.S. Patent Application, US 08637504 B2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hori%2C+A.%3B+Kato%2C+T.+U.S.+Patent+Application%2C+US+08637504+B2%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHori%26aufirst%3DA.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Robak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbage, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and Applications of <i>tert</i>-Butanesulfinamide</span> <span class="citation_source-journal">Chem. Rev. (Washington, DC, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">3600</span><span class="NLM_x">–</span> <span class="NLM_lpage">3740</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+Applications+of+tert-Butanesulfinamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0lgXAreIPsKf4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520Applications%2520of%2520tert-Butanesulfinamide%26jtitle%3DChem.%2520Rev.%2520%2528Washington%252C%2520DC%252C%2520U.S.%2529%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Motoki, T.; Takeda, K.; Kita, Y.; Takaishi, M.; Suzuki, Y.; Ishida, T.</span><span> </span><span class="NLM_article-title">Novel Fused Aminodihydrothiazine Derivative</span>. U.S. Patent Application 2010/0093999 A1, April 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Motoki&author=K.+Takeda&author=Y.+Kita&author=M.+Takaishi&author=Y.+Suzuki&author=T.+Ishida&title=Novel+Fused+Aminodihydrothiazine+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMotoki%26aufirst%3DT.%26atitle%3DNovel%2520Fused%2520Aminodihydrothiazine%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ghosez, L.</span><span> </span><span class="NLM_article-title">α-Chloroenamines: New Reagents for Organic Synthesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=852-853&author=L.+Ghosez&title=%CE%B1-Chloroenamines%3A+New+Reagents+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloroenamines%253A%2520New%2520Reagents%2520for%2520Organic%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1972%26volume%3D11%26spage%3D852%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Castro-Pineiro, J. L.; Hall, A.; Madin, A.; Vo, N.-T.</span><span> </span><span class="NLM_article-title">Fused Aminodihydropyrimidone Derivatives</span>, WO2011009897A1, January 27,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+L.+Castro-Pineiro&author=A.+Hall&author=A.+Madin&author=N.-T.+Vo&title=Fused+Aminodihydropyrimidone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Pineiro%26aufirst%3DJ.%2BL.%26atitle%3DFused%2520Aminodihydropyrimidone%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Water’s Role in Compound Design for Drug Discovery</span>. In  <span class="citation_source-book">UGM & Conference 2013 North America</span>;<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Zhu&title=UGM+%26+Conference+2013+North+America"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DWater%25E2%2580%2599s%2520Role%2520in%2520Compound%2520Design%2520for%2520Drug%2520Discovery%26btitle%3DUGM%2520%2526%2520Conference%25202013%2520North%2520America%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hashimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, K.</span><span> </span><span class="NLM_article-title">A Stereocontrolled Route to Both Enantiomers of the Necine Base Dihydroxyheliotridane via Intramolecular 1,3-Dipolar Addition Using the Same Chiral Precursor</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1995&pages=1&author=K.+Hashimuraauthor=S.+Tomitaauthor=K.+Hiroyaauthor=K.+Ogasawara&title=A+Stereocontrolled+Route+to+Both+Enantiomers+of+the+Necine+Base+Dihydroxyheliotridane+via+Intramolecular+1%2C3-Dipolar+Addition+Using+the+Same+Chiral+Precursor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimura%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DS.%26aulast%3DHiroya%26aufirst%3DK.%26aulast%3DOgasawara%26aufirst%3DK.%26atitle%3DA%2520Stereocontrolled%2520Route%2520to%2520Both%2520Enantiomers%2520of%2520the%2520Necine%2520Base%2520Dihydroxyheliotridane%2520via%2520Intramolecular%25201%252C3-Dipolar%2520Addition%2520Using%2520the%2520Same%2520Chiral%2520Precursor%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1995%26volume%3D229%26spage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleator, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, A.</span><span> </span><span class="NLM_article-title">Development of a Robust Procedure for the Copper-Catalyzed Ring-Opening of Epoxides with Grignard Reagents</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/op200329x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=435-441&author=M.+Alamauthor=C.+Wiseauthor=C.+A.+Baxterauthor=E.+Cleatorauthor=A.+Walkinshaw&title=Development+of+a+Robust+Procedure+for+the+Copper-Catalyzed+Ring-Opening+of+Epoxides+with+Grignard+Reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fop200329x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200329x%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DWise%26aufirst%3DC.%26aulast%3DBaxter%26aufirst%3DC.%2BA.%26aulast%3DCleator%26aufirst%3DE.%26aulast%3DWalkinshaw%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520a%2520Robust%2520Procedure%2520for%2520the%2520Copper-Catalyzed%2520Ring-Opening%2520of%2520Epoxides%2520with%2520Grignard%2520Reagents%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D435%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Tahtaoui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demailly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyeux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span> </span><span class="NLM_article-title">Enantioselective Synthesis of Iclaprim Enantiomers—A Versatile Approach to 2-Substituted Chiral Chromenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100566c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3781-3785&author=C.+Tahtaouiauthor=A.+Demaillyauthor=C.+Guidemannauthor=C.+Joyeuxauthor=P.+Schneider&title=Enantioselective+Synthesis+of+Iclaprim+Enantiomers%E2%80%94A+Versatile+Approach+to+2-Substituted+Chiral+Chromenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo100566c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100566c%26sid%3Dliteratum%253Aachs%26aulast%3DTahtaoui%26aufirst%3DC.%26aulast%3DDemailly%26aufirst%3DA.%26aulast%3DGuidemann%26aufirst%3DC.%26aulast%3DJoyeux%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DP.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520Iclaprim%2520Enantiomers%25E2%2580%2594A%2520Versatile%2520Approach%2520to%25202-Substituted%2520Chiral%2520Chromenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical Analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+Fluid+Amyloid-%CE%B2+%28A%CE%B2%29+as+an+Effect+Biomarker+for+Brain+A%CE%B2+Lowering+Verified+by+Quantitative+Preclinical+Analyses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0lgYgoxa9w7dBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520Fluid%2520Amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520Effect%2520Biomarker%2520for%2520Brain%2520A%25CE%25B2%2520Lowering%2520Verified%2520by%2520Quantitative%2520Preclinical%2520Analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Svoboda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, R.</span><span> </span><span class="NLM_article-title">Principles of Two-Photon Excitation Microscopy and Its Applications to Neuroscience</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.neuron.2006.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16772166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVOjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=823-839&author=K.+Svobodaauthor=R.+Yasuda&title=Principles+of+Two-Photon+Excitation+Microscopy+and+Its+Applications+to+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of two-photon excitation microscopy and its applications to neuroscience</span></div><div class="casAuthors">Svoboda, Karel; Yasuda, Ryohei</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">823-839</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review primer.  The brain is complex and dynamic.  The spatial scales of interest to the neurobiologist range from individual synapses (∼1 μm) to neural circuits (centimeters); the timescales range from the flickering of channels (less than a millisecond) to long-term memory (years).  Remarkably, fluorescence microscopy has the potential to revolutionize research on all of these spatial and temporal scales.  Two-photon excitation (2PE) laser scanning microscopy allows high-resoln. and high-sensitivity fluorescence microscopy in intact neural tissue, which is hostile to traditional forms of microscopy.  Over the last 10 years, applications of 2PE, including microscopy and photostimulation, have contributed to our understanding of a broad array of neurobiol. phenomena, including the dynamics of single channels in individual synapses and the functional organization of cortical maps.  Here the authors review the principles of 2PE microscopy, highlight recent applications, discuss its limitations, and point to areas for future research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_MGbYYiaBoLVg90H21EOLACvtfcHk0lj87MM2MyqZ2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVOjsrg%253D&md5=43c606403089b29de172f9be5c6298af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DSvoboda%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DR.%26atitle%3DPrinciples%2520of%2520Two-Photon%2520Excitation%2520Microscopy%2520and%2520Its%2520Applications%2520to%2520Neuroscience%26jtitle%3DNeuron%26date%3D2006%26volume%3D50%26spage%3D823%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, W.-B.</span><span> </span><span class="NLM_article-title">Two-Photon Imaging of Dendritic Spine Development in the Mouse Cortex</span> <span class="citation_source-journal">Dev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fdneu.20630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=18383548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mt1emsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=771-778&author=F.+Panauthor=W.-B.+Gan&title=Two-Photon+Imaging+of+Dendritic+Spine+Development+in+the+Mouse+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two-photon imaging of dendritic spine development in the mouse cortex</span></div><div class="casAuthors">Pan Feng; Gan Wen-Biao</div><div class="citationInfo"><span class="NLM_cas:title">Developmental neurobiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">771-8</span>
        ISSN:<span class="NLM_cas:issn">1932-8451</span>.
    </div><div class="casAbstract">Dendritic spines are the postsynaptic sites of most excitatory synapses in the mammalian brain.  With the advent of two-photon microscopy and transgenic mice expressing fluorescent proteins, dendritic spines can now be imaged in the living cerebral cortex over time scales ranging from seconds to years.  Recent studies with this in vivo imaging approach have begun to provide important insights into the development and plasticity of dendritic spines in the intact brain.  Here, we review these studies and discuss technical requirements for image acquisition.  We envision that intravital two-photon imaging at the level of individual synapses will greatly expand our current understandings of how neuronal networks are assembled and modified throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_buowwtywSjEC-75aqa5AfW6udTcc2ebQXhgf0a7RbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mt1emsg%253D%253D&md5=b9e465bc8870083849e02a21968020cb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fdneu.20630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdneu.20630%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DF.%26aulast%3DGan%26aufirst%3DW.-B.%26atitle%3DTwo-Photon%2520Imaging%2520of%2520Dendritic%2520Spine%2520Development%2520in%2520the%2520Mouse%2520Cortex%26jtitle%3DDev.%2520Neurobiol.%26date%3D2008%26volume%3D68%26spage%3D771%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svanhagen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelkvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different In Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10075</span><span class="NLM_x">–</span> <span class="NLM_lpage">10084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.1165-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=23761903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhsFKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10075-10084&author=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=F.+Jeppssonauthor=A.+Svanhagenauthor=K.+Kolmodinauthor=S.+Gustavssonauthor=A.-C.+Rades%C3%A4terauthor=K.+Elisonauthor=S.+Briemauthor=P.+Appelkvistauthor=C.+Nivaauthor=A.-L.+Bergauthor=S.+Karlstr%C3%B6mauthor=B.-M.+Swahnauthor=J.+F%C3%A4lting&title=AZ-4217%3A+A+High+Potency+BACE+Inhibitor+Displaying+Acute+Central+Efficacy+in+Different+In+Vivo+Models+and+Reduced+Amyloid+Deposition+in+Tg2576+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice</span></div><div class="casAuthors">Eketjall Susanna; Janson Juliette; Jeppsson Fredrik; Svanhagen Alexander; Kolmodin Karin; Gustavsson Susanne; Radesater Ann-Cathrin; Eliason Kristina; Briem Sveinn; Appelkvist Paulina; Niva Camilla; Berg Anna-Lena; Karlstrom Sofia; Swahn Britt-Marie; Falting Johanna</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10075-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aβ, the product of APP (amyloid precursor protein), has been implicated in the pathophysiology of Alzheimer's disease (AD). β-Site APP cleaving enzyme1 (BACE1) is the enzyme initiating the processing of the APP to Aβ peptides.  Small molecule BACE1 inhibitors are expected to decrease Aβ-peptide generation and thereby reduce amyloid plaque formation in the brain, a neuropathological hallmark of AD.  BACE1 inhibition thus addresses a key mechanism in AD and its potential as a therapeutic target is currently being addressed in clinical studies.  Here, we report the discovery and the pharmacokinetic and pharmacodynamic properties of BACE1 inhibitor AZ-4217, a high potency compound (IC50 160 pM in human SH-SY5Y cells) with an excellent in vivo efficacy.  Central efficacy of BACE1 inhibition was observed after a single dose in C57BL/6 mice, guinea pigs, and in an APP transgenic mouse model of cerebral amyloidosis (Tg2576).  Furthermore, we demonstrate that in a 1 month treatment paradigm BACE1 inhibition of Aβ production does lower amyloid deposition in 12-month-old Tg2576 mice.  These results strongly support BACE1 inhibition as concretely impacting amyloid deposition and therefore potentially an important approach for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRv1jKuScfdJ8-crCu0nI_sfW6udTcc2ebQXhgf0a7RbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhsFKqtQ%253D%253D&md5=d5193ef6c633f7aee50c34954a5a440a</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1165-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1165-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DSvanhagen%26aufirst%3DA.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DElison%26aufirst%3DK.%26aulast%3DBriem%26aufirst%3DS.%26aulast%3DAppelkvist%26aufirst%3DP.%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DA.-L.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DAZ-4217%253A%2520A%2520High%2520Potency%2520BACE%2520Inhibitor%2520Displaying%2520Acute%2520Central%2520Efficacy%2520in%2520Different%2520In%2520Vivo%2520Models%2520and%2520Reduced%2520Amyloid%2520Deposition%2520in%2520Tg2576%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10075%26epage%3D10084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanghe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span> </span><span class="NLM_article-title">Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondon Mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">11621</span><span class="NLM_x">–</span> <span class="NLM_lpage">11630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.1405-14.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=25164658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVynsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=11621-11630&author=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Carusoauthor=R.+Narquizianauthor=H.+Hilpertauthor=B.+Jacobsenauthor=D.+Terwelauthor=A.+Tangheauthor=B.+Bohrmann&title=Combined+Treatment+with+a+BACE+Inhibitor+and+Anti-A%CE%B2+Antibody+Gantenerumab+Enhances+Amyloid+Reduction+in+APPLondon+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice</span></div><div class="casAuthors">Jacobsen, Helmut; Ozmen, Laurence; Caruso, Antonello; Narquizian, Robert; Hilpert, Hans; Jacobsen, Bjoern; Terwel, Dick; Tanghe, An; Bohrmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11621-11630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Therapeutic approaches for prevention or redn. of amyloidosis are currently a main objective in basic and clin. research on Alzheimer's disease.  Among the agents explored in clin. trials are anti-Aβ peptide antibodies and secretase inhibitors.  Most anti-Aβ antibodies are considered to act via inhibition of amyloidosis and enhanced clearance of existing amyloid, although secretase inhibitors reduce the de novo prodn. of Aβ.  Limited information is currently available on the efficacy and potential advantages of combinatorial antiamyloid treatment.  We performed a chronic study in APPLondon transgenic mice that received treatment with anti-Aβ antibody gantenerumab and BACE inhibitor RO5508887, either as mono- or combination treatment.  Treatment aimed to evaluate efficacy on amyloid progression, similar to preexisting amyloidosis as present in Alzheimer's disease patients.  Mono-treatments with either compd. caused a dose-dependent redn. of total brain Aβ and amyloid burden.  Combination treatment with both compds. significantly enhanced the antiamyloid effect.  The obsd. combination effect was most pronounced for lowering of amyloid plaque load and plaque no., which suggests effective inhibition of de novo plaque formation.  Moreover, significantly enhanced clearance of pre-existing amyloid plaques was obsd. when gantenerumab was coadministered with RO5508887.  BACE inhibition led to a significant time- and dose-dependent decrease in CSF Aβ, which was not obsd. for gantenerumab treatment.  Our results demonstrate that combining these two antiamyloid agents enhances overall efficacy and suggests that combination treatments may be of clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHGvFKC3OLarVg90H21EOLACvtfcHk0lgMB0tobzUO0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVynsrvI&md5=a431efea8d03f144cb369cf8c49687ee</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1405-14.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1405-14.2014%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DB.%26aulast%3DTerwel%26aufirst%3DD.%26aulast%3DTanghe%26aufirst%3DA.%26aulast%3DBohrmann%26aufirst%3DB.%26atitle%3DCombined%2520Treatment%2520with%2520a%2520BACE%2520Inhibitor%2520and%2520Anti-A%25CE%25B2%2520Antibody%2520Gantenerumab%2520Enhances%2520Amyloid%2520Reduction%2520in%2520APPLondon%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D11621%26epage%3D11630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Farah, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span> </span><span class="NLM_article-title">Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5744</span><span class="NLM_x">–</span> <span class="NLM_lpage">5754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.6810-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21490216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5744-5754&author=M.+H.+Farahauthor=B.+H.+Panauthor=P.+N.+Hoffmanauthor=D.+Ferrarisauthor=T.+Tsukamotoauthor=T.+Nguyenauthor=P.+C.+Wongauthor=D.+L.+Priceauthor=B.+S.+Slusherauthor=J.+W.+Griffin&title=Reduced+BACE1+Activity+Enhances+Clearance+of+Myelin+Debris+and+Regeneration+of+Axons+in+the+Injured+Peripheral+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system</span></div><div class="casAuthors">Farah, Mohamed H.; Pan, Bao Han; Hoffman, Paul N.; Ferraris, Dana; Tsukamoto, Takashi; Nguyen, Thien; Wong, Philip C.; Price, Donald L.; Slusher, Barbara S.; Griffin, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5744-5754</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is an aspartyl protease best known for its role in generating the amyloid-β peptides that are present in plaques of Alzheimer's disease.  BACE1 has been an attractive target for drug development.  In cultured embryonic neurons, BACE1-cleaved N-terminal APP is further processed to generate a fragment that can trigger axonal degeneration, suggesting a vital role for BACE1 in axonal health.  In addn., BACE1 cleaves neuregulin 1 type III, a protein crit. for myelination of peripheral axons by Schwann cells during development.  Here, we asked whether axonal degeneration or axonal regeneration in adult nerves might be affected by inhibition or elimination of BACE1.  We report that BACE1 knock-out and wild-type nerves degenerated at a similar rate after axotomy and to a similar extent in the exptl. neuropathies produced by administration of paclitaxel and acrylamide.  These data indicate N-APP is not the sole culprit in axonal degeneration in adult nerves.  Unexpectedly, however, we obsd. that BACE1 knock-out mice had markedly enhanced clearance of axonal and myelin debris from degenerated fibers, accelerated axonal regeneration, and earlier reinnervation of neuromuscular junctions, compared with littermate controls.  These observations were reproduced in part by pharmacol. inhibition of BACE1.  These data suggest BACE1 inhibition as a therapeutic approach to accelerate regeneration and recovery after peripheral nerve damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzqY0Xcy71aLVg90H21EOLACvtfcHk0lgMB0tobzUO0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFGgt7w%253D&md5=fa5ff12912d9fc83a16a1289805aecd2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6810-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6810-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DFarah%26aufirst%3DM.%2BH.%26aulast%3DPan%26aufirst%3DB.%2BH.%26aulast%3DHoffman%26aufirst%3DP.%2BN.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26atitle%3DReduced%2520BACE1%2520Activity%2520Enhances%2520Clearance%2520of%2520Myelin%2520Debris%2520and%2520Regeneration%2520of%2520Axons%2520in%2520the%2520Injured%2520Peripheral%2520Nervous%2520System%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5744%26epage%3D5754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">There does remain a possibilty that increases in dose or study duration could result in ocular toxicity, relative to the shorter study with <b>1</b> that implicated that accumulation of autofluoresent material in the RPE could be observed with 1 week of dosing. Thus, a 2-week assessment would be reasonable at this juncture.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Otsu, N. A.</span><span> </span><span class="NLM_article-title">Threshold Selection Method from Gray-Level Histograms</span> <span class="citation_source-journal">IEEE Transactions on Systems, Man and Cybernetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1109%2FTSMC.1979.4310076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1979&pages=62-66&author=N.+A.+Otsu&title=Threshold+Selection+Method+from+Gray-Level+Histograms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1109%2FTSMC.1979.4310076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTSMC.1979.4310076%26sid%3Dliteratum%253Aachs%26aulast%3DOtsu%26aufirst%3DN.%2BA.%26atitle%3DThreshold%2520Selection%2520Method%2520from%2520Gray-Level%2520Histograms%26jtitle%3DIEEE%2520Transactions%2520on%2520Systems%252C%2520Man%2520and%2520Cybernetics%26date%3D1979%26volume%3D9%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Maintz, J. B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viergever, M. A.</span><span> </span><span class="NLM_article-title">A Survey of Medical Image Registration</span> <span class="citation_source-journal">Med. Image Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2FS1361-8415%2801%2980026-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=10638851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1eruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=1-36&author=J.+B.+A.+Maintzauthor=M.+A.+Viergever&title=A+Survey+of+Medical+Image+Registration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A survey of medical image registration</span></div><div class="casAuthors">Maintz J B; Viergever M A</div><div class="citationInfo"><span class="NLM_cas:title">Medical image analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-36</span>
        ISSN:<span class="NLM_cas:issn">1361-8415</span>.
    </div><div class="casAbstract">The purpose of this paper is to present a survey of recent (published in 1993 or later) publications concerning medical image registration techniques.  These publications will be classified according to a model based on nine salient criteria, the main dichotomy of which is extrinsic versus intrinsic methods.  The statistics of the classification show definite trends in the evolving registration techniques, which will be discussed.  At this moment, the bulk of interesting intrinsic methods is based on either segmented points or surfaces, or on techniques endeavouring to use the full information content of the images involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sXx0LsK7uFuY7fW6udTcc2eYg6-m6LGm4HLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1eruw%253D%253D&md5=5f720162a2b93414fdb4d3e7dc6390f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1361-8415%2801%2980026-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1361-8415%252801%252980026-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaintz%26aufirst%3DJ.%2BB.%2BA.%26aulast%3DViergever%26aufirst%3DM.%2BA.%26atitle%3DA%2520Survey%2520of%2520Medical%2520Image%2520Registration%26jtitle%3DMed.%2520Image%2520Anal.%26date%3D1998%26volume%3D2%26spage%3D1%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of Nonspecific Brain and Plasma Binding on CNS Exposure: Implications for Rational Drug Discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+Nonspecific+Brain+and+Plasma+Binding+on+CNS+Exposure%3A+Implications+for+Rational+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0ljY91r2UjHCPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520Nonspecific%2520Brain%2520and%2520Plasma%2520Binding%2520on%2520CNS%2520Exposure%253A%2520Implications%2520for%2520Rational%2520Drug%2520Discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High Yield Expression of Human BACE Constructs in <i>Eschericia coli</i> for Refolding, Purification, and High Resolution Diffracting Crystal Forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+Yield+Expression+of+Human+BACE+Constructs+in+Eschericia+coli+for+Refolding%2C+Purification%2C+and+High+Resolution+Diffracting+Crystal+Forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0ljY91r2UjHCPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520Yield%2520Expression%2520of%2520Human%2520BACE%2520Constructs%2520in%2520Eschericia%2520coli%2520for%2520Refolding%252C%2520Purification%252C%2520and%2520High%2520Resolution%2520Diffracting%2520Crystal%2520Forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and Inhibitor Complex Structures of BACE (beta-Secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+Inhibitor+Complex+Structures+of+BACE+%28beta-Secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520Inhibitor%2520Complex%2520Structures%2520of%2520BACE%2520%2528beta-Secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data Processing and Analysis with the <i>AutoPROC</i> Tool Box</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+Processing+and+Analysis+with+the+AutoPROC+Tool+Box"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0ljY91r2UjHCPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520Processing%2520and%2520Analysis%2520with%2520the%2520AutoPROC%2520Tool%2520Box%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljcfK23wHVFLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">French, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span> </span><span class="NLM_article-title">On The Treatment of Negative Intensity Observations</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">A34</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A34&publication_year=1978&pages=517-525&author=S.+Frenchauthor=K.+Wilson&title=On+The+Treatment+of+Negative+Intensity+Observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DOn%2520The%2520Treatment%2520of%2520Negative%2520Intensity%2520Observations%26jtitle%3DActa%2520Crystallogr.%26date%3D1978%26volume%3DA34%26spage%3D517%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span> Collaborative Computational Project, Number 4. The <i>CCP4</i> Suite: Programs for Protein Crystallography.  <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Collaborative+Computational+Project%2C+Number+4.+The+CCP4+Suite%3A+Programs+for+Protein+Crystallography.+Acta+Crystallogr.%2C+Sect.+D+1994%2C+50%2C+760%E2%80%93763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2eZz6tQZ6Dl477ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> <span class="citation_source-book">BUSTER</span>; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><i>Maestro</i>, 9.7; <span class="NLM_publisher-name">Schrodinger</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+9.7%3B+Schrodinger%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchrodinger%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42a"><span><span class="NLM_label">(a) </span> <span class="citation_source-book">Desmond Molecular Dynamics System</span>, 3.7; <span class="NLM_publisher-name">D. E. Shaw Research</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desmond+Molecular+Dynamics+System%2C+3.7%3B+D.+E.+Shaw+Research%3A+New+York%2C+2014%3B+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%2520Shaw%2520Research%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit42b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">Maestro-Desmond Interoperability Tools</span>, 3.7; <span class="NLM_publisher-name">Schrodinger</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro-Desmond+Interoperability+Tools%2C+3.7%3B+Schrodinger%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro-Desmond%2520Interoperability%2520Tools%26pub%3DSchrodinger%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Integrated Modeling Program, Applied Chemical Theory (IMPACT)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+Modeling+Program%2C+Applied+Chemical+Theory+%28IMPACT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0lhk9haNZ0KC8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520Modeling%2520Program%252C%2520Applied%2520Chemical%2520Theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Martyna, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckerman, M.</span><span> </span><span class="NLM_article-title">Nosé–Hoover Chains: The Canonical Ensemble via Continuous Dynamics</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=2635-2643&author=G.+J.+Martynaauthor=M.+L.+Kleinauthor=M.+Tuckerman&title=Nos%C3%A9%E2%80%93Hoover+Chains%3A+The+Canonical+Ensemble+via+Continuous+Dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartyna%26aufirst%3DG.%2BJ.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26aulast%3DTuckerman%26aufirst%3DM.%26atitle%3DNos%25C3%25A9%25E2%2580%2593Hoover%2520Chains%253A%2520The%2520Canonical%2520Ensemble%2520via%2520Continuous%2520Dynamics%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D2635%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Essmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. G.</span><span> </span><span class="NLM_article-title">A Smooth Particle Mesh Ewald Method</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">8577</span><span class="NLM_x">–</span> <span class="NLM_lpage">8593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+Particle+Mesh+Ewald+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0lhk9haNZ0KC8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520Particle%2520Mesh%2520Ewald%2520Method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Humphreys, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span> </span><span class="NLM_article-title">A Multiple-Time-Step Molecular Dynamics Algorithm for Macromolecules</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">6885</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/j100078a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADyaK2cXktlSnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1994&pages=6885-6892&author=D.+D.+Humphreysauthor=R.+A.+Friesnerauthor=B.+J.+Berne&title=A+Multiple-Time-Step+Molecular+Dynamics+Algorithm+for+Macromolecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A multiple-time-step molecular dynamics algorithm for macromolecules</span></div><div class="casAuthors">Humphreys, Darryl D.; Friesner, Richard A.; Berne, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6885-92</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The authors present a computationally efficient mol. dynamics algorithm designed to take advantage of the inherent sepn. of time scales in biomol. systems.  The algorithm is essentially a generalization of the previously introduced reversible ref. system propagation algorithm(r-RESPA) which employs a Trotter factorization of the Liouville propagator to generate numerical integration schemes for mol. dynamics applications.  The method is compared with the velocity Verlet integration algorithm in a mol. dynamics (MD) simulation of the protein crambin in vacuo.  The multiple-time-step algorithm is shown to be able to take a much larger time step for a comparable level of accuracy than that of the std. method, leading to a 4-5-fold redn. in the CPU time required to calc. the nonbonded forces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEYrnII-bdbLVg90H21EOLACvtfcHk0lhk9haNZ0KC8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktlSnt7Y%253D&md5=e489d1ccf68463d37e096c7f1bc758cd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fj100078a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100078a035%26sid%3Dliteratum%253Aachs%26aulast%3DHumphreys%26aufirst%3DD.%2BD.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26atitle%3DA%2520Multiple-Time-Step%2520Molecular%2520Dynamics%2520Algorithm%2520for%2520Macromolecules%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1994%26volume%3D98%26spage%3D6885%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="note"><p class="first last">The preparation of intermediate <b>7</b> is described in detail in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':[],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29a','cit29b'],'ref30':['cit30'],'ref31':[],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42a','cit42b'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':[]}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 36 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Heinrich Rueeger, Rainer Lueoend, Rainer Machauer, Siem J. Veenstra, Philipp Holzer, Konstanze Hurth, Markus Voegtle, Mathias Frederiksen, Jean-Michel Rondeau, Marina Tintelnot-Blomley, Laura H. Jacobson, Matthias Staufenbiel, Grit Laue, <span class="NLM_string-name hlFld-ContribAuthor">Ulf Neumann</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of the Potent, Selective, and Efficacious β-Secretase (BACE1) Inhibitor NB-360. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4677-4696. <a href="https://doi.org/10.1021/acs.jmedchem.0c02143" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02143%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252BPotent%25252C%252BSelective%25252C%252Band%252BEfficacious%252B%2525CE%2525B2-Secretase%252B%252528BACE1%252529%252BInhibitor%252BNB-360%26aulast%3DRueeger%26aufirst%3DHeinrich%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11122020%26date%3D12042021%26volume%3D64%26issue%3D8%26spage%3D4677%26epage%3D4696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeffery Richardson, Peter J. Lindsay-Scott, Vladimir Larichev, <span class="NLM_string-name hlFld-ContribAuthor">Emily Pocock</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Method for the Synthesis of Amino-1,3-Oxazines from Thioureas. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (12)
                                     , 2853-2863. <a href="https://doi.org/10.1021/acs.oprd.0c00369" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00369%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEfficient%252BMethod%252Bfor%252Bthe%252BSynthesis%252Bof%252BAmino-1%25252C3-Oxazines%252Bfrom%252BThioureas%26aulast%3DRichardson%26aufirst%3DJeffery%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D24112020%26volume%3D24%26issue%3D12%26spage%3D2853%26epage%3D2863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Stéphane Caron</span>. </span><span class="cited-content_cbyCitation_article-title">Where Does the Fluorine Come From? A Review on the Challenges Associated with the Synthesis of Organofluorine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2020,</strong> <em>24 </em>
                                    (4)
                                     , 470-480. <a href="https://doi.org/10.1021/acs.oprd.0c00030" title="DOI URL">https://doi.org/10.1021/acs.oprd.0c00030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.0c00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.0c00030%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DWhere%252BDoes%252Bthe%252BFluorine%252BCome%252BFrom%25253F%252BA%252BReview%252Bon%252Bthe%252BChallenges%252BAssociated%252Bwith%252Bthe%252BSynthesis%252Bof%252BOrganofluorine%252BCompounds%26aulast%3DCaron%26aufirst%3DSt%25C3%25A9phane%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D24012020%26date%3D17032020%26date%3D05032020%26volume%3D24%26issue%3D4%26spage%3D470%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jack A. Henderson, Robert C. Harris, Cheng-Chieh Tsai, <span class="NLM_string-name hlFld-ContribAuthor">Jana Shen</span>. </span><span class="cited-content_cbyCitation_article-title">How Ligand Protonation State Controls Water in Protein–Ligand Binding. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (18)
                                     , 5440-5444. <a href="https://doi.org/10.1021/acs.jpclett.8b02440" title="DOI URL">https://doi.org/10.1021/acs.jpclett.8b02440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.8b02440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.8b02440%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DHow%252BLigand%252BProtonation%252BState%252BControls%252BWater%252Bin%252BProtein%2525E2%252580%252593Ligand%252BBinding%26aulast%3DHenderson%26aufirst%3DJack%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D08082018%26date%3D06092018%26date%3D10092018%26date%3D06092018%26volume%3D9%26issue%3D18%26spage%3D5440%26epage%3D5444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Anshu Singh, Abhijeet Srivastava, <span class="NLM_string-name hlFld-ContribAuthor">Maya Shankar Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-Free One-Pot Four-Component Cascade Annulation in Ionic Liquids at Room Temperature: Convergent Access to Thiazoloquinolinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (15)
                                     , 7950-7961. <a href="https://doi.org/10.1021/acs.joc.8b00814" title="DOI URL">https://doi.org/10.1021/acs.joc.8b00814</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b00814&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b00814%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMetal-Free%252BOne-Pot%252BFour-Component%252BCascade%252BAnnulation%252Bin%252BIonic%252BLiquids%252Bat%252BRoom%252BTemperature%25253A%252BConvergent%252BAccess%252Bto%252BThiazoloquinolinone%252BDerivatives%26aulast%3DSingh%26aufirst%3DAnshu%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31032018%26date%3D16072018%26date%3D06072018%26volume%3D83%26issue%3D15%26spage%3D7950%26epage%3D7961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Lei Zhang, Laigao Chen, Jason K. Dutra, Elizabeth M. Beck, Sangram Nag, Akihiro Takano, Nahid Amini, Ryosuke Arakawa, Michael A. Brodney, Leanne M. Buzon, Shawn D. Doran, Lorraine F. Lanyon, Timothy J. McCarthy, Kelly R. Bales, Charles E. Nolan, Brian T. O’Neill, Klaas Schildknegt, Christer Halldin, <span class="NLM_string-name hlFld-ContribAuthor">Anabella Villalobos</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (8)
                                     , 3296-3308. <a href="https://doi.org/10.1021/acs.jmedchem.7b01769" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01769</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01769%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BNovel%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BLigand%252Bfor%252BImaging%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252B%252528BACE-1%252529%252Bin%252BBrain%26aulast%3DZhang%26aufirst%3DLei%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30112017%26date%3D02022018%26date%3D22012018%26volume%3D61%26issue%3D8%26spage%3D3296%26epage%3D3308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luis A.  Martinez-Alsina</span>, <span class="hlFld-ContribAuthor ">John C.  Murray</span>, <span class="hlFld-ContribAuthor ">Leanne M.  Buzon</span>, <span class="hlFld-ContribAuthor ">Mark W.  Bundesmann</span>, <span class="hlFld-ContribAuthor ">Joseph M.  Young</span>, and <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Spiropiperidine Sultam and Lactam Templates: Diastereoselective Overman Rearrangement and Metathesis followed by NH Arylation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>82 </em>
                                    (23)
                                     , 12246-12256. <a href="https://doi.org/10.1021/acs.joc.7b02096" title="DOI URL">https://doi.org/10.1021/acs.joc.7b02096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.7b02096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.7b02096%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSpiropiperidine%252BSultam%252Band%252BLactam%252BTemplates%25253A%252BDiastereoselective%252BOverman%252BRearrangement%252Band%252BMetathesis%252Bfollowed%252Bby%252BNH%252BArylation%26aulast%3DMartinez-Alsina%26aufirst%3DLuis%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18082017%26date%3D13112017%26date%3D01122017%26date%3D02112017%26volume%3D82%26issue%3D23%26spage%3D12246%26epage%3D12256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert C.  Harris</span>, <span class="hlFld-ContribAuthor ">Cheng-Chieh  Tsai</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Ellis</span>, and <span class="hlFld-ContribAuthor ">Jana  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Proton-Coupled Conformational Allostery Modulates the Inhibitor Selectivity for β-Secretase. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (19)
                                     , 4832-4837. <a href="https://doi.org/10.1021/acs.jpclett.7b02309" title="DOI URL">https://doi.org/10.1021/acs.jpclett.7b02309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.7b02309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.7b02309%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DProton-Coupled%252BConformational%252BAllostery%252BModulates%252Bthe%252BInhibitor%252BSelectivity%252Bfor%252B%2525CE%2525B2-Secretase%26aulast%3DHarris%26aufirst%3DRobert%2BC.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D30082017%26date%3D19092017%26date%3D21092017%26date%3D05102017%26date%3D19092017%26volume%3D8%26issue%3D19%26spage%3D4832%26epage%3D4837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.  Butler</span>, <span class="hlFld-ContribAuthor ">Kevin  Ogilvie</span>, <span class="hlFld-ContribAuthor ">Luis  Martinez-Alsina</span>, <span class="hlFld-ContribAuthor ">Gabriela  Barreiro</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Eric  Benvenuti</span>, <span class="hlFld-ContribAuthor ">Leanne  Buzon</span>, <span class="hlFld-ContribAuthor ">Shawn  Doran</span>, <span class="hlFld-ContribAuthor ">Cathleen  Gonzales</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Mei-Hui  Hsu</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">Kimberly  Lapham</span>, <span class="hlFld-ContribAuthor ">Lorraine  Lanyon</span>, <span class="hlFld-ContribAuthor ">Kevin  Parris</span>, <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>, <span class="hlFld-ContribAuthor ">David  Riddell</span>, <span class="hlFld-ContribAuthor ">Ashley  Robshaw</span>, <span class="hlFld-ContribAuthor ">Felix  Vajdos</span>, and <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>  . </span><span class="cited-content_cbyCitation_article-title">Aminomethyl-Derived Beta Secretase (BACE1) Inhibitors: Engaging Gly230 without an Anilide Functionality. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 386-402. <a href="https://doi.org/10.1021/acs.jmedchem.6b01451" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01451%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAminomethyl-Derived%252BBeta%252BSecretase%252B%252528BACE1%252529%252BInhibitors%25253A%252BEngaging%252BGly230%252Bwithout%252Ban%252BAnilide%252BFunctionality%26aulast%3DButler%26aufirst%3DChristopher%2BR.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D03102016%26date%3D20122016%26date%3D12012017%26date%3D06122016%26volume%3D60%26issue%3D1%26spage%3D386%26epage%3D402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Sarah W.  Li</span>, <span class="hlFld-ContribAuthor ">Andrew P. J.  Brunskill</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Mark  Forman</span>, <span class="hlFld-ContribAuthor ">Eric J.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Robert A.  Hodgson</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ulrich  Iserloh</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Hong  Mei</span>, <span class="hlFld-ContribAuthor ">John  Meredith</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Lana M.  Rossiter</span>, <span class="hlFld-ContribAuthor ">Meagan  Slater</span>, <span class="hlFld-ContribAuthor ">Julie  Stone</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes H.  Voigt</span>, <span class="hlFld-ContribAuthor ">Ganfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10435-10450. <a href="https://doi.org/10.1021/acs.jmedchem.6b00307" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252B3-Imino-1%25252C2%25252C4-thiadiazinane%252B1%25252C1-Dioxide%252BDerivative%252BVerubecestat%252B%252528MK-8931%252529%2525E2%252580%252593A%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DScott%26aufirst%3DJack%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D18112016%26date%3D08122016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nedyalka  Radeva</span>, <span class="hlFld-ContribAuthor ">Johannes  Schiebel</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Wang</span>, <span class="hlFld-ContribAuthor ">Stefan G.  Krimmer</span>, <span class="hlFld-ContribAuthor ">Kan  Fu</span>, <span class="hlFld-ContribAuthor ">Martin  Stieler</span>, <span class="hlFld-ContribAuthor ">Frederik R.  Ehrmann</span>, <span class="hlFld-ContribAuthor ">Alexander  Metz</span>, <span class="hlFld-ContribAuthor ">Thomas  Rickmeyer</span>, <span class="hlFld-ContribAuthor ">Michael  Betz</span>, <span class="hlFld-ContribAuthor ">Johan  Winquist</span>, <span class="hlFld-ContribAuthor ">Ah Young  Park</span>, <span class="hlFld-ContribAuthor ">Franziska U.  Huschmann</span>, <span class="hlFld-ContribAuthor ">Manfred S.  Weiss</span>, <span class="hlFld-ContribAuthor ">Uwe  Mueller</span>, <span class="hlFld-ContribAuthor ">Andreas  Heine</span>, and <span class="hlFld-ContribAuthor ">Gerhard  Klebe</span>  . </span><span class="cited-content_cbyCitation_article-title">Active Site Mapping of an Aspartic Protease by Multiple Fragment Crystal Structures: Versatile Warheads To Address a Catalytic Dyad. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (21)
                                     , 9743-9759. <a href="https://doi.org/10.1021/acs.jmedchem.6b01195" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01195%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DActive%252BSite%252BMapping%252Bof%252Ban%252BAspartic%252BProtease%252Bby%252BMultiple%252BFragment%252BCrystal%252BStructures%25253A%252BVersatile%252BWarheads%252BTo%252BAddress%252Ba%252BCatalytic%252BDyad%26aulast%3DRadeva%26aufirst%3DNedyalka%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26042016%26date%3D28102016%26date%3D10112016%26date%3D11102016%26volume%3D59%26issue%3D21%26spage%3D9743%26epage%3D9759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Jason  Guernon</span>, <span class="hlFld-ContribAuthor ">Jianliang  Shi</span>, <span class="hlFld-ContribAuthor ">Lawrence  Marcin</span>, <span class="hlFld-ContribAuthor ">Mendi  Higgins</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Jodi  Muckelbauer</span>, <span class="hlFld-ContribAuthor ">Hal  Lewis</span>, <span class="hlFld-ContribAuthor ">ChiehYing  Chang</span>, <span class="hlFld-ContribAuthor ">Dan  Camac</span>, <span class="hlFld-ContribAuthor ">Jeremy H.  Toyn</span>, <span class="hlFld-ContribAuthor ">Michael K.  Ahlijanian</span>, <span class="hlFld-ContribAuthor ">Charles F.  Albright</span>, <span class="hlFld-ContribAuthor ">John E.  Macor</span>, and <span class="hlFld-ContribAuthor ">Lorin A.  Thompson</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (18)
                                     , 8593-8600. <a href="https://doi.org/10.1021/acs.jmedchem.6b01012" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BS3-Truncated%25252C%252BC-6%252BHeteroaryl%252BSubstituted%252BAminothiazine%252B%2525CE%2525B2-Site%252BAPP%252BCleaving%252BEnzyme-1%252B%252528BACE1%252529%252BInhibitors%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D11072016%26date%3D07092016%26date%3D22092016%26date%3D25082016%26volume%3D59%26issue%3D18%26spage%3D8593%26epage%3D8600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mihirbaran  Mandal</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Guoqing  Li</span>, <span class="hlFld-ContribAuthor ">Alexei  Buevich</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Xiaoxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Robert D.  Mazzola</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Corey  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes  Voigt</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Zhaoning  Zhu</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Michael  Grzelak</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Prescott T.  Leach</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Terracina</span>, <span class="hlFld-ContribAuthor ">Lili  Zhang</span>, <span class="hlFld-ContribAuthor ">Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Maria S.  Michener</span>, <span class="hlFld-ContribAuthor ">Brad  Smith</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Diane  Grotz</span>, <span class="hlFld-ContribAuthor ">Leonard  Favreau</span>, <span class="hlFld-ContribAuthor ">Kaushik  Mitra</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Brian A.  McKittrick</span>, <span class="hlFld-ContribAuthor ">William  Greenlee</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (7)
                                     , 3231-3248. <a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BDesign%252Bof%252Ban%252BIminoheterocyclic%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B%252528BACE%252529%252BInhibitor%252Bthat%252BLowers%252BCentral%252BA%2525CE%2525B2%252Bin%252BNonhuman%252BPrimates%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D23122015%26date%3D22032016%26date%3D14042016%26date%3D03032016%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.  Ellis</span>, <span class="hlFld-ContribAuthor ">Cheng-Chieh  Tsai</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, and <span class="hlFld-ContribAuthor ">Jana  Shen</span>  . </span><span class="cited-content_cbyCitation_article-title">Constant pH Molecular Dynamics Reveals pH-Modulated Binding of Two Small-Molecule BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (6)
                                     , 944-949. <a href="https://doi.org/10.1021/acs.jpclett.6b00137" title="DOI URL">https://doi.org/10.1021/acs.jpclett.6b00137</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpclett.6b00137&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpclett.6b00137%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520Letters%26atitle%3DConstant%252BpH%252BMolecular%252BDynamics%252BReveals%252BpH-Modulated%252BBinding%252Bof%252BTwo%252BSmall-Molecule%252BBACE1%252BInhibitors%26aulast%3DEllis%26aufirst%3DChristopher%2BR.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D21012016%26date%3D23022016%26date%3D25022016%26date%3D17032016%26date%3D23022016%26volume%3D7%26issue%3D6%26spage%3D944%26epage%3D949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Butler</span>, <span class="hlFld-ContribAuthor ">Gabriela  Barreiro</span>, <span class="hlFld-ContribAuthor ">Eric F.  Johnson</span>, <span class="hlFld-ContribAuthor ">David  Riddell</span>, <span class="hlFld-ContribAuthor ">Kevin  Parris</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Ying  Fan</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Cathleen  Gonzales</span>, <span class="hlFld-ContribAuthor ">Ashley E.  Robshaw</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Mark W.  Bundesmann</span>, <span class="hlFld-ContribAuthor ">Leanne  Buzon</span>, <span class="hlFld-ContribAuthor ">Jason  Dutra</span>, <span class="hlFld-ContribAuthor ">Kevin  Henegar</span>, <span class="hlFld-ContribAuthor ">Erik  LaChapelle</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">Bruce N.  Rogers</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Ricardo  Lira</span>, <span class="hlFld-ContribAuthor ">Luis  Martinez-Alsina</span>, <span class="hlFld-ContribAuthor ">Peter  Mikochik</span>, <span class="hlFld-ContribAuthor ">John C.  Murray</span>, <span class="hlFld-ContribAuthor ">Kevin  Ogilvie</span>, <span class="hlFld-ContribAuthor ">Loren  Price</span>, <span class="hlFld-ContribAuthor ">Subas M.  Sakya</span>, <span class="hlFld-ContribAuthor ">Aijia  Yu</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>  . </span><span class="cited-content_cbyCitation_article-title">Utilizing Structures of CYP2D6 and BACE1 Complexes To Reduce Risk of Drug–Drug Interactions with a Novel Series of Centrally Efficacious BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 3223-3252. <a href="https://doi.org/10.1021/acs.jmedchem.5b00191" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00191%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUtilizing%252BStructures%252Bof%252BCYP2D6%252Band%252BBACE1%252BComplexes%252BTo%252BReduce%252BRisk%252Bof%252BDrug%2525E2%252580%252593Drug%252BInteractions%252Bwith%252Ba%252BNovel%252BSeries%252Bof%252BCentrally%252BEfficacious%252BBACE1%252BInhibitors%26aulast%3DBrodney%26aufirst%3DMichael%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D02022015%26date%3D01042015%26date%3D09042015%26date%3D17032015%26volume%3D58%26issue%3D7%26spage%3D3223%26epage%3D3252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haizhou  Zhu</span>, <span class="hlFld-ContribAuthor ">Venkateshwara  Dronamraju</span>, <span class="hlFld-ContribAuthor ">Wei  Xie</span>, <span class="hlFld-ContribAuthor ">Swati S.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfur-containing therapeutics in the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 305-352. <a href="https://doi.org/10.1007/s00044-020-02687-1" title="DOI URL">https://doi.org/10.1007/s00044-020-02687-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-020-02687-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-020-02687-1%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSulfur-containing%252Btherapeutics%252Bin%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhu%26aufirst%3DHaizhou%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D305%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhipeng  Yu</span>, <span class="hlFld-ContribAuthor ">Sijia  Wu</span>, <span class="hlFld-ContribAuthor ">Wenzhu  Zhao</span>, <span class="hlFld-ContribAuthor ">Long  Ding</span>, <span class="hlFld-ContribAuthor ">David  Shiuan</span>, <span class="hlFld-ContribAuthor ">Fuping  Zheng</span>, <span class="hlFld-ContribAuthor ">Jianrong  Li</span>, <span class="hlFld-ContribAuthor ">Jingbo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Biological evaluation and interaction mechanism of beta-site APP cleaving enzyme 1 inhibitory pentapeptide from egg albumin. </span><span class="cited-content_cbyCitation_journal-name">Food Science and Human Wellness</span><span> <strong>2020,</strong> <em>9 </em>
                                    (2)
                                     , 162-167. <a href="https://doi.org/10.1016/j.fshw.2020.01.004" title="DOI URL">https://doi.org/10.1016/j.fshw.2020.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fshw.2020.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fshw.2020.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520Science%2520and%2520Human%2520Wellness%26atitle%3DBiological%252Bevaluation%252Band%252Binteraction%252Bmechanism%252Bof%252Bbeta-site%252BAPP%252Bcleaving%252Benzyme%252B1%252Binhibitory%252Bpentapeptide%252Bfrom%252Begg%252Balbumin%26aulast%3DYu%26aufirst%3DZhipeng%26date%3D2020%26volume%3D9%26issue%3D2%26spage%3D162%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies suggest the important role of interactions among the catalytic dyad and inhibitors for designing Bace1 specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127893. <a href="https://doi.org/10.1016/j.molstruc.2020.127893" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127893%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDocking%252Bstudies%252Bsuggest%252Bthe%252Bimportant%252Brole%252Bof%252Binteractions%252Bamong%252Bthe%252Bcatalytic%252Bdyad%252Band%252Binhibitors%252Bfor%252Bdesigning%252BBace1%252Bspecific%252Binhibitors%26aulast%3DYildiz%26aufirst%3DMuslum%26date%3D2020%26volume%3D1208%26spage%3D127893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aida  Iraji</span>, <span class="hlFld-ContribAuthor ">Mahsima  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Omidreza  Firuzi</span>, <span class="hlFld-ContribAuthor ">Mehdi  Khoshneviszadeh</span>, <span class="hlFld-ContribAuthor ">Najmeh  Edraki</span>. </span><span class="cited-content_cbyCitation_article-title">Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103649. <a href="https://doi.org/10.1016/j.bioorg.2020.103649" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103649</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103649%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252Bsmall%252Bmolecule%252Btherapeutic%252Bagents%252Bfor%252BAlzheimer%252Bdisease%25253A%252BFocusing%252Bon%252BBACE1%252Band%252Bmulti-target%252Bdirected%252Bligands%26aulast%3DIraji%26aufirst%3DAida%26date%3D2020%26volume%3D97%26spage%3D103649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aldo  Peschiulli</span>, <span class="hlFld-ContribAuthor ">Daniel  Oehlrich</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ann  Vos</span>, <span class="hlFld-ContribAuthor ">Harrie JM  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (8)
                                     , 126999. <a href="https://doi.org/10.1016/j.bmcl.2020.126999" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.126999</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.126999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.126999%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D3%25252C3-Difluoro-3%25252C4%25252C5%25252C6-tetrahydropyridin-2-amines%25253A%252BPotent%252Band%252Bpermeable%252BBACE-1%252Binhibitors%26aulast%3DPeschiulli%26aufirst%3DAldo%26date%3D2020%26volume%3D30%26issue%3D8%26spage%3D126999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kosuke  Anan</span>, <span class="hlFld-ContribAuthor ">Yasuyoshi  Iso</span>, <span class="hlFld-ContribAuthor ">Takuya  Oguma</span>, <span class="hlFld-ContribAuthor ">Kenji  Nakahara</span>, <span class="hlFld-ContribAuthor ">Shinji  Suzuki</span>, <span class="hlFld-ContribAuthor ">Takahiko  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Eriko  Matsuoka</span>, <span class="hlFld-ContribAuthor ">Hisanori  Ito</span>, <span class="hlFld-ContribAuthor ">Gaku  Sakaguchi</span>, <span class="hlFld-ContribAuthor ">Shigeru  Ando</span>, <span class="hlFld-ContribAuthor ">Kenji  Morimoto</span>, <span class="hlFld-ContribAuthor ">Naoki  Kanegawa</span>, <span class="hlFld-ContribAuthor ">Yasuto  Kido</span>, <span class="hlFld-ContribAuthor ">Tomoyuki  Kawachi</span>, <span class="hlFld-ContribAuthor ">Tamio  Fukushima</span>, <span class="hlFld-ContribAuthor ">Ard  Teisman</span>, <span class="hlFld-ContribAuthor ">Vijay  Urmaliya</span>, <span class="hlFld-ContribAuthor ">Deborah  Dhuyvetter</span>, <span class="hlFld-ContribAuthor ">Herman  Borghys</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">An  Van Den Bergh</span>, <span class="hlFld-ContribAuthor ">Peter  Verboven</span>, <span class="hlFld-ContribAuthor ">Francois  Bischoff</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>, <span class="hlFld-ContribAuthor ">Yoshinori  Yamano</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>. </span><span class="cited-content_cbyCitation_article-title">Trifluoromethyl Dihydrothiazine‐Based β‐Secretase (BACE1) Inhibitors with Robust Central β‐Amyloid Reduction and Minimal Covalent Binding Burden. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (22)
                                     , 1894-1910. <a href="https://doi.org/10.1002/cmdc.201900478" title="DOI URL">https://doi.org/10.1002/cmdc.201900478</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900478&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900478%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTrifluoromethyl%252BDihydrothiazine%2525E2%252580%252590Based%252B%2525CE%2525B2%2525E2%252580%252590Secretase%252B%252528BACE1%252529%252BInhibitors%252Bwith%252BRobust%252BCentral%252B%2525CE%2525B2%2525E2%252580%252590Amyloid%252BReduction%252Band%252BMinimal%252BCovalent%252BBinding%252BBurden%26aulast%3DAnan%26aufirst%3DKosuke%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D22%26spage%3D1894%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Harrie J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">New evolutions in the BACE1 inhibitor field from 2014 to 2018. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 761-777. <a href="https://doi.org/10.1016/j.bmcl.2018.12.049" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.049%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bevolutions%252Bin%252Bthe%252BBACE1%252Binhibitor%252Bfield%252Bfrom%252B2014%252Bto%252B2018%26aulast%3DHsiao%26aufirst%3DChien-Chi%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D761%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siem Jakob  Veenstra</span>, <span class="hlFld-ContribAuthor ">Heinrich  Rueeger</span>, <span class="hlFld-ContribAuthor ">Markus  Voegtle</span>, <span class="hlFld-ContribAuthor ">Rainer  Lueoend</span>, <span class="hlFld-ContribAuthor ">Philipp  Holzer</span>, <span class="hlFld-ContribAuthor ">Konstanze  Hurth</span>, <span class="hlFld-ContribAuthor ">Marina  Tintelnot-Blomley</span>, <span class="hlFld-ContribAuthor ">Mathias  Frederiksen</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Rondeau</span>, <span class="hlFld-ContribAuthor ">Laura  Jacobson</span>, <span class="hlFld-ContribAuthor ">Matthias  Staufenbiel</span>, <span class="hlFld-ContribAuthor ">Ulf  Neumann</span>, <span class="hlFld-ContribAuthor ">Rainer  Machauer</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of amino-1,4-oxazines as potent BACE-1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (12)
                                     , 2195-2200. <a href="https://doi.org/10.1016/j.bmcl.2018.05.003" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bamino-1%25252C4-oxazines%252Bas%252Bpotent%252BBACE-1%252Binhibitors%26aulast%3DVeenstra%26aufirst%3DSiem%2BJakob%26date%3D2018%26volume%3D28%26issue%3D12%26spage%3D2195%26epage%3D2200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hwanjong  Jang</span>, <span class="hlFld-ContribAuthor ">Filippo  Romiti</span>, <span class="hlFld-ContribAuthor ">Sebastian  Torker</span>, <span class="hlFld-ContribAuthor ">Amir H.  Hoveyda</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic diastereo- and enantioselective additions of versatile allyl groups to N–H ketimines. </span><span class="cited-content_cbyCitation_journal-name">Nature Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (12)
                                     , 1269-1275. <a href="https://doi.org/10.1038/nchem.2816" title="DOI URL">https://doi.org/10.1038/nchem.2816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nchem.2816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnchem.2816%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Chemistry%26atitle%3DCatalytic%252Bdiastereo-%252Band%252Benantioselective%252Badditions%252Bof%252Bversatile%252Ballyl%252Bgroups%252Bto%252BN%2525E2%252580%252593H%252Bketimines%26aulast%3DJang%26aufirst%3DHwanjong%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D12%26spage%3D1269%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.  Ellis</span>, <span class="hlFld-ContribAuthor ">Cheng‐Chieh  Tsai</span>, <span class="hlFld-ContribAuthor ">Fang‐Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Jana  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational dynamics of cathepsin D and binding to a small‐molecule BACE1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computational Chemistry</span><span> <strong>2017,</strong> <em>38 </em>
                                    (15)
                                     , 1260-1269. <a href="https://doi.org/10.1002/jcc.24719" title="DOI URL">https://doi.org/10.1002/jcc.24719</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcc.24719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcc.24719%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computational%2520Chemistry%26atitle%3DConformational%252Bdynamics%252Bof%252Bcathepsin%252BD%252Band%252Bbinding%252Bto%252Ba%252Bsmall%2525E2%252580%252590molecule%252BBACE1%252Binhibitor%26aulast%3DEllis%26aufirst%3DChristopher%2BR.%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D15%26spage%3D1260%26epage%3D1269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.W.  Stamford</span>, <span class="hlFld-ContribAuthor ">J.N.  Cumming</span>, <span class="hlFld-ContribAuthor ">J.D.  Scott</span>, <span class="hlFld-ContribAuthor ">C.O.  Strickland</span>. </span><span class="cited-content_cbyCitation_article-title">Verubecestat. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 204-251. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12453-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12453-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12453-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12453-9%26sid%3Dliteratum%253Aachs%26atitle%3DVerubecestat%26aulast%3DStamford%26aufirst%3DA.W.%26date%3D2017%26spage%3D204%26epage%3D251%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan D.  Low</span>, <span class="hlFld-ContribAuthor ">Michael D.  Bartberger</span>, <span class="hlFld-ContribAuthor ">Kui  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Mark R.  Fielden</span>, <span class="hlFld-ContribAuthor ">Vijay  Gore</span>, <span class="hlFld-ContribAuthor ">Dean  Hickman</span>, <span class="hlFld-ContribAuthor ">Qingyian  Liu</span>, <span class="hlFld-ContribAuthor ">E.  Allen Sickmier</span>, <span class="hlFld-ContribAuthor ">Hugo M.  Vargas</span>, <span class="hlFld-ContribAuthor ">Jonathan  Werner</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>, <span class="hlFld-ContribAuthor ">Stephen  Wood</span>, <span class="hlFld-ContribAuthor ">Ana E.  Minatti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 1196-1206. <a href="https://doi.org/10.1039/C7MD00106A" title="DOI URL">https://doi.org/10.1039/C7MD00106A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7MD00106A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7MD00106A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252B2-aminooxazoline%252B3-azaxanthene%252B%2525CE%2525B2-amyloid%252Bcleaving%252Benzyme%252B%252528BACE%252529%252Binhibitors%252Bwith%252Bimproved%252Bselectivity%252Bagainst%252BCathepsin%252BD%26aulast%3DLow%26aufirst%3DJonathan%2BD.%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D6%26spage%3D1196%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea M.  Zuhl</span>, <span class="hlFld-ContribAuthor ">Charles E.  Nolan</span>, <span class="hlFld-ContribAuthor ">Michael A.  Brodney</span>, <span class="hlFld-ContribAuthor ">Sherry  Niessen</span>, <span class="hlFld-ContribAuthor ">Kevin  Atchison</span>, <span class="hlFld-ContribAuthor ">Christopher  Houle</span>, <span class="hlFld-ContribAuthor ">David A.  Karanian</span>, <span class="hlFld-ContribAuthor ">Claude  Ambroise</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Brulet</span>, <span class="hlFld-ContribAuthor ">Elizabeth M.  Beck</span>, <span class="hlFld-ContribAuthor ">Shawn D.  Doran</span>, <span class="hlFld-ContribAuthor ">Brian T.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Kieran F.  Geoghegan</span>, <span class="hlFld-ContribAuthor ">Graham M.  West</span>, <span class="hlFld-ContribAuthor ">Joshua C.  Judkins</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>, <span class="hlFld-ContribAuthor ">David R.  Riddell</span>, <span class="hlFld-ContribAuthor ">Douglas S.  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Chemoproteomic profiling reveals that cathepsin D off-target activity drives ocular toxicity of β-secretase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2016,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms13042" title="DOI URL">https://doi.org/10.1038/ncomms13042</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms13042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms13042%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DChemoproteomic%252Bprofiling%252Breveals%252Bthat%252Bcathepsin%252BD%252Boff-target%252Bactivity%252Bdrives%252Bocular%252Btoxicity%252Bof%252B%2525CE%2525B2-secretase%252Binhibitors%26aulast%3DZuhl%26aufirst%3DAndrea%2BM.%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susanna  Eketjäll</span>, <span class="hlFld-ContribAuthor ">Juliette  Janson</span>, <span class="hlFld-ContribAuthor ">Karin  Kaspersson</span>, <span class="hlFld-ContribAuthor ">Anna  Bogstedt</span>, <span class="hlFld-ContribAuthor ">Fredrik  Jeppsson</span>, <span class="hlFld-ContribAuthor ">Johanna  Fälting</span>, <span class="hlFld-ContribAuthor ">Samantha Budd  Haeberlein</span>, <span class="hlFld-ContribAuthor ">Alan R.  Kugler</span>, <span class="hlFld-ContribAuthor ">Robert C.  Alexander</span>, <span class="hlFld-ContribAuthor ">Gvido  Cebers</span>, . </span><span class="cited-content_cbyCitation_article-title">AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate Kinetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2016,</strong> <em>50 </em>
                                    (4)
                                     , 1109-1123. <a href="https://doi.org/10.3233/JAD-150834" title="DOI URL">https://doi.org/10.3233/JAD-150834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-150834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-150834%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DAZD3293%25253A%252BA%252BNovel%25252C%252BOrally%252BActive%252BBACE1%252BInhibitor%252Bwith%252BHigh%252BPotency%252Band%252BPermeability%252Band%252BMarkedly%252BSlow%252BOff-Rate%252BKinetics%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DSusanna%26date%3D2016%26volume%3D50%26issue%3D4%26spage%3D1109%26epage%3D1123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rachel K.  Chambers</span>, <span class="hlFld-ContribAuthor ">Tanweer A.  Khan</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Brad E.  Sleebs</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of amino heterocycle aspartyl protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (22)
                                     , 4970-4985. <a href="https://doi.org/10.1039/C5OB01842K" title="DOI URL">https://doi.org/10.1039/C5OB01842K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01842K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01842K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bamino%252Bheterocycle%252Baspartyl%252Bprotease%252Binhibitors%26aulast%3DChambers%26aufirst%3DRachel%2BK.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D22%26spage%3D4970%26epage%3D4985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandria P.  Taylor</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Yvette M.  Fobian</span>, <span class="hlFld-ContribAuthor ">David C.  Blakemore</span>, <span class="hlFld-ContribAuthor ">Lyn H.  Jones</span>, <span class="hlFld-ContribAuthor ">Olugbeminiyi  Fadeyi</span>. </span><span class="cited-content_cbyCitation_article-title">Modern advances in heterocyclic chemistry in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2016,</strong> <em>14 </em>
                                    (28)
                                     , 6611-6637. <a href="https://doi.org/10.1039/C6OB00936K" title="DOI URL">https://doi.org/10.1039/C6OB00936K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6OB00936K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6OB00936K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DModern%252Badvances%252Bin%252Bheterocyclic%252Bchemistry%252Bin%252Bdrug%252Bdiscovery%26aulast%3DTaylor%26aufirst%3DAlexandria%2BP.%26date%3D2016%26date%3D2016%26volume%3D14%26issue%3D28%26spage%3D6611%26epage%3D6637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0013.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Literature thioamidine-derived BACE1 inhibitors and properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 3-bromobut-3-en-1-yl 4-methylbenzenesulfonate, (Ph<sub>3</sub>P)<sub>4</sub>Pd, CsF, THF, 70 °C, 90%. (b) Thiourea, CH<sub>3</sub>CN, 75 °C, 83%; (c) 6 N HCl, 95 °C, 17%, then chiral separation.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0014.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) X-ray crystal structure of <b>6</b> with BACE1 (green ball and stick/light blue ribbon) with a model of <b>6</b> in cathepsin D (orange ball and stick/yellow ribbon). Residues in the areas of interest are labeled with BACE1 residue names and numbers (light blue) following by the corresponding CatD residue names (yellow). (b) Potential regions to exploit for BACE1 vs cathepsin D selectivity. (c) Strategic construction to explore S2′.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1,5-dibromo-2,4-difluorobenzene, <i>n</i>-BuLi, AlMe<sub>3</sub>, −70 °C, tol. (b) HCl in dioxane, rt. (c) PhC(O)NCS, THF, rt. (d) Tf<sub>2</sub>O, pyridine, −20 °C, CH<sub>2</sub>Cl<sub>2</sub>. (e) DBU, MeOH, 80 °C. (f) <i>t</i>-BOC<sub>2</sub>O, aq NaHCO<sub>3</sub>–THF, rt, then chromatography. (g) <b>13a</b> and <b>13b</b> separately: <i>n</i>-BuLi, −78 °C, THF then TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>n</i> = 1:<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> HOCH<sub>2</sub>CH<sub>2</sub>OH, KOH, THF, 60 °C; <i>n</i> = 2, BrCH<sub>2</sub>CH(OEt)<sub>2</sub>, NaH, THF, 0 °C then 68 °C. (b) <i>n</i> = 1: (COCl)<sub>2</sub>, DMSO, CH<sub>2</sub>Cl<sub>2</sub>, −78 °C. <i>n</i> = 2: aq HCl, THF, 70 °C. (c) <i>n</i> = 1, 2: NH<sub>2</sub>OH–HCl, NaOAc, EtOH–H<sub>2</sub>O, 60 °C. (d) <i>n</i> = 1, 2: NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt. <i>n</i> = 2: then chiral HPLC. (e) <i>n</i> = 1, 2: <i>n</i>-BuLi, 1-bromo-2,4-difluorobenzene, THF–tol 1:3, −78 °C then BF<sub>3</sub>–OEt<sub>2</sub>, <b>19a,b</b>, toluene, −78 °C to rt. (f) <i>n</i> = 1, 2: Zn, AcOH, rt. (g) <i>n</i> = 1: BzNCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. <i>n</i> = 2: FMOC-isothiocyanate, CH<sub>2</sub>Cl<sub>2</sub>, rt. (h) <i>n</i> = 1: Ghosez reagent, tol, 70 °C. <i>n</i> = 2: concd HCl (aq), MeOH, 70 °C. (i) <i>n</i> = 1: DBU, MeOH, 60 °C, then chiral HPLC. <i>n</i> = 2: MeCN, piperidine, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray cocrystal of <b>24b</b> (magenta) in BACE1 in comparison with <b>6</b> (green). Tyr-71 has rotated to a different rotameric conformation, to accommodate the THP ring. A crystallographically observed water is making a hydrogen bond to the oxygen of the THP. A computationally predicted “unstable” water molecule is shown in cyan.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Retrosynthetic Analysis for Analog Generation</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0010.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) R = CH<sub>2</sub>OBn: vinylMgBr, CuI–Et<sub>2</sub>O, THF −78 °C to rt. R = c-C<sub>3</sub>H<sub>5</sub>: ref <a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">24</a>. (b) BrCH<sub>2</sub>CH(OEt)<sub>2</sub>, NaH, THF, 0 °C then 68 °C. (c) aq HCl, THF, 40–70 °C. (d) NH<sub>2</sub>OH–HCl, NaOAc, EtOH–H<sub>2</sub>O, 60 °C. (e) aq NaOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt. (f) BF<sub>3</sub>–OEt<sub>2</sub>, IPE–tol 1:1, or tol, −78 °C, then 1-bromo-2,4-difluorobenzene, <i>n</i>-BuLi, −78 °C to rt. (g) Zn, AcOH, rt. (h) R = CH<sub>2</sub>OBn: FMOC-NCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. Alternatively, R = CH<sub>2</sub>OBn: Bz-NCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. R = c-C<sub>3</sub>H<sub>5</sub>: BzNCS, CH<sub>2</sub>Cl<sub>2</sub>, rt. (i) P = FMOC, R = CH<sub>2</sub>OBn: concd HCl, aq, MeOH, 70 °C. P = Bz, R = CH<sub>2</sub>OBn: Tf<sub>2</sub>O, pyr, CH<sub>2</sub>Cl<sub>2</sub>, −60 °C. R = c-C<sub>3</sub>H<sub>5</sub>: Tf<sub>2</sub>O, pyr, CH<sub>2</sub>Cl<sub>2</sub>, −50 °C. (j) R = c-C<sub>3</sub>H<sub>5</sub>: DBU, MeOH, 60 °C, then chiral HPLC. (k) P = FMOC, R = CH<sub>2</sub>OBn: concd HCl, 120 °C followed by piperidine, DMF, rt then <i>t</i>-BOC)<sub>2</sub>O, Et<sub>3</sub>N, THF/MeOH, rt. P = Bz, R = CH<sub>2</sub>OBn: NaBrO<sub>3</sub>, EtOAc–H<sub>2</sub>O, 0 °C.</p></p></figure><figure data-id="sch6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 6. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) P = <i>t</i>-BOC: DAST, pentane–CH<sub>2</sub>Cl<sub>2</sub> 1:1, rt, 51%, then TFA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 74%. (b) P = Bz: MeI, NaH, THF, 40 °C, 69% then DBU, MeOH, 70 °C, 72%. (c) P = Bz: SO<sub>3</sub>–Pyr, DMSO, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, rt, 71%. (d) DAST, CH<sub>2</sub>Cl<sub>2</sub>, −20 °C, 58%, then DBU, MeOH, 60 °C, 96%. (e) Ph<sub>3</sub>P<sup>+</sup>Me Br<sup>–</sup>, <i>t</i>-BuOK, THF, −15 °C to rt, 82% then H<sub>2</sub>, Pd/C, MeOH, rt, 100%, then DBU, MeOH, 80°, 58%. (f) SOCl<sub>2</sub>, tol, 80 °C, 90%. (g) LiEt<sub>3</sub>BH, THF, 0 °C, 81%, then DBU, MeOH, 80 °C, 81%. (h) Ph<sub>3</sub>P<sup>+</sup><i>i</i>-Pr Br<sup>–</sup>, <i>n</i>-BuLi, THF, 0 °C to rt, 38% then H<sub>2</sub>, Pd/C, MeOH, rt, 26%, then DBU, MeOH, 60 °C, 52%.</p></p></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <b>36</b> and BACE1. The fluoromethyl substituent is directed toward the lipophilic pocket revealed by the rotation of Tyr-71.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0001.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Time course effect of <b>36</b> on brain, plasma, and CSF Aβ following acute administration in mouse. Compound <b>36</b> was dosed at 30 or 150 mg/kg sc at time = 0. Data are the mean ± SEM, <i>n</i> = 5/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0002.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Time course of effect of <b>36</b> on plasma and CSF Aβ following acute 18 mg/kg po administration in beagle dogs. Compound <b>36</b> was dosed at 18 mg/kg po at time = 0. Data are the mean ± SEM, <i>n</i> = 4/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0003.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effect of <b>36</b> on amyloid-plaque-lowering efficacy in 8.5-month-old PS1/APP mice. Fluorescence intensity was quantitated from a defined cortical region (600 × 600 × 200 μm) at baseline (6.5 months of age) and after 2 months of treatment (8.5 months of age) with vehicle or <b>36</b>. Data are the mean ± SEM; <i>n</i> = 14 for vehicle and <i>n</i> = 6 for compound <b>36</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0004.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Representative two-photon imaging of preexisting amyloid plaques and subsequent reductions following 2 months of chronic treatment (po) with vehicle or compound <b>36</b>. (A, B) The same cortical region (600 × 600 × 200 μm) was imaged at baseline (A) and after 2-month vehicle treatment (B). (C) Examples of plaques that had increased volume with higher magnification (boxed region in A, B). (A′, B′) A significant percentage of parenchymal plaques showed volume reduction after 2-month BACE1 inhibitor (<b>36</b>) treatment. (C′) Examples of plaque regression (boxed region in A′, B′).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/medium/jm-2014-01833t_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0005.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Time course data for the acute effect of <b>36</b> on CSF and plasma Aβ concentrations in 8–9-month-old PS1/APP mice. Compound <b>36</b> was dosed at 30 mg/kg (sc) at time = 0. Data are the mean ± SEM, <i>n</i> = 2–5/group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-6/jm501833t/20150320/images/large/jm-2014-01833t_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501833t&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i89">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77372" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77372" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allsop, D.</span><span> </span><span class="NLM_article-title">Amyloid Deposition as the Central Event in the Aetiology of Alzheimer’s Disease</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1991&pages=383&author=J.+Hardyauthor=D.+Allsop&title=Amyloid+Deposition+as+the+Central+Event+in+the+Aetiology+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DAllsop%26aufirst%3DD.%26atitle%3DAmyloid%2520Deposition%2520as%2520the%2520Central%2520Event%2520in%2520the%2520Aetiology%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1991%26volume%3D12%26spage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Tanzi, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertram, L.</span><span> </span><span class="NLM_article-title">Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">120</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=120&publication_year=2005&pages=545&author=R.+E.+Tanziauthor=L.+Bertram&title=Twenty+Years+of+the+Alzheimer%E2%80%99s+Disease+Amyloid+Hypothesis%3A+A+Genetic+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanzi%26aufirst%3DR.%2BE.%26aulast%3DBertram%26aufirst%3DL.%26atitle%3DTwenty%2520Years%2520of%2520the%2520Alzheimer%25E2%2580%2599s%2520Disease%2520Amyloid%2520Hypothesis%253A%2520A%2520Genetic%2520Perspective%26jtitle%3DCell%26date%3D2005%26volume%3D120%26spage%3D545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1152%2Fphysrev.00023.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=20393191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=465-494&author=B.+De+Strooper&title=Proteases+and+Proteolysis+in+Alzheimer+Disease%3A+A+Multifactorial+View+on+the+Disease+Process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process</span></div><div class="casAuthors">De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-494</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer disease is characterized by the accumulation of abnormally folded protein fragments, i.e., amyloid beta peptide (Aβ) and tau that ppt. in amyloid plaques and neuronal tangles, resp.  In this review we discuss the complicated proteolytic pathways that are responsible for the generation and clearance of these fragments, and how disturbances in these pathways interact and provide a background for a novel understanding of Alzheimer disease as a multifactorial disorder.  Recent insights evolve from the static view that the morphol. defined plaques and tangles are disease driving towards a more dynamic, biochem. view in which the intermediary sol. Aβ oligomers and sol. tau fragments are considered as the main mediators of neurotoxicity.  The relevance of proteolytic pathways, centered on the generation and clearance of toxic Aβ, on the cleavage and nucleation of tau, and on the general proteostasis of the neurons, then becomes obvious.  Blocking or stimulating these pathways provide, or have the potential to provide, interesting drug targets, which raises the hope that we will be able to provide a cure for this dreadful disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrstXCXtuTzCrVg90H21EOLACvtfcHk0ljEubtskmJ3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1erurjF&md5=be45257bc56a5779b6ef7e18e98b0738</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00023.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00023.2009%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DProteases%2520and%2520Proteolysis%2520in%2520Alzheimer%2520Disease%253A%2520A%2520Multifactorial%2520View%2520on%2520the%2520Disease%2520Process%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D465%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovacs, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span> </span><span class="NLM_article-title">The beta-Secretase Enzyme BACE in Health and Alzheimer’s Disease: Regulation, Cell Biology, Function, and Therapeutic Potential</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">12787</span><span class="NLM_x">–</span> <span class="NLM_lpage">12794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.3657-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=19828790" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=12787-12794&author=R.+Vassarauthor=D.+M.+Kovacsauthor=R.+Yanauthor=P.+C.+Wong&title=The+beta-Secretase+Enzyme+BACE+in+Health+and+Alzheimer%E2%80%99s+Disease%3A+Regulation%2C+Cell+Biology%2C+Function%2C+and+Therapeutic+Potential"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The β-secretase enzyme BACE in health and Alzheimer's disease: regulation, cell biology, function, and therapeutic potential</span></div><div class="casAuthors">Vassar, Robert; Kovacs, Dora M.; Yan, Riqiang; Wong, Philip C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">12787-12794</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">A review.  The β-amyloid (Aβ) peptide is the major constituent of amyloid plaques in Alzheimer's disease (AD) brain and is likely to play a central role in the pathogenesis of this devastating neurodegenerative disorder.  The β-secretase, β-site amyloid precursor protein cleaving enzyme (BACE1; also called Asp2, memapsin 2), is the enzyme responsible for initiating Aβ generation.  Thus, BACE is a prime drug target for the therapeutic inhibition of Aβ prodn. in AD.  Since its discovery 10 years ago, much has been learned about BACE.  This review summarizes BACE properties, describes BACE translation dysregulation in AD, and discusses BACE physiol. functions in sodium current, synaptic transmission, myelination, and schizophrenia.  The therapeutic potential of BACE will also be considered.  This is a summary of topics covered at a symposium held at the 39th annual meeting of the Society for Neuroscience and is not meant to be a comprehensive review of BACE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqGn8h_x-7_bVg90H21EOLACvtfcHk0ljEubtskmJ3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlSit7bP&md5=a462ad002cf3801570725719d71647c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3657-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3657-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKovacs%26aufirst%3DD.%2BM.%26aulast%3DYan%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DP.%2BC.%26atitle%3DThe%2520beta-Secretase%2520Enzyme%2520BACE%2520in%2520Health%2520and%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Regulation%252C%2520Cell%2520Biology%252C%2520Function%252C%2520and%2520Therapeutic%2520Potential%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D12787%26epage%3D12794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Marks, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, M. J.</span><span> </span><span class="NLM_article-title">BACE and gamma-Secretase Characterization and Their Sorting as Therapeutic Targets To Reduce Amyloidogenesis</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">210</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1007%2Fs11064-009-0054-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=19760173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=181-210&author=N.+Marksauthor=M.+J.+Berg&title=BACE+and+gamma-Secretase+Characterization+and+Their+Sorting+as+Therapeutic+Targets+To+Reduce+Amyloidogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">BACE and γ-secretase characterization and their sorting as therapeutic targets to reduce amyloidogenesis</span></div><div class="casAuthors">Marks, Neville; Berg, Martin J.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">181-210</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Secretases are enzymes that process amyloid precursor protein (APP), a prototypic type-1 membrane protein.  This has led directly to discovery of novel aspartic proteases (β-secretase or BACE), a tetramer complex, γ-secretase (γ-SC) contg. presenilins, nicastrin, aph-1 and pen-2, and a new role for metalloprotease(s) of the ADAM family as α-secretases.  Recent advances in defining pathways that mediate endosomal/lysosomal/autophagic/exosomal trafficking now provide targets for new drugs to attenuate abnormal prodn. of fibril-forming products characteristic of Alzheimer's disease (AD).  A key to success includes not only characterization of relevant secretases, but mechanisms for sorting and transport of key metabolites to abnormal vesicles or sites for assembly of fibrils.  New developments highlighted here include an important role for an 'early recycling endosome' coated in a retromer complex contg. lipoprotein receptor LRP-II (SorLA) for switching APP to a non-amyloidogenic pathway for α-secretase processing, or to shuttle APP to a 'late endosome compartment' to form Aβ or AICD.  LRP11 (SorLA) is of particular importance since it decreases in sporadic AD whose etiol. is otherwise unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptFxOS-WJwAbVg90H21EOLACvtfcHk0ljEubtskmJ3jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFentLnJ&md5=312eb981ae39671456e316bf050166dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1007%2Fs11064-009-0054-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-009-0054-1%26sid%3Dliteratum%253Aachs%26aulast%3DMarks%26aufirst%3DN.%26aulast%3DBerg%26aufirst%3DM.%2BJ.%26atitle%3DBACE%2520and%2520gamma-Secretase%2520Characterization%2520and%2520Their%2520Sorting%2520as%2520Therapeutic%2520Targets%2520To%2520Reduce%2520Amyloidogenesis%26jtitle%3DNeurochem.%2520Res.%26date%3D2010%26volume%3D35%26spage%3D181%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A Mutation in APP Protects against Alzheimer’s Disease and Age-Related Cognitive Decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x"> (</span><span class="NLM_issue">7409</span><span class="NLM_x">) </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">9</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-9&issue=7409&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Jonssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+Mutation+in+APP+Protects+against+Alzheimer%E2%80%99s+Disease+and+Age-Related+Cognitive+Decline"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJonsson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520Mutation%2520in%2520APP%2520Protects%2520against%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Age-Related%2520Cognitive%2520Decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26issue%3D7409%26spage%3D96%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Evin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hince, C.</span><span> </span><span class="NLM_article-title">BACE1 as a Therapeutic Target in Alzheimer’s Disease: Rationale and Current Status</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">755</span><span class="NLM_x">–</span> <span class="NLM_lpage">764</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1007%2Fs40266-013-0099-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=23842796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2013&pages=755-764&author=G.+Evinauthor=C.+Hince&title=BACE1+as+a+Therapeutic+Target+in+Alzheimer%E2%80%99s+Disease%3A+Rationale+and+Current+Status"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 as a Therapeutic Target in Alzheimer's Disease: Rationale and Current Status</span></div><div class="casAuthors">Evin, Genevieve; Hince, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">755-764</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disease of the central nervous system that causes dementia in a large percentage of the aged population and for which there are only symptomatic treatments.  Disease-modifying therapies that are currently being pursued are based on the amyloid cascade theory.  This states that accumulation of amyloid β (Aβ) in the brain triggers a cascade of cellular events leading to neurodegeneration.  Aβ, which is the major constituent of amyloid plaques, is a peptidic fragment derived from proteolytic processing of the amyloid precursor protein (APP) by sequential cleavages that involve β-site APP-cleaving enzyme 1 (BACE1) and γ-secretase.  Targeting BACE1 is a rational approach as its cleavage of APP is the rate-limiting step in Aβ prodn. and this enzyme is elevated in the brain of patients with AD.  Furthermore, knocking out the BACE1 gene in mice showed little apparent consequences.  Ten years of intensive research has led to the design of efficacious BACE1 inhibitors with favorable pharmacol. properties.  Several drug candidates have shown promising results in animal models, as they reduce amyloid plaque pathol. in the brain and rescue cognitive deficits.  Phase I clin. trials indicate that these drugs are well tolerated, and the results from further trials in AD patients are now awaited eagerly.  Yet, recent novel information on BACE1 biol., and the discovery that BACE1 cleaves a selection of substrates involved in myelination, retinal homeostasis, brain circuitry, and synaptic function, alert us to potential side effects of BACE1 inhibitors that will require further evaluation to provide a safe therapy for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEqXQKm8PabVg90H21EOLACvtfcHk0li5CZDuI5BRkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVWmt7bI&md5=356aae7bd5a2aeb1ea1c208be4b0a5f3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40266-013-0099-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40266-013-0099-3%26sid%3Dliteratum%253Aachs%26aulast%3DEvin%26aufirst%3DG.%26aulast%3DHince%26aufirst%3DC.%26atitle%3DBACE1%2520as%2520a%2520Therapeutic%2520Target%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Rationale%2520and%2520Current%2520Status%26jtitle%3DDrugs%2520Aging%26date%3D2013%26volume%3D30%26spage%3D755%26epage%3D764" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span> </span><span class="NLM_article-title">Structure-Based Design of β-Site APP Cleaving Enzyme 1 (BACE1) Inhibitors for the Treatment of Alzheimer’s Disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4156</span><span class="NLM_x">–</span> <span class="NLM_lpage">4180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301659n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4156-4180&author=J.+Yuanauthor=S.+Venkatramanauthor=Y.+Zhengauthor=B.+M.+McKeeverauthor=L.+W.+Dillardauthor=S.+B.+Singh&title=Structure-Based+Design+of+%CE%B2-Site+APP+Cleaving+Enzyme+1+%28BACE1%29+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm301659n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301659n%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DZheng%26aufirst%3DY.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26atitle%3DStructure-Based%2520Design%2520of%2520%25CE%25B2-Site%2520APP%2520Cleaving%2520Enzyme%25201%2520%2528BACE1%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4156%26epage%3D4180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Travagli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollastrini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marconi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabellieri, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">BACE1 Inhibitors: A Head Group Scan on a Series of Amides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">4239</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=4239-43&author=T.+J.+Wolteringauthor=W.+Wostlauthor=H.+Hilpertauthor=M.+Rogers-Evansauthor=E.+Pinardauthor=A.+Maywegauthor=M.+Gobelauthor=D.+W.+Bannerauthor=J.+Benzauthor=M.+Travagliauthor=M.+Pollastriniauthor=G.+Marconiauthor=E.+Gabellieriauthor=W.+Gubaauthor=H.+Mauserauthor=M.+Andreiniauthor=H.+Jacobsenauthor=E.+Powerauthor=R.+Narquizian&title=BACE1+Inhibitors%3A+A+Head+Group+Scan+on+a+Series+of+Amides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMayweg%26aufirst%3DA.%26aulast%3DGobel%26aufirst%3DM.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DBenz%26aufirst%3DJ.%26aulast%3DTravagli%26aufirst%3DM.%26aulast%3DPollastrini%26aufirst%3DM.%26aulast%3DMarconi%26aufirst%3DG.%26aulast%3DGabellieri%26aufirst%3DE.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DAndreini%26aufirst%3DM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DPower%26aufirst%3DE.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3DBACE1%2520Inhibitors%253A%2520A%2520Head%2520Group%2520Scan%2520on%2520a%2520Series%2520of%2520Amides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D4239%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambroise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanyon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Efremov, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Spirocyclic Sulfamides as β-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer’s Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies to Identify Centrally Efficacious Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9224</span><span class="NLM_x">–</span> <span class="NLM_lpage">9239</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3009426" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9224-9239&author=M.+A.+Brodneyauthor=G.+Barreiroauthor=K.+Ogilvieauthor=E.+Hajos-Korcsokauthor=J.+Murrayauthor=F.+Vajdosauthor=C.+Ambroiseauthor=C.+Christoffersenauthor=K.+Fisherauthor=L.+Lanyonauthor=J.+Liuauthor=C.+E.+Nolanauthor=J.+M.+Withkaauthor=K.+A.+Borzilleriauthor=I.+Efremovauthor=C.+E.+Oborskiauthor=A.+Vargheseauthor=B.+T.+O%E2%80%99Neill&title=Spirocyclic+Sulfamides+as+%CE%B2-Secretase+1+%28BACE-1%29+Inhibitors+for+the+Treatment+of+Alzheimer%E2%80%99s+Disease%3A+Utilization+of+Structure+Based+Drug+Design%2C+WaterMap%2C+and+CNS+Penetration+Studies+to+Identify+Centrally+Efficacious+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm3009426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009426%26sid%3Dliteratum%253Aachs%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DAmbroise%26aufirst%3DC.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFisher%26aufirst%3DK.%26aulast%3DLanyon%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DEfremov%26aufirst%3DI.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DVarghese%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DSpirocyclic%2520Sulfamides%2520as%2520%25CE%25B2-Secretase%25201%2520%2528BACE-1%2529%2520Inhibitors%2520for%2520the%2520Treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%253A%2520Utilization%2520of%2520Structure%2520Based%2520Drug%2520Design%252C%2520WaterMap%252C%2520and%2520CNS%2520Penetration%2520Studies%2520to%2520Identify%2520Centrally%2520Efficacious%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9224%26epage%3D9239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Johnson, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deal, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engstrom, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kania, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kath, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lingardo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McTigue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sach, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smeal, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timofeevski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span> </span><span class="NLM_article-title">Discovery of (10<i>R</i>)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2<i>H</i>-8,4-(metheno)pyrazolo[4,3-<i>h</i>][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">4720</span><span class="NLM_x">–</span> <span class="NLM_lpage">4744</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm500261q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=4720-4744&author=T.+W.+Johnsonauthor=P.+F.+Richardsonauthor=S.+Baileyauthor=A.+Broounauthor=B.+J.+Burkeauthor=M.+R.+Collinsauthor=J.+J.+Cuiauthor=J.+G.+Dealauthor=Y.-L.+Dengauthor=D.+Dinhauthor=L.+D.+Engstromauthor=M.+Heauthor=J.+Hoffmanauthor=R.+L.+Hoffmanauthor=Q.+Huangauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=H.+Lamauthor=J.+L.+Lamauthor=P.+T.+Leauthor=L.+Lingardoauthor=W.+Liuauthor=M.+McTigueauthor=C.+L.+Palmerauthor=N.+W.+Sachauthor=T.+Smealauthor=G.+L.+Smithauthor=A.+E.+Stewartauthor=S.+Timofeevskiauthor=H.+Zhuauthor=J.+Zhuauthor=H.+Y.+Zouauthor=M.+P.+Edwards&title=Discovery+of+%2810R%29-7-Amino-12-fluoro-2%2C10%2C16-trimethyl-15-oxo-10%2C15%2C16%2C17-tetrahydro-2H-8%2C4-%28metheno%29pyrazolo%5B4%2C3-h%5D%5B2%2C5%2C11%5Dbenzoxadiazacyclotetradecine-3-carbonitrile+%28PF-06463922%29%2C+a+Macrocyclic+Inhibitor+of+Anaplastic+Lymphoma+Kinase+%28ALK%29+and+c-ros+Oncogene+1+%28ROS1%29+with+Preclinical+Brain+Exposure+and+Broad-Spectrum+Potency+against+ALK-Resistant+Mutations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm500261q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500261q%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DT.%2BW.%26aulast%3DRichardson%26aufirst%3DP.%2BF.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DB.%2BJ.%26aulast%3DCollins%26aufirst%3DM.%2BR.%26aulast%3DCui%26aufirst%3DJ.%2BJ.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DEngstrom%26aufirst%3DL.%2BD.%26aulast%3DHe%26aufirst%3DM.%26aulast%3DHoffman%26aufirst%3DJ.%26aulast%3DHoffman%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DLam%26aufirst%3DH.%26aulast%3DLam%26aufirst%3DJ.%2BL.%26aulast%3DLe%26aufirst%3DP.%2BT.%26aulast%3DLingardo%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMcTigue%26aufirst%3DM.%26aulast%3DPalmer%26aufirst%3DC.%2BL.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DSmeal%26aufirst%3DT.%26aulast%3DSmith%26aufirst%3DG.%2BL.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTimofeevski%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZou%26aufirst%3DH.%2BY.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26atitle%3DDiscovery%2520of%2520%252810R%2529-7-Amino-12-fluoro-2%252C10%252C16-trimethyl-15-oxo-10%252C15%252C16%252C17-tetrahydro-2H-8%252C4-%2528metheno%2529pyrazolo%255B4%252C3-h%255D%255B2%252C5%252C11%255Dbenzoxadiazacyclotetradecine-3-carbonitrile%2520%2528PF-06463922%2529%252C%2520a%2520Macrocyclic%2520Inhibitor%2520of%2520Anaplastic%2520Lymphoma%2520Kinase%2520%2528ALK%2529%2520and%2520c-ros%2520Oncogene%25201%2520%2528ROS1%2529%2520with%2520Preclinical%2520Brain%2520Exposure%2520and%2520Broad-Spectrum%2520Potency%2520against%2520ALK-Resistant%2520Mutations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D4720%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust Central Reduction of Amyloid-beta in Humans with an Orally Available, Non-Peptidic beta-Secretase Inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+G.+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+Central+Reduction+of+Amyloid-beta+in+Humans+with+an+Orally+Available%2C+Non-Peptidic+beta-Secretase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0ljxVpNTPV0s3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DHall%26aufirst%3DD.%2BG.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520Central%2520Reduction%2520of%2520Amyloid-beta%2520in%2520Humans%2520with%2520an%2520Orally%2520Available%252C%2520Non-Peptidic%2520beta-Secretase%2520Inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Müller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennemärker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinheckel, T.</span><span> </span><span class="NLM_article-title">Specific Functions of Lysosomal Proteases in Endocytic and Autophagic Pathways</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Proteins Proteomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">1824</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">34</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.bbapap.2011.07.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21767668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1824&publication_year=2012&pages=34-43&issue=1&author=S.+M%C3%BCllerauthor=J.+Dennem%C3%A4rkerauthor=T.+Reinheckel&title=Specific+Functions+of+Lysosomal+Proteases+in+Endocytic+and+Autophagic+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Specific functions of lysosomal proteases in endocytic and autophagic pathways</span></div><div class="casAuthors">Mueller, Sabrina; Dennemaerker, Julia; Reinheckel, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">1824</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">34-43</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">A review.  Endolysosomal vesicles form a highly dynamic multifunctional cellular compartment that contains multiple highly potent proteolytic enzymes.  Originally these proteases have been assigned to cooperate solely in executing the unselective 'bulk proteolysis' within the acidic milieu of the lysosome.  Although to some degree this notion still holds true, evidence is accumulating for specific and regulatory functions of individual 'acidic' proteases in many cellular processes linked to the endosomal/lysosomal compartment.  Here we summarize and discuss the functions of individual endolysosomal proteases in such diverse processes as the termination of growth factor signaling, lipoprotein particle degrdn., infection, antigen presentation, and autophagy.  This article is part of a Special Issue entitled: Proteolysis 50 years after the discovery of lysosome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCzZ1LeFcrGbVg90H21EOLACvtfcHk0licbl2QLxoLkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFOns7rM&md5=fcb49bcadddced25d1d0aef37f266d9e</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2011.07.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2011.07.003%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DDennem%25C3%25A4rker%26aufirst%3DJ.%26aulast%3DReinheckel%26aufirst%3DT.%26atitle%3DSpecific%2520Functions%2520of%2520Lysosomal%2520Proteases%2520in%2520Endocytic%2520and%2520Autophagic%2520Pathways%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2012%26volume%3D1824%26issue%3D1%26spage%3D34%26epage%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Steinfeld, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinhardt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiber, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hillebrand, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraetzner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brück, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gärtner, J.</span><span> </span><span class="NLM_article-title">Cathepsin D Deficiency Is Associated with a Human Neurodegenerative Disorder</span> <span class="citation_source-journal">Am. J. Hum. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">998</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1086%2F504159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16685649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD28XltVyks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=988-998&author=R.+Steinfeldauthor=K.+Reinhardtauthor=K.+Schreiberauthor=M.+Hillebrandauthor=R.+Kraetznerauthor=W.+Br%C3%BCckauthor=P.+Saftigauthor=J.+G%C3%A4rtner&title=Cathepsin+D+Deficiency+Is+Associated+with+a+Human+Neurodegenerative+Disorder"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Cathepsin D deficiency is associated with a human neurodegenerative disorder</span></div><div class="casAuthors">Steinfeld, Robert; Reinhardt, Konstanze; Schreiber, Kathrin; Hillebrand, Merle; Kraetzner, Ralph; Brueck, Wolfgang; Saftig, Paul; Gaertner, Jutta</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">988-998</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">Cathepsin D is a ubiquitously expressed lysosomal protease that is involved in proteolytic degrdn., cell invasion, and apoptosis.  In mice and sheep, cathepsin D deficiency is known to cause a fatal neurodegenerative disease.  Here, we report a novel disorder in a child with early blindness and progressive psychomotor disability.  Two missense mutations in the CTSD gene, F229I and W383C, were identified and were found to cause markedly reduced proteolytic activity and a diminished amt. of cathepsin D in patient fibroblasts.  Expression of cathepsin D mutants in cathepsin D-/- mouse fibroblasts revealed disturbed posttranslational processing and intracellular targeting for W383C and diminished maximal enzyme velocity for F229I.  The structural effects of cathepsin D mutants were estd. by computer modeling, which suggested larger structural alterations for W383C than for F229I.  Our studies broaden the group of human neurodegenerative disorders and add new insight into the cellular functions of human cathepsin D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohf0ApK0eyVLVg90H21EOLACvtfcHk0licbl2QLxoLkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltVyks78%253D&md5=96a9bf74f1823244552ed50391eb5278</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1086%2F504159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F504159%26sid%3Dliteratum%253Aachs%26aulast%3DSteinfeld%26aufirst%3DR.%26aulast%3DReinhardt%26aufirst%3DK.%26aulast%3DSchreiber%26aufirst%3DK.%26aulast%3DHillebrand%26aufirst%3DM.%26aulast%3DKraetzner%26aufirst%3DR.%26aulast%3DBr%25C3%25BCck%26aufirst%3DW.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DG%25C3%25A4rtner%26aufirst%3DJ.%26atitle%3DCathepsin%2520D%2520Deficiency%2520Is%2520Associated%2520with%2520a%2520Human%2520Neurodegenerative%2520Disorder%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2006%26volume%3D78%26spage%3D988%26epage%3D998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamura, Y.; Suzuki, S.; Tada, Y.; Yonezawa, S.; Fujikoshi, C.; Matsumoto, S.; Kooriyama, Y.; Ueno, T.</span><span> </span><span class="NLM_article-title">Aminodihydrothiazine Derivatives Substituted with a Cyclic Group</span>. U.S. Patent Application 2010/0075957 A1, March 25,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=Y.+Tamura&author=S.+Suzuki&author=Y.+Tada&author=S.+Yonezawa&author=C.+Fujikoshi&author=S.+Matsumoto&author=Y.+Kooriyama&author=T.+Ueno&title=Aminodihydrothiazine+Derivatives+Substituted+with+a+Cyclic+Group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26atitle%3DAminodihydrothiazine%2520Derivatives%2520Substituted%2520with%2520a%2520Cyclic%2520Group%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H. J.</span><span> </span><span class="NLM_article-title">The Evolution of Amidine-Based Brain Penetrant BACE1 Inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">2033</span><span class="NLM_x">–</span> <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.bmcl.2014.03.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=24704031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2033-45&author=D.+Oehlrichauthor=H.+Prokopcovaauthor=H.+J.+Gijsen&title=The+Evolution+of+Amidine-Based+Brain+Penetrant+BACE1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of amidine-based brain penetrant BACE1 inhibitors</span></div><div class="casAuthors">Oehlrich, Daniel; Prokopcova, Hana; Gijsen, Harrie J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2033-2045</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Beta site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors hold great potential as disease modifying anti-Alzheimer's drugs.  This digest provides an overview of the amidine contg. class of BACE1 inhibitors, of which multiple examples are now progressing through clin. trials.  The various structural modifications highlight the struggle to combine potency with the optimal properties for a brain penetrant BACE1 inhibitor, and illustrate the crowded competitive landscape.  This overview concludes with a summary of potential issues including substrate and target selectivity and a synopsis of the status of the current and past clin. assets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-4h1WxzUvbbVg90H21EOLACvtfcHk0licbl2QLxoLkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSqsrY%253D&md5=a929f7f1be0c7d2ff1a10fc5853de06b</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.03.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.03.025%26sid%3Dliteratum%253Aachs%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DGijsen%26aufirst%3DH.%2BJ.%26atitle%3DThe%2520Evolution%2520of%2520Amidine-Based%2520Brain%2520Penetrant%2520BACE1%2520Inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2033%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-95&author=S.+A.+Hitchcock&title=Structural+Modifications+that+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520that%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving Beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">49</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-49&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+Beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0ljIdv3SDpBytQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520Beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16bR"><div class="casContent"><span class="casTitleNuber">16b</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljIdv3SDpBytQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">A similar fragment was identified by the authors of ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">12</a> that lacked the fluoro groups on the aryl group.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Hori, A.; Kato, T.</span> U.S. Patent Application, US 08637504 B2,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hori%2C+A.%3B+Kato%2C+T.+U.S.+Patent+Application%2C+US+08637504+B2%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHori%26aufirst%3DA.%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Robak, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbage, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Synthesis and Applications of <i>tert</i>-Butanesulfinamide</span> <span class="citation_source-journal">Chem. Rev. (Washington, DC, U.S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">3600</span><span class="NLM_x">–</span> <span class="NLM_lpage">3740</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr900382t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2010&pages=3600-3740&author=M.+T.+Robakauthor=M.+A.+Herbageauthor=J.+A.+Ellman&title=Synthesis+and+Applications+of+tert-Butanesulfinamide"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Applications of tert-Butanesulfinamide</span></div><div class="casAuthors">Robak, MaryAnn T.; Herbage, Melissa A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">3600-3740</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Over the past decade, an ever increasing collection of methods based upon the chiral amine reagent tert-butanesulfinamide (I) have become some of the most extensively used synthetic approaches for both the discovery and prodn. of drug candidates.  Either enantiomer of I is inexpensive to prep. on a large scale in enantiomerically pure form.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsVMjLa-pP7Vg90H21EOLACvtfcHk0ljIdv3SDpBytQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltFChsbs%253D&md5=ad2c9e9a2b2044f47a00be408d0907d2</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fcr900382t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr900382t%26sid%3Dliteratum%253Aachs%26aulast%3DRobak%26aufirst%3DM.%2BT.%26aulast%3DHerbage%26aufirst%3DM.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520and%2520Applications%2520of%2520tert-Butanesulfinamide%26jtitle%3DChem.%2520Rev.%2520%2528Washington%252C%2520DC%252C%2520U.S.%2529%26date%3D2010%26volume%3D110%26spage%3D3600%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Motoki, T.; Takeda, K.; Kita, Y.; Takaishi, M.; Suzuki, Y.; Ishida, T.</span><span> </span><span class="NLM_article-title">Novel Fused Aminodihydrothiazine Derivative</span>. U.S. Patent Application 2010/0093999 A1, April 15,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=T.+Motoki&author=K.+Takeda&author=Y.+Kita&author=M.+Takaishi&author=Y.+Suzuki&author=T.+Ishida&title=Novel+Fused+Aminodihydrothiazine+Derivative"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMotoki%26aufirst%3DT.%26atitle%3DNovel%2520Fused%2520Aminodihydrothiazine%2520Derivative%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ghosez, L.</span><span> </span><span class="NLM_article-title">α-Chloroenamines: New Reagents for Organic Synthesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">853</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=852-853&author=L.+Ghosez&title=%CE%B1-Chloroenamines%3A+New+Reagents+for+Organic+Synthesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhosez%26aufirst%3DL.%26atitle%3D%25CE%25B1-Chloroenamines%253A%2520New%2520Reagents%2520for%2520Organic%2520Synthesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1972%26volume%3D11%26spage%3D852%26epage%3D853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Castro-Pineiro, J. L.; Hall, A.; Madin, A.; Vo, N.-T.</span><span> </span><span class="NLM_article-title">Fused Aminodihydropyrimidone Derivatives</span>, WO2011009897A1, January 27,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+L.+Castro-Pineiro&author=A.+Hall&author=A.+Madin&author=N.-T.+Vo&title=Fused+Aminodihydropyrimidone+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCastro-Pineiro%26aufirst%3DJ.%2BL.%26atitle%3DFused%2520Aminodihydropyrimidone%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhu, H.</span><span> </span><span class="NLM_article-title">Water’s Role in Compound Design for Drug Discovery</span>. In  <span class="citation_source-book">UGM & Conference 2013 North America</span>;<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=H.+Zhu&title=UGM+%26+Conference+2013+North+America"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DWater%25E2%2580%2599s%2520Role%2520in%2520Compound%2520Design%2520for%2520Drug%2520Discovery%26btitle%3DUGM%2520%2526%2520Conference%25202013%2520North%2520America%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hashimura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiroya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogasawara, K.</span><span> </span><span class="NLM_article-title">A Stereocontrolled Route to Both Enantiomers of the Necine Base Dihydroxyheliotridane via Intramolecular 1,3-Dipolar Addition Using the Same Chiral Precursor</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=1995&pages=1&author=K.+Hashimuraauthor=S.+Tomitaauthor=K.+Hiroyaauthor=K.+Ogasawara&title=A+Stereocontrolled+Route+to+Both+Enantiomers+of+the+Necine+Base+Dihydroxyheliotridane+via+Intramolecular+1%2C3-Dipolar+Addition+Using+the+Same+Chiral+Precursor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimura%26aufirst%3DK.%26aulast%3DTomita%26aufirst%3DS.%26aulast%3DHiroya%26aufirst%3DK.%26aulast%3DOgasawara%26aufirst%3DK.%26atitle%3DA%2520Stereocontrolled%2520Route%2520to%2520Both%2520Enantiomers%2520of%2520the%2520Necine%2520Base%2520Dihydroxyheliotridane%2520via%2520Intramolecular%25201%252C3-Dipolar%2520Addition%2520Using%2520the%2520Same%2520Chiral%2520Precursor%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1995%26volume%3D229%26spage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Alam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wise, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleator, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walkinshaw, A.</span><span> </span><span class="NLM_article-title">Development of a Robust Procedure for the Copper-Catalyzed Ring-Opening of Epoxides with Grignard Reagents</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/op200329x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2012&pages=435-441&author=M.+Alamauthor=C.+Wiseauthor=C.+A.+Baxterauthor=E.+Cleatorauthor=A.+Walkinshaw&title=Development+of+a+Robust+Procedure+for+the+Copper-Catalyzed+Ring-Opening+of+Epoxides+with+Grignard+Reagents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=10.1021%2Fop200329x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop200329x%26sid%3Dliteratum%253Aachs%26aulast%3DAlam%26aufirst%3DM.%26aulast%3DWise%26aufirst%3DC.%26aulast%3DBaxter%26aufirst%3DC.%2BA.%26aulast%3DCleator%26aufirst%3DE.%26aulast%3DWalkinshaw%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520a%2520Robust%2520Procedure%2520for%2520the%2520Copper-Catalyzed%2520Ring-Opening%2520of%2520Epoxides%2520with%2520Grignard%2520Reagents%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2012%26volume%3D16%26spage%3D435%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Tahtaoui, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demailly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joyeux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span> </span><span class="NLM_article-title">Enantioselective Synthesis of Iclaprim Enantiomers—A Versatile Approach to 2-Substituted Chiral Chromenes</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">3781</span><span class="NLM_x">–</span> <span class="NLM_lpage">3785</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo100566c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=3781-3785&author=C.+Tahtaouiauthor=A.+Demaillyauthor=C.+Guidemannauthor=C.+Joyeuxauthor=P.+Schneider&title=Enantioselective+Synthesis+of+Iclaprim+Enantiomers%E2%80%94A+Versatile+Approach+to+2-Substituted+Chiral+Chromenes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo100566c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo100566c%26sid%3Dliteratum%253Aachs%26aulast%3DTahtaoui%26aufirst%3DC.%26aulast%3DDemailly%26aufirst%3DA.%26aulast%3DGuidemann%26aufirst%3DC.%26aulast%3DJoyeux%26aufirst%3DC.%26aulast%3DSchneider%26aufirst%3DP.%26atitle%3DEnantioselective%2520Synthesis%2520of%2520Iclaprim%2520Enantiomers%25E2%2580%2594A%2520Versatile%2520Approach%2520to%25202-Substituted%2520Chiral%2520Chromenes%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D3781%26epage%3D3785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal Fluid Amyloid-β (Aβ) as an Effect Biomarker for Brain Aβ Lowering Verified by Quantitative Preclinical Analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+Fluid+Amyloid-%CE%B2+%28A%CE%B2%29+as+an+Effect+Biomarker+for+Brain+A%CE%B2+Lowering+Verified+by+Quantitative+Preclinical+Analyses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0lgGILkmMY_Uug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520Fluid%2520Amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520Effect%2520Biomarker%2520for%2520Brain%2520A%25CE%25B2%2520Lowering%2520Verified%2520by%2520Quantitative%2520Preclinical%2520Analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Svoboda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, R.</span><span> </span><span class="NLM_article-title">Principles of Two-Photon Excitation Microscopy and Its Applications to Neuroscience</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">839</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2Fj.neuron.2006.05.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16772166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVOjsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=823-839&author=K.+Svobodaauthor=R.+Yasuda&title=Principles+of+Two-Photon+Excitation+Microscopy+and+Its+Applications+to+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of two-photon excitation microscopy and its applications to neuroscience</span></div><div class="casAuthors">Svoboda, Karel; Yasuda, Ryohei</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">823-839</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review primer.  The brain is complex and dynamic.  The spatial scales of interest to the neurobiologist range from individual synapses (∼1 μm) to neural circuits (centimeters); the timescales range from the flickering of channels (less than a millisecond) to long-term memory (years).  Remarkably, fluorescence microscopy has the potential to revolutionize research on all of these spatial and temporal scales.  Two-photon excitation (2PE) laser scanning microscopy allows high-resoln. and high-sensitivity fluorescence microscopy in intact neural tissue, which is hostile to traditional forms of microscopy.  Over the last 10 years, applications of 2PE, including microscopy and photostimulation, have contributed to our understanding of a broad array of neurobiol. phenomena, including the dynamics of single channels in individual synapses and the functional organization of cortical maps.  Here the authors review the principles of 2PE microscopy, highlight recent applications, discuss its limitations, and point to areas for future research and development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_MGbYYiaBoLVg90H21EOLACvtfcHk0ljsPCIeJa1MXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVOjsrg%253D&md5=43c606403089b29de172f9be5c6298af</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2006.05.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2006.05.019%26sid%3Dliteratum%253Aachs%26aulast%3DSvoboda%26aufirst%3DK.%26aulast%3DYasuda%26aufirst%3DR.%26atitle%3DPrinciples%2520of%2520Two-Photon%2520Excitation%2520Microscopy%2520and%2520Its%2520Applications%2520to%2520Neuroscience%26jtitle%3DNeuron%26date%3D2006%26volume%3D50%26spage%3D823%26epage%3D839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, W.-B.</span><span> </span><span class="NLM_article-title">Two-Photon Imaging of Dendritic Spine Development in the Mouse Cortex</span> <span class="citation_source-journal">Dev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fdneu.20630" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=18383548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD1c3mt1emsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2008&pages=771-778&author=F.+Panauthor=W.-B.+Gan&title=Two-Photon+Imaging+of+Dendritic+Spine+Development+in+the+Mouse+Cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Two-photon imaging of dendritic spine development in the mouse cortex</span></div><div class="casAuthors">Pan Feng; Gan Wen-Biao</div><div class="citationInfo"><span class="NLM_cas:title">Developmental neurobiology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">771-8</span>
        ISSN:<span class="NLM_cas:issn">1932-8451</span>.
    </div><div class="casAbstract">Dendritic spines are the postsynaptic sites of most excitatory synapses in the mammalian brain.  With the advent of two-photon microscopy and transgenic mice expressing fluorescent proteins, dendritic spines can now be imaged in the living cerebral cortex over time scales ranging from seconds to years.  Recent studies with this in vivo imaging approach have begun to provide important insights into the development and plasticity of dendritic spines in the intact brain.  Here, we review these studies and discuss technical requirements for image acquisition.  We envision that intravital two-photon imaging at the level of individual synapses will greatly expand our current understandings of how neuronal networks are assembled and modified throughout life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT_buowwtywSjEC-75aqa5AfW6udTcc2ea4egJJawV9bLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c3mt1emsg%253D%253D&md5=b9e465bc8870083849e02a21968020cb</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1002%2Fdneu.20630&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdneu.20630%26sid%3Dliteratum%253Aachs%26aulast%3DPan%26aufirst%3DF.%26aulast%3DGan%26aufirst%3DW.-B.%26atitle%3DTwo-Photon%2520Imaging%2520of%2520Dendritic%2520Spine%2520Development%2520in%2520the%2520Mouse%2520Cortex%26jtitle%3DDev.%2520Neurobiol.%26date%3D2008%26volume%3D68%26spage%3D771%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svanhagen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briem, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appelkvist, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, A.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">AZ-4217: A High Potency BACE Inhibitor Displaying Acute Central Efficacy in Different In Vivo Models and Reduced Amyloid Deposition in Tg2576 Mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">10075</span><span class="NLM_x">–</span> <span class="NLM_lpage">10084</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.1165-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=23761903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BC3sjhsFKqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=10075-10084&author=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=F.+Jeppssonauthor=A.+Svanhagenauthor=K.+Kolmodinauthor=S.+Gustavssonauthor=A.-C.+Rades%C3%A4terauthor=K.+Elisonauthor=S.+Briemauthor=P.+Appelkvistauthor=C.+Nivaauthor=A.-L.+Bergauthor=S.+Karlstr%C3%B6mauthor=B.-M.+Swahnauthor=J.+F%C3%A4lting&title=AZ-4217%3A+A+High+Potency+BACE+Inhibitor+Displaying+Acute+Central+Efficacy+in+Different+In+Vivo+Models+and+Reduced+Amyloid+Deposition+in+Tg2576+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29aR"><div class="casContent"><span class="casTitleNuber">29a</span><div class="casTitle"><span class="NLM_cas:atitle">AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice</span></div><div class="casAuthors">Eketjall Susanna; Janson Juliette; Jeppsson Fredrik; Svanhagen Alexander; Kolmodin Karin; Gustavsson Susanne; Radesater Ann-Cathrin; Eliason Kristina; Briem Sveinn; Appelkvist Paulina; Niva Camilla; Berg Anna-Lena; Karlstrom Sofia; Swahn Britt-Marie; Falting Johanna</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuroscience : the official journal of the Society for Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10075-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aβ, the product of APP (amyloid precursor protein), has been implicated in the pathophysiology of Alzheimer's disease (AD). β-Site APP cleaving enzyme1 (BACE1) is the enzyme initiating the processing of the APP to Aβ peptides.  Small molecule BACE1 inhibitors are expected to decrease Aβ-peptide generation and thereby reduce amyloid plaque formation in the brain, a neuropathological hallmark of AD.  BACE1 inhibition thus addresses a key mechanism in AD and its potential as a therapeutic target is currently being addressed in clinical studies.  Here, we report the discovery and the pharmacokinetic and pharmacodynamic properties of BACE1 inhibitor AZ-4217, a high potency compound (IC50 160 pM in human SH-SY5Y cells) with an excellent in vivo efficacy.  Central efficacy of BACE1 inhibition was observed after a single dose in C57BL/6 mice, guinea pigs, and in an APP transgenic mouse model of cerebral amyloidosis (Tg2576).  Furthermore, we demonstrate that in a 1 month treatment paradigm BACE1 inhibition of Aβ production does lower amyloid deposition in 12-month-old Tg2576 mice.  These results strongly support BACE1 inhibition as concretely impacting amyloid deposition and therefore potentially an important approach for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRv1jKuScfdJ8-crCu0nI_sfW6udTcc2ea4egJJawV9bLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjhsFKqtQ%253D%253D&md5=d5193ef6c633f7aee50c34954a5a440a</span></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1165-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1165-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DSvanhagen%26aufirst%3DA.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DElison%26aufirst%3DK.%26aulast%3DBriem%26aufirst%3DS.%26aulast%3DAppelkvist%26aufirst%3DP.%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DBerg%26aufirst%3DA.-L.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DAZ-4217%253A%2520A%2520High%2520Potency%2520BACE%2520Inhibitor%2520Displaying%2520Acute%2520Central%2520Efficacy%2520in%2520Different%2520In%2520Vivo%2520Models%2520and%2520Reduced%2520Amyloid%2520Deposition%2520in%2520Tg2576%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D10075%26epage%3D10084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanghe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohrmann, B.</span><span> </span><span class="NLM_article-title">Combined Treatment with a BACE Inhibitor and Anti-Aβ Antibody Gantenerumab Enhances Amyloid Reduction in APPLondon Mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">11621</span><span class="NLM_x">–</span> <span class="NLM_lpage">11630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.1405-14.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=25164658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVynsrvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=11621-11630&author=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Carusoauthor=R.+Narquizianauthor=H.+Hilpertauthor=B.+Jacobsenauthor=D.+Terwelauthor=A.+Tangheauthor=B.+Bohrmann&title=Combined+Treatment+with+a+BACE+Inhibitor+and+Anti-A%CE%B2+Antibody+Gantenerumab+Enhances+Amyloid+Reduction+in+APPLondon+Mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29bR"><div class="casContent"><span class="casTitleNuber">29b</span><div class="casTitle"><span class="NLM_cas:atitle">Combined treatment with a BACE inhibitor and anti-Aβ antibody gantenerumab enhances amyloid reduction in APPLondon mice</span></div><div class="casAuthors">Jacobsen, Helmut; Ozmen, Laurence; Caruso, Antonello; Narquizian, Robert; Hilpert, Hans; Jacobsen, Bjoern; Terwel, Dick; Tanghe, An; Bohrmann, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">11621-11630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Therapeutic approaches for prevention or redn. of amyloidosis are currently a main objective in basic and clin. research on Alzheimer's disease.  Among the agents explored in clin. trials are anti-Aβ peptide antibodies and secretase inhibitors.  Most anti-Aβ antibodies are considered to act via inhibition of amyloidosis and enhanced clearance of existing amyloid, although secretase inhibitors reduce the de novo prodn. of Aβ.  Limited information is currently available on the efficacy and potential advantages of combinatorial antiamyloid treatment.  We performed a chronic study in APPLondon transgenic mice that received treatment with anti-Aβ antibody gantenerumab and BACE inhibitor RO5508887, either as mono- or combination treatment.  Treatment aimed to evaluate efficacy on amyloid progression, similar to preexisting amyloidosis as present in Alzheimer's disease patients.  Mono-treatments with either compd. caused a dose-dependent redn. of total brain Aβ and amyloid burden.  Combination treatment with both compds. significantly enhanced the antiamyloid effect.  The obsd. combination effect was most pronounced for lowering of amyloid plaque load and plaque no., which suggests effective inhibition of de novo plaque formation.  Moreover, significantly enhanced clearance of pre-existing amyloid plaques was obsd. when gantenerumab was coadministered with RO5508887.  BACE inhibition led to a significant time- and dose-dependent decrease in CSF Aβ, which was not obsd. for gantenerumab treatment.  Our results demonstrate that combining these two antiamyloid agents enhances overall efficacy and suggests that combination treatments may be of clin. relevance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHGvFKC3OLarVg90H21EOLACvtfcHk0ljGan9IYr_F_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVynsrvI&md5=a431efea8d03f144cb369cf8c49687ee</span></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1405-14.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1405-14.2014%26sid%3Dliteratum%253Aachs%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DJacobsen%26aufirst%3DB.%26aulast%3DTerwel%26aufirst%3DD.%26aulast%3DTanghe%26aufirst%3DA.%26aulast%3DBohrmann%26aufirst%3DB.%26atitle%3DCombined%2520Treatment%2520with%2520a%2520BACE%2520Inhibitor%2520and%2520Anti-A%25CE%25B2%2520Antibody%2520Gantenerumab%2520Enhances%2520Amyloid%2520Reduction%2520in%2520APPLondon%2520Mice%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D11621%26epage%3D11630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Farah, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slusher, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, J. W.</span><span> </span><span class="NLM_article-title">Reduced BACE1 Activity Enhances Clearance of Myelin Debris and Regeneration of Axons in the Injured Peripheral Nervous System</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">5744</span><span class="NLM_x">–</span> <span class="NLM_lpage">5754</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1523%2FJNEUROSCI.6810-10.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21490216" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltFGgt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=5744-5754&author=M.+H.+Farahauthor=B.+H.+Panauthor=P.+N.+Hoffmanauthor=D.+Ferrarisauthor=T.+Tsukamotoauthor=T.+Nguyenauthor=P.+C.+Wongauthor=D.+L.+Priceauthor=B.+S.+Slusherauthor=J.+W.+Griffin&title=Reduced+BACE1+Activity+Enhances+Clearance+of+Myelin+Debris+and+Regeneration+of+Axons+in+the+Injured+Peripheral+Nervous+System"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Reduced BACE1 activity enhances clearance of myelin debris and regeneration of axons in the injured peripheral nervous system</span></div><div class="casAuthors">Farah, Mohamed H.; Pan, Bao Han; Hoffman, Paul N.; Ferraris, Dana; Tsukamoto, Takashi; Nguyen, Thien; Wong, Philip C.; Price, Donald L.; Slusher, Barbara S.; Griffin, John W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5744-5754</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1) is an aspartyl protease best known for its role in generating the amyloid-β peptides that are present in plaques of Alzheimer's disease.  BACE1 has been an attractive target for drug development.  In cultured embryonic neurons, BACE1-cleaved N-terminal APP is further processed to generate a fragment that can trigger axonal degeneration, suggesting a vital role for BACE1 in axonal health.  In addn., BACE1 cleaves neuregulin 1 type III, a protein crit. for myelination of peripheral axons by Schwann cells during development.  Here, we asked whether axonal degeneration or axonal regeneration in adult nerves might be affected by inhibition or elimination of BACE1.  We report that BACE1 knock-out and wild-type nerves degenerated at a similar rate after axotomy and to a similar extent in the exptl. neuropathies produced by administration of paclitaxel and acrylamide.  These data indicate N-APP is not the sole culprit in axonal degeneration in adult nerves.  Unexpectedly, however, we obsd. that BACE1 knock-out mice had markedly enhanced clearance of axonal and myelin debris from degenerated fibers, accelerated axonal regeneration, and earlier reinnervation of neuromuscular junctions, compared with littermate controls.  These observations were reproduced in part by pharmacol. inhibition of BACE1.  These data suggest BACE1 inhibition as a therapeutic approach to accelerate regeneration and recovery after peripheral nerve damage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzqY0Xcy71aLVg90H21EOLACvtfcHk0ljGan9IYr_F_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltFGgt7w%253D&md5=fa5ff12912d9fc83a16a1289805aecd2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.6810-10.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.6810-10.2011%26sid%3Dliteratum%253Aachs%26aulast%3DFarah%26aufirst%3DM.%2BH.%26aulast%3DPan%26aufirst%3DB.%2BH.%26aulast%3DHoffman%26aufirst%3DP.%2BN.%26aulast%3DFerraris%26aufirst%3DD.%26aulast%3DTsukamoto%26aufirst%3DT.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DSlusher%26aufirst%3DB.%2BS.%26aulast%3DGriffin%26aufirst%3DJ.%2BW.%26atitle%3DReduced%2520BACE1%2520Activity%2520Enhances%2520Clearance%2520of%2520Myelin%2520Debris%2520and%2520Regeneration%2520of%2520Axons%2520in%2520the%2520Injured%2520Peripheral%2520Nervous%2520System%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D5744%26epage%3D5754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">There does remain a possibilty that increases in dose or study duration could result in ocular toxicity, relative to the shorter study with <b>1</b> that implicated that accumulation of autofluoresent material in the RPE could be observed with 1 week of dosing. Thus, a 2-week assessment would be reasonable at this juncture.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Otsu, N. A.</span><span> </span><span class="NLM_article-title">Threshold Selection Method from Gray-Level Histograms</span> <span class="citation_source-journal">IEEE Transactions on Systems, Man and Cybernetics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">–</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1109%2FTSMC.1979.4310076" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1979&pages=62-66&author=N.+A.+Otsu&title=Threshold+Selection+Method+from+Gray-Level+Histograms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1109%2FTSMC.1979.4310076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1109%252FTSMC.1979.4310076%26sid%3Dliteratum%253Aachs%26aulast%3DOtsu%26aufirst%3DN.%2BA.%26atitle%3DThreshold%2520Selection%2520Method%2520from%2520Gray-Level%2520Histograms%26jtitle%3DIEEE%2520Transactions%2520on%2520Systems%252C%2520Man%2520and%2520Cybernetics%26date%3D1979%26volume%3D9%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Maintz, J. B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viergever, M. A.</span><span> </span><span class="NLM_article-title">A Survey of Medical Image Registration</span> <span class="citation_source-journal">Med. Image Anal.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">36</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1016%2FS1361-8415%2801%2980026-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=10638851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD3c7gt1eruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1998&pages=1-36&author=J.+B.+A.+Maintzauthor=M.+A.+Viergever&title=A+Survey+of+Medical+Image+Registration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A survey of medical image registration</span></div><div class="casAuthors">Maintz J B; Viergever M A</div><div class="citationInfo"><span class="NLM_cas:title">Medical image analysis</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-36</span>
        ISSN:<span class="NLM_cas:issn">1361-8415</span>.
    </div><div class="casAbstract">The purpose of this paper is to present a survey of recent (published in 1993 or later) publications concerning medical image registration techniques.  These publications will be classified according to a model based on nine salient criteria, the main dichotomy of which is extrinsic versus intrinsic methods.  The statistics of the classification show definite trends in the evolving registration techniques, which will be discussed.  At this moment, the bulk of interesting intrinsic methods is based on either segmented points or surfaces, or on techniques endeavouring to use the full information content of the images involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSyzhdlYh9sXx0LsK7uFuY7fW6udTcc2eanmyMUunkXsLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c7gt1eruw%253D%253D&md5=5f720162a2b93414fdb4d3e7dc6390f1</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS1361-8415%2801%2980026-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1361-8415%252801%252980026-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaintz%26aufirst%3DJ.%2BB.%2BA.%26aulast%3DViergever%26aufirst%3DM.%2BA.%26atitle%3DA%2520Survey%2520of%2520Medical%2520Image%2520Registration%26jtitle%3DMed.%2520Image%2520Anal.%26date%3D1998%26volume%3D2%26spage%3D1%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kalvass, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, T. S.</span><span> </span><span class="NLM_article-title">Influence of Nonspecific Brain and Plasma Binding on CNS Exposure: Implications for Rational Drug Discovery</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fbdd.325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=12415573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2002&pages=327&author=J.+C.+Kalvassauthor=T.+S.+Maurer&title=Influence+of+Nonspecific+Brain+and+Plasma+Binding+on+CNS+Exposure%3A+Implications+for+Rational+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery</span></div><div class="casAuthors">Kalvass, J. Cory; Maurer, Tristan S.</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">327-338</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Relative plasma, brain and cerebrospinal fluid (CSF) exposures and unbound fractions in plasma and brain were examd. for 18 proprietary compds. in rats.  The relation between in vivo brain-to-plasma ratio and in vitro plasma-to-brain unbound fraction (fu) was examd.  In addn., plasma fu and brain fu were examd. for their relation to in vivo CSF-to-plasma and CSF-to-brain ratios, resp.  Findings were delineated based on the presence or absence of active efflux.  Finally, the same comparisons were examd. in FVB vs. MDR 1a/1b knockout mice for a selected P-glycoprotein (Pgp) substrate.  For the nine compds. without indications of active efflux, predictive correlations were obsd. between ratios of brain-to-plasma exposure and plasma-to-brain fu (r2 = 0.98), CSF-to-brain exposure vs. brain fu (r2 = 0.72), and CSF-to-plasma exposure vs. plasma fu (r2 = 0.82).  For the nine compds. with indications of active efflux, nonspecific binding data tended to over predict the brain-to-plasma and CSF-to-plasma exposure ratios.  Interestingly, CSF-to-brain exposure ratio was consistently under predicted by brain fu for this set.  Using a select Pgp substrate, it was demonstrated that the brain-to-plasma exposure ratio was identical to that predicted by plasma-to-brain fu ratio in MDR 1a/1b knockout mice.  In FVB mice, plasma-to-brain fu over predicted brain-to-plasma exposure ratio to the same degree as the difference in brain-to-plasma exposure ratio between MDR 1a/1b and FVB mice.  Consistent results were obtained in rats, suggesting a similar kinetic behavior between species.  These data illustrate how an understanding of relative tissue binding (plasma, brain) can allow for a quant. examn. of active processes that det. CNS exposure.  The general applicability of this approach offers advantages over species- and mechanism-specific approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfFvLLvDQohLVg90H21EOLACvtfcHk0lha05Di73ITPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XpsVansbk%253D&md5=96b80d1a745b254f74b9c19e8e8af627</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1002%2Fbdd.325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.325%26sid%3Dliteratum%253Aachs%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DMaurer%26aufirst%3DT.%2BS.%26atitle%3DInfluence%2520of%2520Nonspecific%2520Brain%2520and%2520Plasma%2520Binding%2520on%2520CNS%2520Exposure%253A%2520Implications%2520for%2520Rational%2520Drug%2520Discovery%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2002%26volume%3D23%26spage%3D327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paddock, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mildner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lull, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cialdella, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prince, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinrikson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">High Yield Expression of Human BACE Constructs in <i>Eschericia coli</i> for Refolding, Purification, and High Resolution Diffracting Crystal Forms</span> <span class="citation_source-journal">Protein Pept. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.2174%2F092986608783489553" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=18289105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35a&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=131&author=A.+G.+Tomasselliauthor=D.+J.+Paddockauthor=T.+L.+Emmonsauthor=A.+M.+Mildnerauthor=J.+W.+Leoneauthor=J.+M.+Lullauthor=J.+I.+Cialdellaauthor=D.+B.+Princeauthor=H.+D.+Fischerauthor=R.+L.+Heinriksonauthor=T.+E.+Benson&title=High+Yield+Expression+of+Human+BACE+Constructs+in+Eschericia+coli+for+Refolding%2C+Purification%2C+and+High+Resolution+Diffracting+Crystal+Forms"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35aR"><div class="casContent"><span class="casTitleNuber">35a</span><div class="casTitle"><span class="NLM_cas:atitle">High yield expression of human BACE constructs in Escherichia coli for refolding, purification, and high resolution diffracting crystal forms</span></div><div class="casAuthors">Tomasselli, A. G.; Paddock, D. J.; Emmons, T. L.; Mildner, A. M.; Leone, J. W.; Lull, J. M.; Cialdella, J. I.; Prince, D. B.; Fischer, H. D.; Heinrikson, R. L.; Benson, T. E.</div><div class="citationInfo"><span class="NLM_cas:title">Protein & Peptide Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-143</span>CODEN:
                <span class="NLM_cas:coden">PPELEN</span>;
        ISSN:<span class="NLM_cas:issn">0929-8665</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">BACE (β-site APP cleaving enzyme) or β-secretase, the enzyme responsible for processing APP to give the N-terminal portion of the Aβ peptide, is a membrane bound aspartyl protease consisting of an ectodomain catalytic unit, a C-terminal transmembrane segment and a cytoplasmic domain.  Three BACE constructs, pET11a-BACE, pQE80L-BACE, and pQE70-BACE were designed to terminate at a position just before the transmembrane domain (Ser432) and are described schematically below.  (1) PET11a-T7.Tag-G-S-M-(A-8GV......QTDES432),.  (2) PQE80L-Met-R-G-S-(His)6-G-S-I-E-T-D-(T1QH...QTDES432), and.  (3) PQE70-Met-BACE (R36GSFVEMG....PQTDES432(His)6).  Each construct was over-expressed in Escherichia coli as inclusion bodies.  The inclusion body proteins were solubilized in urea and refolded by diln. in water to yield active enzyme.  Maximal activity for pET11a-BACE and pQE80L-BACE was usually reached at day 3 to 4, while construct pQE70-BACE required about 21 days.  Active BACE was purified to homogeneity by anion-exchange chromatog. and affinity chromatog. over a column of immobilized peptide inhibitor.  The process, easily scalable to 60 L of cell culture, yielded in excess of 400 mg of active enzyme for crystallog. anal.  Highly purified pET11a-BACE and pQE70-BACE formed complexes with various inhibitors, the latter protein giving crystals diffracting up to 1.45 Å resoln.  In addn., a crystal form that does not require the presence of an inhibitor has been obtained for pQE70-BACE.  This ligand-free crystal form has proven useful for the prepn. of BACE-inhibitor complexes in soaking expts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEJA1PQtQJMrVg90H21EOLACvtfcHk0lhxQ5iwJw0xuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVarurY%253D&md5=b4b34ea8ea98fe464c924be9e583238d</span></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=10.2174%2F092986608783489553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986608783489553%26sid%3Dliteratum%253Aachs%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DPaddock%26aufirst%3DD.%2BJ.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DMildner%26aufirst%3DA.%2BM.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DLull%26aufirst%3DJ.%2BM.%26aulast%3DCialdella%26aufirst%3DJ.%2BI.%26aulast%3DPrince%26aufirst%3DD.%2BB.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DHeinrikson%26aufirst%3DR.%2BL.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DHigh%2520Yield%2520Expression%2520of%2520Human%2520BACE%2520Constructs%2520in%2520Eschericia%2520coli%2520for%2520Refolding%252C%2520Purification%252C%2520and%2520High%2520Resolution%2520Diffracting%2520Crystal%2520Forms%26jtitle%3DProtein%2520Pept.%2520Lett.%26date%3D2008%26volume%3D15%26spage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vuillard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yon, J.</span><span> </span><span class="NLM_article-title">Apo and Inhibitor Complex Structures of BACE (beta-Secretase)</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">343</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">416</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=343&publication_year=2004&pages=407-416&author=S.+Patelauthor=L.+Vuillardauthor=A.+Cleasbyauthor=C.+W.+Murrayauthor=J.+Yon&title=Apo+and+Inhibitor+Complex+Structures+of+BACE+%28beta-Secretase%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DVuillard%26aufirst%3DL.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DYon%26aufirst%3DJ.%26atitle%3DApo%2520and%2520Inhibitor%2520Complex%2520Structures%2520of%2520BACE%2520%2528beta-Secretase%2529%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2004%26volume%3D343%26spage%3D407%26epage%3D416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Vonrhein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flensburg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smart, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paciorek, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Womack, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bricogne, G.</span><span> </span><span class="NLM_article-title">Data Processing and Analysis with the <i>AutoPROC</i> Tool Box</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444911007773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=21460447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=293-302&author=C.+Vonrheinauthor=C.+Flensburgauthor=P.+Kellerauthor=A.+Sharffauthor=O.+Smartauthor=W.+Paciorekauthor=T.+Womackauthor=G.+Bricogne&title=Data+Processing+and+Analysis+with+the+AutoPROC+Tool+Box"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Data processing and analysis with the autoPROC toolbox</span></div><div class="casAuthors">Vonrhein, Clemens; Flensburg, Claus; Keller, Peter; Sharff, Andrew; Smart, Oliver; Paciorek, Wlodek; Womack, Thomas; Bricogne, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-302</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A typical diffraction expt. will generate many images and data sets from different crystals in a very short time.  This creates a challenge for the high-throughput operation of modern synchrotron beamlines as well as for the subsequent data processing.  Novice users in particular may feel overwhelmed by the tables, plots and nos. that the different data-processing programs and software packages present to them.  Here, some of the more common problems that a user has to deal with when processing a set of images that will finally make up a processed data set are shown, concg. on difficulties that may often show up during the first steps along the path of turning the expt. (i.e. data collection) into a model (i.e. interpreted electron d.).  Difficulties such as unexpected crystal forms, issues in crystal handling and suboptimal choices of data-collection strategies can often be dealt with, or at least diagnosed, by analyzing specific data characteristics during processing.  In the end, one wants to distinguish problems over which one has no immediate control once the expt. is finished from problems that can be remedied a posteriori.  A new software package, autoPROC, is also presented that combines third-party processing programs with new tools and an automated workflow script that is intended to provide users with both guidance and insight into the offline processing of data affected by the difficulties mentioned above, with particular emphasis on the automated treatment of multi-sweep data sets collected on multi-axis goniostats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmah7iUrMLXLVg90H21EOLACvtfcHk0lhxQ5iwJw0xuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLs%253D&md5=a0a3579f6b371b6312819883864aa80d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1107%2FS0907444911007773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911007773%26sid%3Dliteratum%253Aachs%26aulast%3DVonrhein%26aufirst%3DC.%26aulast%3DFlensburg%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DP.%26aulast%3DSharff%26aufirst%3DA.%26aulast%3DSmart%26aufirst%3DO.%26aulast%3DPaciorek%26aufirst%3DW.%26aulast%3DWomack%26aufirst%3DT.%26aulast%3DBricogne%26aufirst%3DG.%26atitle%3DData%2520Processing%2520and%2520Analysis%2520with%2520the%2520AutoPROC%2520Tool%2520Box%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D2011%26volume%3D67%26spage%3D293%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0litFfTAEyGsIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">French, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K.</span><span> </span><span class="NLM_article-title">On The Treatment of Negative Intensity Observations</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">A34</span><span class="NLM_x">, </span> <span class="NLM_fpage">517</span><span class="NLM_x">–</span> <span class="NLM_lpage">525</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=A34&publication_year=1978&pages=517-525&author=S.+Frenchauthor=K.+Wilson&title=On+The+Treatment+of+Negative+Intensity+Observations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFrench%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DK.%26atitle%3DOn%2520The%2520Treatment%2520of%2520Negative%2520Intensity%2520Observations%26jtitle%3DActa%2520Crystallogr.%26date%3D1978%26volume%3DA34%26spage%3D517%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span> Collaborative Computational Project, Number 4. The <i>CCP4</i> Suite: Programs for Protein Crystallography.  <span class="citation_source-journal">Acta Crystallogr., Sect. D</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">760</span><span class="NLM_x">–</span> <span class="NLM_lpage">763</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1107%2FS0907444994003112" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=15299374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Collaborative+Computational+Project%2C+Number+4.+The+CCP4+Suite%3A+Programs+for+Protein+Crystallography.+Acta+Crystallogr.%2C+Sect.+D+1994%2C+50%2C+760%E2%80%93763."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">The CCP4 suite: programs for protein crystallography</span></div><div class="casAuthors">Anonymous</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">Pt 5</span>),
    <span class="NLM_cas:pages">760-3</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The CCP4 (Collaborative Computational Project, number 4) program suite is a collection of programs and associated data and subroutine libraries which can be used for macromolecular structure determination by X-ray crystallography.  The suite is designed to be flexible, allowing users a number of methods of achieving their aims and so there may be more than one program to cover each function.  The programs are written mainly in standard Fortran77.  They are from a wide variety of sources but are connected by standard data file formats.  The package has been ported to all the major platforms under both Unix and VMS.  The suite is distributed by anonymous ftp from Daresbury Laboratory and is widely used throughout the world.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1Q-skJYIZ2IYPsCkJIw00fW6udTcc2eYJmPEvGBEJ37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czpsV2gug%253D%253D&md5=92b759927d6071ea3f20c08b78ad1eb2</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1107%2FS0907444994003112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444994003112%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%26date%3D1994%26volume%3D50%26spage%3D760%26epage%3D763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</span> <span class="citation_source-journal">Acta Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Likelihood+Method"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Likelihood%2520Method%26jtitle%3DActa%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> <span class="citation_source-book">BUSTER</span>; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><i>Maestro</i>, 9.7; <span class="NLM_publisher-name">Schrodinger</span>: <span class="NLM_publisher-loc">New York, NY</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro%2C+9.7%3B+Schrodinger%3A+New+York%2C+NY%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26pub%3DSchrodinger%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42a"><span><span class="NLM_label">(a) </span> <span class="citation_source-book">Desmond Molecular Dynamics System</span>, 3.7; <span class="NLM_publisher-name">D. E. Shaw Research</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Desmond+Molecular+Dynamics+System%2C+3.7%3B+D.+E.+Shaw+Research%3A+New+York%2C+2014%3B+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DDesmond%2520Molecular%2520Dynamics%2520System%26pub%3DD.%2520E.%2520Shaw%2520Research%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit42b"><span><span class="NLM_label">(b) </span> <span class="citation_source-book">Maestro-Desmond Interoperability Tools</span>, 3.7; <span class="NLM_publisher-name">Schrodinger</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maestro-Desmond+Interoperability+Tools%2C+3.7%3B+Schrodinger%3A+New+York%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DMaestro-Desmond%2520Interoperability%2520Tools%26pub%3DSchrodinger%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Banks, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beard, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Felts, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halgren, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mainz, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maple, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philipp, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repasky, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levy, R. M.</span><span> </span><span class="NLM_article-title">Integrated Modeling Program, Applied Chemical Theory (IMPACT)</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">1752</span><span class="NLM_x">–</span> <span class="NLM_lpage">1780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1002%2Fjcc.20292" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm501833t&amp;key=16211539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=1752-1780&author=J.+L.+Banksauthor=H.+S.+Beardauthor=Y.+Caoauthor=A.+E.+Choauthor=W.+Dammauthor=R.+Faridauthor=A.+K.+Feltsauthor=T.+A.+Halgrenauthor=D.+T.+Mainzauthor=J.+R.+Mapleauthor=R.+Murphyauthor=D.+M.+Philippauthor=M.+P.+Repaskyauthor=L.+Y.+Zhangauthor=B.+J.+Berneauthor=R.+A.+Friesnerauthor=E.+Gallicchioauthor=R.+M.+Levy&title=Integrated+Modeling+Program%2C+Applied+Chemical+Theory+%28IMPACT%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Integrated modeling program, applied chemical theory (IMPACT)</span></div><div class="casAuthors">Banks, Jay L.; Beard, Hege S.; Cao, Yixiang; Cho, Art E.; Damm, Wolfgang; Farid, Ramy; Felts, Anthony K.; Halgren, Thomas A.; Mainz, Daniel T.; Maple, Jon R.; Murphy, Robert; Philipp, Dean M.; Repasky, Matthew P.; Zhang, Linda Y.; Berne, Bruce J.; Friesner, Richard A.; Gallicchio, Emilio; Levy, Ronald M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1752-1780</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  We provide an overview of the IMPACT mol. mechanics program with an emphasis on recent developments and a description of its current functionality.  With respect to core mol. mechanics technologies we include a status report for the fixed charge and polarizable force fields that can be used with the program and illustrate how the force fields, when used together with new atom typing and parameter assignment modules, have greatly expanded the coverage of org. compds. and medicinally relevant ligands.  As we discuss in this review, explicit solvent simulations have been used to guide our design of implicit solvent models based on the generalized Born framework and a novel nonpolar estimator that have recently been incorporated into the program.  With IMPACT it is possible to use several different advanced conformational sampling algorithms based on combining features of mol. dynamics and Monte Carlo simulations.  The program includes two specialized mol. mechanics modules: Glide, a high-throughput docking program, and QSite, a mixed quantum mechanics/mol. mechanics module.  These modules employ the IMPACT infrastructure as a starting point for the construction of the protein model and assignment of mol. mechanics parameters, but have then been developed to meet specialized objectives with respect to sampling and the energy function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZX2FzcGWGM7Vg90H21EOLACvtfcHk0ljiKsLLnDm-Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1SlsbbI&md5=0094f15727c7fb77a0fae16ccf8292f0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20292&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20292%26sid%3Dliteratum%253Aachs%26aulast%3DBanks%26aufirst%3DJ.%2BL.%26aulast%3DBeard%26aufirst%3DH.%2BS.%26aulast%3DCao%26aufirst%3DY.%26aulast%3DCho%26aufirst%3DA.%2BE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFarid%26aufirst%3DR.%26aulast%3DFelts%26aufirst%3DA.%2BK.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26aulast%3DMaple%26aufirst%3DJ.%2BR.%26aulast%3DMurphy%26aufirst%3DR.%26aulast%3DPhilipp%26aufirst%3DD.%2BM.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DL.%2BY.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DGallicchio%26aufirst%3DE.%26aulast%3DLevy%26aufirst%3DR.%2BM.%26atitle%3DIntegrated%2520Modeling%2520Program%252C%2520Applied%2520Chemical%2520Theory%2520%2528IMPACT%2529%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2005%26volume%3D26%26spage%3D1752%26epage%3D1780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Martyna, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuckerman, M.</span><span> </span><span class="NLM_article-title">Nosé–Hoover Chains: The Canonical Ensemble via Continuous Dynamics</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">2635</span><span class="NLM_x">–</span> <span class="NLM_lpage">2643</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1992&pages=2635-2643&author=G.+J.+Martynaauthor=M.+L.+Kleinauthor=M.+Tuckerman&title=Nos%C3%A9%E2%80%93Hoover+Chains%3A+The+Canonical+Ensemble+via+Continuous+Dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartyna%26aufirst%3DG.%2BJ.%26aulast%3DKlein%26aufirst%3DM.%2BL.%26aulast%3DTuckerman%26aufirst%3DM.%26atitle%3DNos%25C3%25A9%25E2%2580%2593Hoover%2520Chains%253A%2520The%2520Canonical%2520Ensemble%2520via%2520Continuous%2520Dynamics%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1992%26volume%3D97%26spage%3D2635%26epage%3D2643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Essmann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkowitz, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darden, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedersen, L. G.</span><span> </span><span class="NLM_article-title">A Smooth Particle Mesh Ewald Method</span> <span class="citation_source-journal">J. Chem. Phys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">8577</span><span class="NLM_x">–</span> <span class="NLM_lpage">8593</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm501833t&amp;key=10.1063%2F1.470117" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1995&pages=8577-8593&author=U.+Essmannauthor=L.+Pereraauthor=M.+L.+Berkowitzauthor=T.+Dardenauthor=H.+Leeauthor=L.+G.+Pedersen&title=A+Smooth+Particle+Mesh+Ewald+Method"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A smooth particle mesh Ewald method</span></div><div class="casAuthors">Essmann, Ulrich; Perera, Lalith; Berkowitz, Max L.; Darden, Tom; Lee, Hsing; Pedersen, Lee G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Physics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8577-93</span>CODEN:
                <span class="NLM_cas:coden">JCPSA6</span>;
        ISSN:<span class="NLM_cas:issn">0021-9606</span>.
    
            (<span class="NLM_cas:orgname">American Institute of Physics</span>)
        </div><div class="casAbstract">The previously developed particle mesh Ewald method is reformulated in terms of efficient B-spline interpolation of the structure factors.  This reformulation allows a natural extension of the method to potentials of the form 1/rp with p ≥ 1.  Furthermore, efficient calcn. of the virial tensor follows.  Use of B-splines in the place of Lagrange interpolation leads to analytic gradients as well as a significant improvement in the accuracy.  The authors demonstrate that arbitrary accuracy can be achieved, independent of system size N, at a cost that scales as N log(N).  For biomol. systems with many thousands of atoms and this method permits the use of Ewald summation at a computational cost comparable to that of a simple truncation method of 10 Å or less.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_Bp1XlSY32LVg90H21EOLACvtfcHk0ljiKsLLnDm-Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXptlehtrw%253D&md5=092a679dd3bee08da28df41e302383a7</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1063%2F1.470117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1063%252F1.470117%26sid%3Dliteratum%253Aachs%26aulast%3DEssmann%26aufirst%3DU.%26aulast%3DPerera%26aufirst%3DL.%26aulast%3DBerkowitz%26aufirst%3DM.%2BL.%26aulast%3DDarden%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DPedersen%26aufirst%3DL.%2BG.%26atitle%3DA%2520Smooth%2520Particle%2520Mesh%2520Ewald%2520Method%26jtitle%3DJ.%2520Chem.%2520Phys.%26date%3D1995%26volume%3D103%26spage%3D8577%26epage%3D8593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Humphreys, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friesner, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berne, B. J.</span><span> </span><span class="NLM_article-title">A Multiple-Time-Step Molecular Dynamics Algorithm for Macromolecules</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">6885</span><span class="NLM_x">–</span> <span class="NLM_lpage">6892</span></span><div class="citationLinks">[<a href="/doi/10.1021/j100078a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501833t&amp;key=1%3ACAS%3A528%3ADyaK2cXktlSnt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=1994&pages=6885-6892&author=D.+D.+Humphreysauthor=R.+A.+Friesnerauthor=B.+J.+Berne&title=A+Multiple-Time-Step+Molecular+Dynamics+Algorithm+for+Macromolecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A multiple-time-step molecular dynamics algorithm for macromolecules</span></div><div class="casAuthors">Humphreys, Darryl D.; Friesner, Richard A.; Berne, Bruce J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">6885-92</span>CODEN:
                <span class="NLM_cas:coden">JPCHAX</span>;
        ISSN:<span class="NLM_cas:issn">0022-3654</span>.
    </div><div class="casAbstract">The authors present a computationally efficient mol. dynamics algorithm designed to take advantage of the inherent sepn. of time scales in biomol. systems.  The algorithm is essentially a generalization of the previously introduced reversible ref. system propagation algorithm(r-RESPA) which employs a Trotter factorization of the Liouville propagator to generate numerical integration schemes for mol. dynamics applications.  The method is compared with the velocity Verlet integration algorithm in a mol. dynamics (MD) simulation of the protein crambin in vacuo.  The multiple-time-step algorithm is shown to be able to take a much larger time step for a comparable level of accuracy than that of the std. method, leading to a 4-5-fold redn. in the CPU time required to calc. the nonbonded forces.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEYrnII-bdbLVg90H21EOLACvtfcHk0ljiKsLLnDm-Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXktlSnt7Y%253D&md5=e489d1ccf68463d37e096c7f1bc758cd</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fj100078a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fj100078a035%26sid%3Dliteratum%253Aachs%26aulast%3DHumphreys%26aufirst%3DD.%2BD.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DBerne%26aufirst%3DB.%2BJ.%26atitle%3DA%2520Multiple-Time-Step%2520Molecular%2520Dynamics%2520Algorithm%2520for%2520Macromolecules%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1994%26volume%3D98%26spage%3D6885%26epage%3D6892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="note"><p class="first last">The preparation of intermediate <b>7</b> is described in detail in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1LYA','PDB','1LYA'); return false;">PDB: 1LYA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X2L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X2L','PDB','4X2L'); return false;">PDB: 4X2L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY1','PDB','4WY1'); return false;">PDB: 4WY1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY6','PDB','4WY6'); return false;">PDB: 4WY6</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i86"><a href="/doi/suppl/10.1021/jm501833t">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_48264"></div></div></div></div></div><hr /></hr><p class="last">Exposure data for in vivo mouse experiments, data collection and refinement statistics for crystal structures of BACE1 with <b>6</b>, <b>24b</b>, and <b>36</b>, and preparation of intermediate compound <b>7</b>.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501833t/suppl_file/jm501833t_si_001.pdf">jm501833t_si_001.pdf (1.35 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and structure factors for the following BACE cocrystal structures have been deposited with the RCSB: compound <b>6</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X2L">4X2L</a>), compound <b>24b</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY1">4WY1</a>), and compound <b>36</b> (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WY6">4WY6</a>). Single-Crystal X-ray Structural Data has been deposited with the CCDC: compound <b>13a</b> (CCDC ID: <a href="https://1052669" class="ext-link">1052669</a>), compound <b>36</b> (CCDC ID: <a href="https://1043880" class="ext-link">1043880</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501833t&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501833t%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-6%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501833t" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679908ab58c71243","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
